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Abstract
The exact role of neovascularization found in painful Achilles tendons is unknown. The 
amount of the neovascularization is thought to be related to the clinical severity. To 
investigate the quantification of neovascularization and its correlation with the clinical severity 
in the symptomatic Achilles tendon, a novel 3D power Doppler ultrasound scanning system I 
firstly developed to prospectively examine ten patients with twelve symptomatic Achilles 
tendons, as well as twenty asymptomatic Achilles tendons as a control group. The novel 3D 
evaluation system consisted of a scanning rig, a pixel analysis programme, and a 3D  
reconstruction software. By scanning the entire length of the Achilles tendon, the continuous 
slices of the transverse image of the tendon were acquired. The pixel analysis programmed 
then selected a representated frame with maximum vascular lumen from each slice over a 
normally scanning distance of 6 cm. All the frames were fed into the 3D reconstruction 
software for visualization and volume calculation. The volume of the neovascularity (VON) 
was then outputted. The mean volume of neovascularity (VON) in the whole Achilles 
tendon was calculated during the phase of the cardiac cycle displaying maximum and 
minimum vascularity. The mean VONs in the control group were found to be 0.41 mm3 
(maximum) and 0.02 mm3 (minimum), respectively. The mean VONs in patients with 
painful Achilles tendon were 380 mm3 (maximum) and 70.3 mm3 (minimum), respectively. 
The initial results showed that the novel 3D power Doppler ultrasound system could be used 
to measure the mean VON in controls and in patients with symptomatic Achilles tendinopathy. 
The results also demonstrated a significantly greater VON in the maximum phase compared 
to the minimum phase as well as in the patient group compared with that in the control group. 
The system was therefore capable of defining the degree of vascularity in the Achilles tendon. 
Furthermore, to investigate the correlation between the VON and clinical severity, forty
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tendons from 30 patients with chronic painful Achilles tendons were examined. VON was 
evaluated for each tendon. Visual analog scale pain (VAS) and the Victorian Institute of 
Sport Assessment-Achilles questionnaire (VISA-A) were used to assess the subjective 
severity of the Achilles tendinopathy. Of the 40 symptomatic tendons, neovascularization 
was registered in 97.5% (n = 39). The VON ranged from 0 mm3 to 618 mm3 with a mean 
VON of 111 mm3. The Spearman correlation coefficients between the VAS and the VON, 
VSIA-Aand VON were 0.326 (p = 0.04, power = 0.75, effect size = 0.39), -0.246 (p =
0.127, power = 0.89, effect size = 0.46), respectively. As conclusion, the VAS showed a 
positive correlation with VON, while no correlation was found between VISA-A score and 
VON. The VON can be used to interpret the level of the pain in Achilles tendinopathy.
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1. Introduction
Achilles tendon pathology is one of the more common conditions encountered by the foot 
and ankle surgeon. While it most frequently affects the athletic population, it can also lead to 
significant morbidity in the older and sedentary patient (Nicol et al. 2006; Tan and Chan 2008; 
Daftary and Adler 2009; Krahe and Beriet 2009). It has been recommended that the clinical 
syndrome, characterized by a combination of pain, localized tenderness, impaired 
performance and swelling, is labeled “Achilles tendinopathy” (Paavola et al. 2000).
The diagnosis of Achilles tendinopathy is mainly based on a careful history and detailed 
clinical examination (Longo et al. 2009). The natural history of symptomatic chronic Achilles 
tendinopathy and its relationship to future pain or tendon pathology is unknown (Ohberg and 
Alfredson 2002; Maganaris et al. 2008; Tan and Chan 2008). An increasing degree of 
degeneration with limited or no inflammation was present. The cause of pain in chronic 
Achilles tendinopathy is thought to be related to the presence of neovascularization 
(Richards et al. 2005; van Snellenberg et al. 2007). However, there are always some 
arguments about the correlation between the severity of symptoms and the 
neovascularization score. Some studies believed that the presence of neovascularization in 
the Achilles tendon was shown to correlate with pain in patients with chronic midportion 
Achilles tendinosis (Ohberg and Alfredson 2002; Alfredson et al. 2003; Ohberg and Alfredson 
2003; Alfredson and Ohberg 2005; Lind et al. 2006; Sengkerij et al. 2009). Though other 
evidence demonstrated that a negative correlation existed between the presence of 
intratendonous neovascularization and functional tests (Peers et al. 2003; Zanetti et al. 2003; 
Miquel et al. 2009).
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Diagnosis of Achilles tendon disorders is often done by imaging (Schepsis et al. 2002; Harris 
and Peduto 2006). Magnetic resonance imaging (MRI) is often employed to reliably indicate 
the potential for measuring tendon structural changes after an injury, disease, and altered 
loading(Shin et al. 2008). Some reports (Romaneehsen and Kreitner 2005; Gardin et al.
2006) interpreted the severity of pain and functional impairment was correlated to increased 
mean intratendinous signal in the painful tendon in all MR sequences. High resolution 
ultrasonography has been likely to be introduced in the observation of the Achilles 
tendinopathy in the last decade, providing high levels of accuracy and reproducibility in the 
hands of experienced examiners (Reiter et al. 2004). Additional advantages in the use of 
ultrasound is that it is readily available, noninvasive, and low cost (Astrom et al. 1996).
Recently power Doppler ultrasound (PDU) has been often applied in the evaluation of 
potential tendinopathy (Weinberg et al. 1998; Ohberg L 2001; Richards et al. 2001; 
Premkumar et al. 2002; Richards et al. 2009), especially in correlating the PDU findings with 
the clinical severity of the symptom (Breidahl et al. 1998; Reiter et al. 2004; Sengkerij et al. 
2009). The preferential use of PDU is because it shows more tendon microvascularity than 
colour Doppler ultrasound (CDU) in tendinopathy (Richards et al. 2005). Most of the previous 
work concluded there was a non-linear relationship between Achilles tendonopathy and the 
amount of microvascularity, but not between PDU and duration of symptoms (Fenwick et al. 
2002; Richards et al. 2005; Richards et al. 2008). In other words, the symptomatic Achilles 
tendin can exist with or without detectable neovascularization. There might be 
neovascularization in all Achilles tendinopathy; however, a report indicated that a flow slower 
than 4-6 mm/sec is not detectable on Doppler ultrasonography (Peers et al. 2003).
The clinical applications of vascular 3D ultrasound (3D US) imaging has been developed in 
the last decades and the assessment of flow in the kidney, placenta, prostate and carotid 
artery (Fenster and Downey 1996; Nelson and Pretorius 1998). The benefit of 3D US is that
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it is able to localize and visualize a functional abnormality relative to the underlying anatomy. 
In addition, a study (Katamay et al. 2009) presented a new method for measurement of the 
volumetric blood flow in absolute units in the ophthalmic artery by using an ordinary 3 - 1 2  
MHz linear ultrasound transducer.
A previous study in corpses showed that the quantitative assessment of intravascular volume 
and the vascular patterns of the human Achilles tendon may play an important role in the 
pathogenesis of Achilles tendon rupture (Stein et al. 2000).
A special 3D PDU analysis system was therefore devised to observe the vascular conditions 
in the symptomatic Achilles tendon, in order to acquire the overall neovascularization flow 
pattern. In addition, by knowing the quantification of neovascularity, the thesis also aims to 
correlate the neovascularization to the clinical severity in Achilles tendinopathy.
The presence of neovascularization in Achilles tendon is associated with the tendinopathy, 
the VON correlates with the clinical severity.
16
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2. Achilles Tendon Anatomy
A tendon is a tough bundle of fibrous connective tissue that usually connects muscle to bone 
and is capable of withstanding tension (Franchi et al. 2007). Tendons are similar to ligaments 
and fascia as they are all made of collagen. The difference is that ligaments join one bone to 
another bone, while fascia connects muscles to other muscles. Tendons and muscles work 
together and can only exert a pulling force (Jozsa et al. 1980).
2.1 Tendon Structure
2.1.1 Macrostructure
Tendons are anatomic structures interposed between muscles and bones transmitting the 
force created in the muscle to bone. Basically, each muscle has two tendons, proximal and 
distal. The point of union with a muscle is called a myotendinous junction (MTJ), and the 
point of union with a bone an osteotendinous junction (OTJ) as shown in Fig. 2.1. The 
attachment of the proximal tendon of a muscle to bone is called a muscle origin, and that of 
the distal tendon an insertion (Kannus 2000).
Healthy tendons are brilliant white in colour and fibro-elastic in texture, varying considerably 
in shape and in the way they are attached to bone ranging from wide and flat tendons to 
cylindrical, fanshaped, and ribbon-shaped tendons. The shape and properties of tendons are 
significantly related to the behaviour of the entire muscle-tendon complex (Kannus 2000; 
Magnusson et al. 2003; Franchi et al. 2007).
17
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Osteotendinous junction (OTJ)
Proximal enc Myotendinous junction (MTJ)
Biceps muscle
Distal end
Fig. 2.1 Tendons are anatomic structures interposed between muscles and bones 
transmitting the force created in the muscle to bone
There are five surrounding structures of the tendon: (1) the fibrous sheaths or retinacula, are 
the canals through which the tendons glide during their course; (2) the reflection pulleys, are 
the anatomic reinforcements of the fibrous sheaths located in places where there are curves 
along the course of the tendon; (3) the synovial sheaths, are access tunnels for tendons at 
bone surfaces or other anatomic structures that might cause friction; (4) the peritendinous 
sheets or paratenons, are alternative structures to reduce friction in some tendons without a 
true synovial sheath; (5) the tendon bursae, are the fifth extratendinous structure playing an 
important role in the reduction of friction (Kannus 2000).
2.1.2 Microstructure
The appreciable movement of a tendon may cause friction against the surrounding tissues, 
then the tendon is often surrounded by a connective tissue called paratenons (Franchi et al.
2007). The main components of the paratenons are type I and type III collagen fibrils and 
elastic fibrils (Kvist et al. 1985), also the paratenon is lined on its inner surface by synovial
18
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cells (Jozsa et al. 1990). Paratenon functions as an elastic sleeve, permitting free movement 
of the tendon against the surrounding tissues (Hess et al. 1989). Only some parts of a few 
tendons in the hands and feet are actually provided with the two-layer tendon sheaths, where 
a change of direction and increase in friction necessitate very efficient lubrication (Kannus 
2000).
Under the paratenon, the entire tendon is surrounded by a fine connective tissue sheath 
called epitenon (Fig. 2.2). The epitenon is a relatively dense fibrillar network of collagen with 
strands of 8 -  10 nm in thickness. This network contains longitudinal, oblique, as well as 
transversal fibrils. It shows little variation in density or fibril orientation. Occasionally, the fibrils 
of epitenon are fused with the superficially located tendon fibrils (Jozsa et al. 1991).
On the outer surface, the epitenon is contiguous with paratenon and on its inner surface with 
the endotenon, which is a thin reticular network of connective tissue inside the tendon that 
has a well developed crisscross pattern of collagen fibrils (Rowe 1985). The endotenon 
invests each tendon fibre and binds individual fibres, primary, secondary, and tertiary fibre 
bundles, together (Jozsa et al. 1991).
1 -  Epitenon
2 — Endotenon
3 -  Tertiary fiber bundle
4 -  Secondary fiber bundle (fascicle)
5 -  Primary fiber bundle (subfascicle)
6 -  Collagen fiber
7 -  Collagen fibril
tC 4
Fig. 2.2 Microstructure of the tendon
(http://patientsites.com/media/img/21/ankle_anatomy_tendons01.jpg)
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A bunch of collagen fibres forms a primary bundle or subfascicle (15-400pm in diameter), 
and a group of primary bundles forms secondary fibre bundles or fascicles whose diameter 
range from 150 to 1000pm in human tendons. A group of secondary fibre bundles forms a 
tertiary bundle (diameter from 1000 to 3000pm in human tendons), which makes up the 
tendon surrounded by epitenon (Silver et al. 1992; Kannus 2000).
Inside each fibre bundle, collagen fibrils are arranged in parallel fibre bundles running 
longitudinally but also transversally and horizontally, with longitudinal fibrils also crossing 
each other, forming spirals and plaits (Chansky and lannotti 1991; Jozsa et al. 1991).
It is concluded that tendon is composed of collagen fibre bundles each of them resulting from 
the aggregation of single collagen fibrils, namely tens of millions of collagen fibrils, each 
hundreds of microns long (Canty and Kadler 2002). The collagen fibril is the basic unit of a 
tendon, and the collagen fibre is the smallest tendon unit visible using light microscopy and is 
aligned from end to end in a tendon. A fibre also represents the smallest collagenous 
structure that can be tested mechanically, although a larger fibre bundle makes the testing 
more reliable (O'Brien 1997).
2.1.3 Tendon and collagen
Tendon contains 86% collagen, 1-5%  proteoglycan, and 2% elastin as measured by dry 
weights, and water is responsible for 60-80%  of the total wet weight of the tendon (Lin et al. 
2004). The collagen portion is made up of 97-98% type I collagen, with small amounts of 
other types of collagen. These include type II collagen in the cartilaginous zones, type III 
collagen in the reticulin fibres of the vascular walls, type IX collagen, type IV collagen in the 
basement membranes of the capillaries, type V collagen in the vascular walls, and type X 
collagen in the mineralized fibrocartilage near the interface with the bone (Fukuta et al.
1998).
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The mechanical stability of the tendinous collagen is the most important factor for the 
mechanical strength of a tendon. The function of elastic fibres is not entirely clear, but they 
may contribute to the recovery of the wavy configuration of the collagen fibres after tendinous 
stretch (Butler et al. 1978).
2.1.4 Tendon cells
The tendon cells, called tenoblasts and tenocytes, comprise about 90% to 95% of the cellular 
elements of the tendon. The other 5% to 10% includes the chondrocytes found at the 
pressure and insertion sites, the synovial cells of the tendon sheath on the tendon surface, 
and the vascular cells, such as capillary endothelial cells and smooth muscle cells of the 
arterioles in the endotenon and epitenon (Kannus 2000). In pathological conditions, many 
other types of cells can be observed in the tendon tissue, such as inflammatory cells, 
macrophages, and myofibroblasts.
2.1.5 Junctions
The myotendinous junction (MTJ, Fig. 2.1) is a highly specialized anatomic region in the 
muscle-tendon unit. In this region, the tension generated by muscle fibres is transmitted from 
intracellular contractile proteins to extracellular connective tissue proteins (collagen fibrils) of 
the tendon (Trotter and Baca 1987).
Morphological studies show that at the MTJ, the collagen fibrils insert into deep recesses that 
are formed between the fingerlike processes (endings) of the muscle cells (Fig. 2.3) (Trotter 
et al. 1983). This type of folding of the basal membrane of the muscle cell endings markedly 
increases the contact area between the muscle fibres and tendon collagen fibres, by 10- to 
20-fold (Tidball 1991). This in turn can significantly reduce the force applied per surface unit 
of the MTJ during muscle contraction.
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B -  Bone 
T -  Tendon
TCF — Tendinous collagen fibrils 
P -  Muscle cell processus 
M — Muscle 
MC — Muscle cell
Fig. 2.3 The collagen fibrils insert into deep recesses that formed between the fingerlike
processes of the muscle cells at myotendinous junction
(http://www.medicalmultimediagroup.com/)
It is very likely that the various glycoproteins and glycosaminoglycans found at the MTJ have 
a joint function in helping to transmit the forces between the muscle-cell membrane and 
tendinous collagen fibrils. The high concentration of these polysaccharides in the 
myotendinous interface possibly increase the adhesive forces between the two structures 
(the glue effect) and therefore may be important in improving the elastic buffer capacity of the 
MTJ against loading. Chondroitin and dermatan sulfates especially may possess this 
adhesive function (Trotter et al. 1983).
Despite the membrane folding specific macromolecular composition, the MTJ is the weakest 
point in the muscle-tendon unit, making it susceptible to strain injuries (Nikolaou et al. 1987). 
Thus, this area is clinically very important and of special interest in tendon pathology.
The osteotendinous junction (OTJ) is a specialized region in the muscle-tendon unit where 
the tendon inserts into a bone (Fig. 2.1). In the OTJ, the viscoelastic tendon transmits the
22
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force to a rigid bone. The insertion of a tendon into a bone was first comprehensively 
presented and divided into four light-microscopic zones (Becker 1971): (1) tendon, consisting 
of dense collagen bundles with interspersed, elongated tenoblasts; (2) fibrocartilage, the 
transition from the tendon tissue to fibrocartilage; (3) mineralized fibrocartilage, where the 
fibrocartilage is separated from; (4) bone, which shows no special features that would 
separate it from normal bone.
The architecture of the collagen fibre of the OTJ varies considerably with the directions of the 
transmitting forces. In the fibrocartilage and its mineralized counterpart, the fibres crisscross 
around the chondrocytes (Becker 1978). The real functional behavior of the OTJ under 
various loading conditions in vivo is not clear.
2.1.6 Blood supply of tendons
As a general rule, tendons have a vascular supply that is considerably less than that of the 
more metabolically active muscles with which they are associated. This is why fresh tendons 
are white and muscles are red. Nevertheless, contrary to the view of early anatomists, 
tendons are still vascularized, and the presence of vessels is important for the normal 
functioning of tendon cells and the ability of tendons to repair (Benjamin et al. 2008). The 
blood flow within the tendon itself and in the muscle belly of gastrocnemius remains at a 
lower level for an extended period of time after tenotomy and this may inhibit repair. It is also 
commonly argued that reduced tendon blood supply can lead to tendon degeneration, 
particularly in association with certain tendons that have avascular or poorly vascularized 
regions, for example the Achilles tendon, tibialis posterior and supraspinatus (Rees et al.
2006).
The tendons receive their blood supply from three sites: (1) from vessels coming from the 
muscle, (2) from vessels coming from the bone and periosteum surrounding the OTJ, and (3)
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especially from the vessels that surround the tendon (paratenon, mesotenon, and synovial 
sheath) (Fig. 2.4) (Carr and Norris 1989).
The major blood supply to the tendon is provided through vessels surrounding the tendon 
and that the tendon cannot receive the entire circulation required from its proximal or distal 
attachments (Archambault et al. 1995). In the Achilles tendon, for example, a zone of relative 
avascularity has been demonstrated at between 2 and 6cm proximal to the tendon insertion. 
At the MTJ, the connective blood vessels of the muscle continue between the fascicule of the 
tendon and are of the same size as its vessels elsewhere.
A -  Osteotendinous junction (OTJ) 
B -  Mesotenon
C -  Myotendinous junction (M TJ)
Fig. 2.4 Tendon receives blood supply from three sites
(http://images.conquestchronicles.com/images/admin/foot_achilles_tendon_anatomy01a.jpg)
Other small vessels enter by the paratenon, branching several times in the long axis of the 
tendon, and where there is a synovial sheath, a plexus traverses the mesotenon or vinculum 
(Elliott 1965). It has been stated that the OTJ is not an important site of entry (Edwards 
1946).
There is evidence that blood flow in the peritendinous tissues is increased as a result of 
enhanced physical activity, and tissues adjacent to tendons, including tendon sheaths and 
tendon-associated adipose tissue, have a richer blood supply than then tendons themselves.
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The vessels run longitudinally in the tendon itself, parallel to the fascicles and within the 
endotenon. Numerous vessels enter tendons at their MTJ and some vascular injection 
studies suggested that this is also the case at entheses. Furthermore, there is clear 
histological evidence of little vascular continuity between bone and tendon (Benjamin et al.
2007).
The venous network of tendons is composed of venules and veins that usually, in pairs, 
follow the arteries and their branches. Outside the tendon belly, the venous blood is collected 
into the venous network of the peritendinous tissues (Laszlo G. Jozsa 1997).
2.1.7 Nerve supply
The innervation of tendons, sensory by nature, as deriving from neighbouring muscular, 
peritendinous, or deep nerve trunks and consisting of a longitudinal plexus with the various 
terminations lying mainly near the MTJ (Stilwell 1957). Those from the MTJ cross the 
junction and continue into the endotenon septa. Those from the paratenon form rich 
plexuses, send branches that penetrate the epitenon, and anastomose with the branches of 
muscular origin (Ippolito et al. 1980). Where the tendon has a synovial sheath, the nerves go 
through the mesotenon, branch out into the visceral sheet of the synovial sheath, and then 
penetrate into the tendon. Many of the nerve fibres do not go inside the tendon but terminate 
in the sensory nerve endings on the surface of the tendon.
The nerves inside a tendon, which are very few in number, follow the vascular channels that 
run along the long axis of the tendon, anastomose with each other via obliquely and 
transversely oriented nerve fibres, and finally terminate in the sensory nerve endings.
It has been suggested that the nerve fibres regulate blood flow within the tendon (Ackermann 
et al. 2001). Further, free nerve fibres containing substance P and calcitonin gene-related
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peptide (CGRP) might be involved in collecting sensory information (including pain) and 
relaying this to the central nervous system (Ackermann et al. 2001).
The sensory innervations of tendons is of particular interest in relation to tendinopathies and 
the repair of ruptured tendons (Benjamin et al. 2008). There is now considerable evidence 
that nerves can grow into damaged or ruptured tendons in association with blood vessels 
and that the site where this happens correlates with the region of tendon pain (Alfredson and 
Lorentzon 2007). The neurovascular invasion of damaged tendon tissue has led to an 
interest in the use of sclerosing agents for treating painful tendons (Hoksrud et al. 2006; 
Alfredson and Lorentzon 2007) and to the development of training programmes that can 
reduce tendon neovascularization.
2.2 Tendon Function and Mechanical Behavior
2.2.1 Function
Tendons have been traditionally considered to simply be a mechanism by which muscles 
connect to bone, functioning simply to transmit forces, thus making joint and limb movement 
possible (Kannus 2000; Magnusson et al. 2008). It is also well known that tendons are not 
inextensible, but that they exhibit important elastic and time-dependant characteristics that 
may influence the function of the overall muscle-tendon complex (Magnusson et al. 2008).
In other words, tendons transmit loads with minimal energy loss and deformation. The 
greater the force generated by muscle is, the greater the stress transmitted through the 
tendon (Buchanan and Marsh 2002).
Muscle-tendon interactions have been explored during skeletal loading and describe the 
relation of sarcomere shortening at the expense of tendon lengthening (Lieber et al. 1992).
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However, over the past two decades, many studies focused on the elastic properties of 
tendons and their ability to function as springs (Lieber et al. 1992), which allows tendons to 
passively modulate forces during locomotion, providing additional stability with no active 
work (Kannus 2000).
Tendon rotation, if present, plays an important role in tendon mechanics and function. The 
Achilles tendon, for example, twists as it descends. Rotation begins above the region where 
the soleus tends to join, and the degree of rotation is greater if there is minimal fusion 
(O'Brien 1992). In addition to transmit the force developed by a muscle, a tendon possesses 
certain secondary functions. For instance, the tendon eliminates the need for unnecessary 
length of muscle between origin and insertion, enabling the muscle belly to be at a 
convenient distance from the joint over which it acts while concentrating its pull (Elliott 1965). 
Furthermore, tendons also satisfy both kinematic and damping requirements (TM Best 
1994).
2.2.2 Mechanical properties
The mechanical properties of the tendon are dependent on the collagen fibre diameter and 
orientation. The collagen fibrils are parallel to each other and closely packed, but show a 
wave-like appearance due to planar undulations, or crimps, on a scale of several 
micrometers (Hulmes 2002). In tendons, the collagen I fibres have some flexibility due to the 
absence of hydroxyproline and proline residues at specific locations in the amino acid 
sequence, which allows the formation of other conformations such as bends or internal loops 
in the triple helix and results in the development of crimps (Silver et al. 2003). The crimps in 
the collagen fibrils allow the tendons to have some flexibility as well as a low compressive 
stiffness. In addition, because the tendon is a multi-stranded structure made up of many 
partially independent fibrils and fascicles, it does not behave as a single rod, and this 
property also contributes to its flexibility (Ker 2002).
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One study (Butler et al. 1978) demonstrated a force-elongation curve (Fig. 2.5) which is a 
valuable tool for studying the mechanical properties of tendon.
Stress
Elastic
Modulus
Strain(%)
Partial failureLinear RuptureToe
t » « — 1 ,~
Fig. 2.5 Mechanical properties of tendon
(Butler et al. 1978)
2.3 The Anatomy of the Achilles Tendon
2.3.1 Introduction
The Achilles tendon is one of the longest and strongest tendons in the human body. It is the 
conjoined tendon of the gastrocnemius and the soleus muscles.
The Achilles tendon has the ability to adapt to mechanical loading with tensile loads up to ten 
times body weight during running, jumping, hopping, and skipping (Soma and Mandelbaum
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1994). The Achilles tendon is subjected to stress when running up and down hill, particularly 
if there are associated biomechanical malalignments.
The Achilles tendon is one of the most frequently ruptured tendons in the human body. The 
rupture is thought to be associated with overuse and micro-injuries due to forces affecting the 
tendon during unsuitable physical activity (Hansen et al. 2003). But the physical activity is not 
the only cause of the Achilles tendon tendinopathy. The mechanism of tendinopathy is 
unclear.
2.3.2 Anatomy
The Achilles tendon is a confluence of the gastrocnemius and soleus muscles. The 
gastrocnemius muscle is composed of a medial and lateral head. The medial head arises 
from behind the medial supracondylar ridge and adductor tubercle on the posterior surface of 
the femur. The lateral head arises from the lateral surface of the lateral condyle of the femur, 
proximal and posterior to the lateral epicondyle. Each of these heads has additional 
attachments from the posterior capsule of the knee joint and from the oblique popliteal 
ligament (Cummins E.J. 1946). The soleus muscle lies deep to the gastrocnemius muscle, 
arising from the posterior surface of the upper tibia along the soleal line, the posterior aspect 
of the proximal third of the fibula, and from the inter-muscular septum (Schepsis et al. 2002).
The medial and lateral heads of the gastrocnemius muscle gradually coalesce and 
incorporate into a broad, robust tendon in the posterior aspect of the lower leg. This tendon 
gradually narrows and becomes more rounded as it extends distally. The soleus muscle 
forms a broad tendon about midway down the leg, in a position deep to the tendon of the 
gastrocnemius. This tendon glides freely deep to the gastrocnemius muscle in its more 
proximal extent, thereby allowing independent movement of the two muscles (Schepsis et al. 
2002).
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The tendinous components of these two muscles are variable. The gastrocnemius 
component is the longer potion, contributing 11 to 26 cm. the soleus, in contrast, is shorter, 
containing a tendinous component from 3 to 11 cm in length. The width of the tendon at its 
point of insertion into the calcaneus varies from 1.2 to 2.5 cm (Cummins E.J. 1946).
Approximately 5 to 6 cm proximal to the calcaneal insertion, the independent tendons of the 
gastrocnemius and soleus fuse to become one tendon. At about 12 to 15 cm proximal to the 
insertion of the tendon (Fig. 2.6), at about the level the soleus muscle begins to contribute 
fibres to the Achilles tendon is where rotation of the tendon begins. This rotation becomes 
more marked in the terminal 5 to 6 cm of the tendon. The tendon spirals approximately 90° 
with the medial fibres rotating posteriorly and the posterior fibres rotating laterally (Schepsis 
et al. 2002).
Fig. 2.6 Achilles tendon
(http://images.conquestchronicles.com/images/admin/foot_achilles_tendon_anatomy01a.jpg)
Some individuals exhibit a double spiral where the lateral head runs from the dorsal side, 
then comes ventral, and finally turns to the dorsal aspect. Rotation begins above the region 
where the soleus tends to join the gastrocnemius component, and the degree of rotation is
G -  Gastrocnemius 
S -  Soleus
AT -  Achilles tendon 
C — Calcaneus
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greater if there is minimal fusion. Twisting produces an area of stress within the tendon, 
which is most marked 2 cm to 5 cm above its calcaneal insertion. This is an area of poor 
vascularity, and is a common site of tendinopathy and rupture (Laszlo G  Jozsa 1997).
The insertion becomes broad distally and has a wide deltoid type of attachment, which varies 
from 1.2 cm to 2.5 cm (Schepsis et al. 2002). The deep surface of the inferior portion of the 
tendon above its attachment to the calcaneus has an area of fibrocartilage between the 
tendon and the upper part of calcaneus (Barfred 1971).
Deep and just proximal to the insertion is the retrocalcaneal bursa, which lies between the 
tuberosity on the posterior surface of the calcaneus and the Achilles tendon (Fig. 2.7). The 
bursa that is present at birth is a thick-walled, wedge-shaped sac. It has a horseshoe shape 
on cross-section; the arms extend distally on the medial and lateral edges of the tendon, with 
an average length of 22 mm, a width of 4 mm, and a depth of 8 mm. The area of 
fibro-cartilage on the tendon forms the posterior wall (Schepsis et al. 2002). The anterior wall 
of the retrocalcaneal bursa is the 0.5-mm to 1-mm thick cartilaginous layer on the posterior 
aspect of the calcaneus. The proximal wall of the synovial-lined sac consists of folds, or villus 
synovial projections to allow alterations in its form, that are produced by varying degrees of 
pressure on the fat above it during flexion and extension of the ankle (Snow et al. 1995).
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AT — Achilles tendon 
RB — Retrocalcaneal bursa 
TB -  Tendocalcaneal bursa
Fig. 2.7 Retrocalcaneal bursa and tendocalcaneal bursa
(http://www.eorthopod.com/sites/default/files/images/foot_achilles_tendon_treatment01.jpg)
The Achilles tendon is not encased in a true synovial sheath but is encased in a paratenon 
made up of a single layer of cells. This paratenon anteriorly consists of fatty, mesenteric-like 
areolar tissue. This tissue is richly vascularized and is responsible for a significant portion of 
the blood supply to the tendon (Carr and Norris 1989). This supply comes through a series of 
transverse vincula, which function as passageways for blood vessels to reach the tendon. In 
addition to these mesotenal vessels, the blood supply to the tendon comes from two other 
sources: the musculotendinous junction and the osseous insertion. Angiographic studies 
have shown that the area of most tenuous blood supply is 2 to 6 cm proximal to the insertion 
in the calcaneus (Clain and Baxter 1992). Additionally, the number of intratendinous vessels 
and the relative area occupied by these vessels is lowest 4 cm from the calcaneal insertion 
(Saltzman and Tearse 1998).
The Achilles tendon consists of typical parallel bundles of type I collagen (tropocollagen). The 
average size of the collagen fibres of the Achilles tendon is 60 pm. Collagen fibrils in the 
Achilles tendon vary from 30 nm to 130 nm in diameter, although most are between 50 nm 
and 90 nm in diameter. Collagen forms microfibrils, fibrils, and fibres. A group of fibres
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constitutes a fascicle. The fascicles unite to form bundles, and are surrounded by the 
endotenon. The endotenon is a mesh of elastin-rich, loose connective tissue that holds the 
bundles together and allows some movement of the bundles relative to each other. It carries 
blood vessels, lymphatics, and nerves. Fascicles are the smallest collagenous structure that 
can be tested biomechanically (Butler et al. 1978). A fine connective tissue sheath, the 
epitenon, is continuous throughout on its inner surface with the endotenon and surrounds the 
whole tendon.
2.3.3 Blood supply
The Achilles tendon has long been known to be poorly vascularized, and the tendon was 
once considered to be avascular because of its pale colour and lack of visible blood vessels 
(Peacock 1959). The Achilles tendon is supplied by the peroneal artery laterally and the 
posterior tibial artery medially. Three vascular territories were identified: proximal section, 
midportion, and distal section (Fig. 2.8). The distal section of the tendon, comprising the 
insertion and up to the distal 4 cm of the tendon was found to be supplied by the posterior 
tibial artery (Chen et al. 2009). The midportion of the tendon, which is 4 -7  cm from the 
insertion, was supplied by the peroneal artery. The proximal section of the tendon, 7 cm from 
the insertion up to the myotendinous junction, was also supplied by the posterior tibial artery.
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Achilles tendon
proximal
Peroneal'
artery
MedialLateral
Supplied by posterior Supplied by
tibial artery peroneal artery
Fig. 2.8 The arterial anatomy of the Achilles tendon
(Chen et al. 2009)
Two areas of anastomosis were identified among the three territories. The proximal area of 
anastomosis was found between the proximal section and the midportion, whereas the distal 
area of anastomosis was found between the midportion and the distal section (Fig. 2.8). Both 
areas were found to be comparatively hypo-vascular on dissection and angiography, with 
fewer and smaller caliber vessels seen (Chen et al. 2009).
The Achilles tendon is mainly supplied by arteries from its anterior and deep surface, with 
branches either looping around or passing transverse through the tendon to gain access to 
its posterior superficial surface. The arteries on the anterior surface of the Achilles tendon 
were found to be larger and more numerous than the smaller posterior arteries, which 
contributed less to the tendon blood supply in all regions except for the tendon insertion (Fig. 
2.9).
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Posterior side
Anterior side
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5cm
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Distance from insertion
Fig. 2.9 Radiograph of the Achilles tendon cross section
(Chen et al. 2009)
The arteries of the Achilles tendon and its paratenon were orientated in three directions: 
longitudinal, transverse, deep. In most cases, the large arterial branches ran on the surface 
of the tendon transversely, in a direction perpendicular to the direction of tendon fibres. 
These large transverse vessels distributed numerous branches that ran longitudinally along 
the inter-fibrillar striations. The longitudinal vessels were also seen to run deep into the 
tendon between the tendon fibres. The Achilles tendon fibres spiral from medial to lateral, 
with the arteries running within the inter-fibrillar striation also seen to spiral in a medial to 
lateral direction (Chen et al. 2009).
Because it has the poorest blood supply, the midportion of the Achilles tendon is the most
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common region for rupture (Laine and Vainio 1955; Reinherz et al. 1991; Campbell and 
Lawton 1993). Many previous studies have shown that the midportion is also the most 
hypo-vascular region (Carr and Norris 1989; Ahmed et al. 1998; Zantop et al. 2003).
2.3.4 Nerve supply
The Achilles tendon is supplied by sensory nerves from the overlying superficial nerves or 
from nearby deep nerves, the tibial nerve, and its branches (O'Brien 1992). The afferent 
receptors are found near the myotendinous junction, either on the surface or in the tendon. 
The nerves tend to form a longitudinal plexus and enter by way of the septa of the endotenon 
or the mesotenon if there is a synovial sheath. Branches also pass from the paratenon by 
way of the epitenon to reach the surface or the interior of a tendon (O'Brien 1992; Laszlo G. 
Jozsa 1997).
2.4 Conclusions
This chapter describes that tendons are anatomic structures interposed between muscles 
and bones transmitting the force created in the muscle to bone. They have less vascular 
supply indicated by their white colour. The Achilles tendon is subject to some of the highest 
loads in the body, and is the thickest and strongest tendon in the body. The tensile loads can 
be up to 10 times body weight during running, jumping, hopping and skipping. The Achilles 
tendon is considered to be poorly vascularized and is supplied by posterior tibial artery and 
peroneal arteries. The next chapter will focus on the injuries to the Achilles tendon.
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3. Achilles Tendon Disorders
Achilles tendon disorders are common among athletes and the general public. The number 
and the incidence of tendon injuries, in general, have increased substantially during the last 
few decades. It has been reported that 30% to 50% of tendon injuries are related to sports 
(Jarvinen et al. 2005). Achilles tendon injuries have been divided into overuse injuries and 
spontaneous ruptures (Schepsis et al. 2002).
3.1 Overuse Injuries
3.1.1 Aetiology
Tendinopathy primarily affects active people, the more active they are, the greater chance of 
developing some tendon pathology and pain. Currently, very little is understood about the 
cause of tendinopathy. Experimental and clinical research is attempting to clarify aspects of 
the aetiology of pain and pathology but the relationship between them is unclear (Jarvinen et 
al. 2005).
The source of pain in tendinopathy is obscure. Although biochemical substances as a cause 
have been proposed (Ljung et al. 1999). Vascular and neural mechanisms have also been 
investigated (Ohberg L 2001); however, it is clear that research is still yet to resolve this 
clinically essential question (Zanetti et al. 2003). An unknown pain pathway compromises the 
understanding of the aetiology of symptoms, as both the stimulus for pain and its 
perpetuation are unknown. It is then certain that the treatment for tendon pain must also be 
unclear (Arnoczky 2007).
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Understanding the relationship and interaction between factors and the pain in tendinopathy 
examined in vitro or in animal models is one of the key challenges in tendon research. Some 
factors, such as tendon load and vascular changes, are implicated in the aetiology of both 
pathology and pain and, as such, there must be a priority to investigate these factors 
(Arnoczky 2007). However, both tendon load and vascularity may be factors that are 
responsible for, and affected by, a cascade of smaller changes.
A study investigating 891 tendon ruptures demonstrated that although virtually all tendons 
were pathological prior to rupture, only 34% were painful (Kannus and Jozsa 1991). This 
study showed that tendon pathology is not always painful. In some further studies, 
examinations using imaging to study the tendon pathology in athletes have illustrated that 
pathology not only preceded symptoms in both the Achilles and patellar tendons, but 
abnormal tendons could remain pain free for years despite continued athletic activity (Khan 
et al. 1997; Cook et al. 2001; Fredberg and Bolvig 2002). This demonstrated that the 
aetiology of tendon pathology may be very different to tendon pain.
Although tendon pathology is considered primarily to occur in the tendon, most problematic 
tendon injuries occur at the OTJ (enthesis, Fig. 3.1). The Achilles tendon is clearly 
predisposed to develop midportion tendon pathology and more often enthesis pathology, but 
tendinopathies in athletes primarily occurs at the OTJ, or at sites of functional entheses 
(Benjamin and McGonagle 2001).
While most tendon disease in athletes occurs at the enthesis, the Achilles tendon suffers 
midportion tendon pathology more often than OTJ. This is due to the fact that the Achilles 
tendon is considered to be an energy storage tendon (Komi and Bosco 1978) and 
breakdown is not only influenced by its capacity to store energy, but also by the dimensions
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of the tendon. Therefore, long tendons, like Achilles, appear more at risk of midportion 
tendinopathy and fatigue rupture than shorter, broader tendons (Ker 2002).
The enthesis organ of the adult Achilles tendon.
The enthesis itself is characterised by an enthesis 
fibrocartilage (EF) which is most prominent in the superior 
part of the attachment. In addition, there is a sesamoid 
fibrocartilage (SF) in the deep surface of the tendon, 
immediately adjacent to the enthesis, and a corresponding 
periosteal fibrocartilage (PF) on the opposing surface of 
the superior tuberosity (ST) of the calcaneus. The tendon 
(T) and bone are separated by the retrocalcaneal bursa 
(RB) into which protrudes the tip of Kager’s fat pad (KP).
Note that the heel fat pad (HP) extends upwards from the 
sole of the foot to the posterior part of the Achilles tendon. 
Arrows, fibrous septa of the fat pad. Masson’s trichrome. 
Scale bar: 2 mm
Fig. 3.1 The enthesis organ of the adult Achilles tendon
(Benjamin and McGonagle 2001)
The basic aetiology of the Achilles tendinopathy is known to be multi-factorial as discussed 
below:
3.1.1.1 Load
Overloading is often hypothesized to be the reason for the onset of pain and pathology. 
Traditionally, pathology is reported to be caused by repeated strain that is less than the force 
necessary to rupture (Arnoczky 2007). The strain is reported to disrupt collagen cross-links 
and fibrils and may damage blood vessels, resulting in impaired metabolic and oxygen 
delivery (Kannus and Natri 1997). Collagen tearing caused by tensile load has long been 
considered to be the primary event in tendinopathy. A study (Ker 2002) suggested that
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tendon repair occurred after tendon load, and that collagen showed continued remodeling 
when collagen cross-links were investigated in human rotator cuff tendon, indicating regular, 
and continued matrix replacement.
3.1.1.2 Cyclic loading
During daily living or sporting activities the tendon tissue is subjected to repetitive loading 
and the consecutive changes in mechanical environment can significantly affect the 
mechanical properties of the tissue. While cyclic loading is known to be beneficial to tendon 
health (Hannafin et al. 1995), repetitive tissue strain has also been implicated in the aetiology 
of overuse injuries of tendons (Archambault et al. 1995). In tendon cells the cyclic strain 
activates a wide array of cellular machinery, including DNA synthesis, mitosis and cell 
differentiation (Almekinders et al. 1993).
3.1.1.3 Impingement
Tendon reaction to impingement may result in cartilaginous and bony pathology in tendons 
(Forslund and Aspenberg 2002), and this can cause tendinopathy. The shape of the 
calcaneus appears to affect the morphology of the Achilles tendon insertion and may be the 
result of anatomical impingement (Rufai et al. 1995).
3.1.1.4 Thermal
The storage and release of elastic energy in tendons discharges intratendinous heat. The 
resultant increase in tendon temperature after exercise may induce cell death (Wilson and 
Goodship 1994). Cell loss affects the tendons ability to respond to stress and remodel the 
matrix.
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3.1.1.5 Hypoxia
Without defining the exact mechanism, hypoxia has been hypothesized as a cause of 
tendinopathy (Kannus and Natri 1997). Theoretically, cell disablement or death should be the 
main effect of hypoxia, with a consequent decrease or abolition of the capacity of the tendon 
to produce tendon matrix components and repair. The presence of hypoxia in tendon 
pathology is supported by the presence of increased lactate levels in Achilles tendinopathy 
compared with normal tendons (Alfredson et al. 2002). Increased lactate level suggests 
some anaerobic metabolism, which is used by tendon cells with a limited supply of oxygen.
3.1.1.6 Vascularity
It is believed that hypoxia is a powerful stimulant to angiogenesis. Alternatively, impaired 
vascularity may lead to hypoxia. Increased vascularity is the cornerstone of tendinopathy and 
has been demonstrated histopathologically (Kraushaar and Nirschl 1999), with imaging on 
Doppler ultrasound (Ohberg L 2001; Terslev et al. 2001), and with laser flowmetry (Astrom 
and Westlin 1994). In degenerative tendon disorders histopathologic findings and 
experimental findings revealed increased vascularity and increased blood flow (Kannus and 
Jozsa 1991). Neoangiogenesis controlled by a variety of mitogenic, chemotactic, or inhibitory 
peptides and lipid factors may be involved in beneficial but also in detrimental effects to 
tendon tissue (Ferrara 1999). One of the most important angiogenic factors is the vascular 
endothelial cell growth factor (VEGF). In degenerative tendons, neovascularization was 
accompanied by high VEGF levels (Pufe et al. 2001), this suggests that neovascularization 
may be a reaction to a hypoxic state. However, some pathologic tendons do not demonstrate 
increased vascularity on imaging (Peers et al. 2003; Zanetti et al. 2003), but few studies 
have examined both histopathology and vascularity demonstrated on imaging. It is unknown 
why some tendons react by notably increasing vascularity and why others do not.
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3.1.1.7 Neural
The body of a tendon is poorly innervated. The MTJ and OTJ and the peritendon are well 
innervated. Nerve fibres in the tendon are associated with the vascular, lymphatic, and 
connective tissue channels, some of these nerve fibres have been reported to have direct 
contact with tendon collagen (Andres et al. 1985). Although sparse in sections, the nerve 
supply of the tendon may have important roles in the onset of pathology, pain production, and 
tendon repair.
3.1.1.8 Pharmacology
There are medications that are known to directly and adversely affect tendon tissue. These 
substances can induce tendon damage and can affect symptoms negatively or positively 
(Arnoczky 2007).
3.1.1.9 Blood group
Blood group has been reported to be associated with tendon rupture (Jozsa et al. 1989). The 
ABO antigens of blood groups are found in other tissues including tendons, and may affect 
tendon tissue.
3.1.1.10 Gender
Female gender is reported to increase the risk of tendinopathy due to strength, body 
composition, and biomechanical differences in women compared with men. Despite these 
reports, women are much less likely than men to present for either conservative or surgical 
treatment for tendon injury. This suggests that women suffer less tendinopathy than men 
(Kannus and Natri 1997).
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3.1.1.11 Disease
Collagen disease such as Ehlers-Danlos syndrome, Marfan syndrome and Menkes kinky 
hair syndrome can directly affect tendons. Several other systemic and genetic diseases 
predispose the tendon to symptoms. Systemic lupus erythematosus and rheumatoid arthritis 
can be associated with tendon rupture, and glycogen storage disease has also been 
associated with Achilles tendinopathy (Arnoczky 2007).
3.1.1.12 Age
Aging has been associated with an increase in prevalence of tendinopathy, to a point where 
the thirtieth birthday has been described as a risk factor for tendinopathy. Exactly what 
constitutes old age for a tendon is not defined; however, the incidence of ruptures increases 
in middle age. This suggests that old age for tendon pathology may in fact be earlier than 
middle age, as pathology precedes rupture (Arnoczky 2007).
3.1.2 Epidemiology
Achilles tendon overuse injuries are associated commonly with strenuous physical activities, 
such as running and jumping (Laszlo G  Jozsa 1997; Paavola et al. 2002). The occurrence of 
Achilles tendinopathy is highest among individuals who participate in middle and 
long-distance running, orienteering, track and field, tennis, badminton, volleyball, and soccer 
(Kvist 1994). Studies reported an annual incidence of Achilles disorders to be between 7% 
and 9% in top-level runners (Lysholm and Wiklander 1987).
It has been extensively reported that the most common clinical diagnosis of Achilles 
disorders is tendinopathy (55% ~ 65%), followed by insertional problems (retrocalcaneal 
bursitis and insertional tendinopathy; 20% -  25%) (Kvist 1994). In a study of the 
epidemiology of Achilles tendon disorders in a large group (698 patients) of competitive and
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recreational athletes who had Achilles tendon problems, 66% had Achilles tendinopathy and 
23% had Achilles tendon insertional problems. In 8% of the patients, the injury was located at 
the MTJ, and 3% of the patients had 3 complete tendon rupture. 98% of the patients were 
men. Running was the main sports activity in patients who presented with an Achilles tendon 
disorder (53%); persons who were runners represented 27% of all patients who were studied 
in the sports medicine clinic where the research was performed (Kvist 1994).
Chronic Achilles tendon disorders are more common in older athletes than in young athletes 
(Kannus et al. 1989). In a report of 470 patients who had Achilles tendinopathy and 
insertional complaints, only 25% of subjects were young athletes and 10% were younger 
than 14 years (Kvist 1994). Patients who had unilateral Achilles tendinopathy seem to have a 
high risk of sustaining Achilles tendinopathy in the uninvolved leg as well, almost half of the 
patients who had the Achilles tendinopathy (41%) developed symptoms of this in the 
contralateral leg during the 8-year follow-up period (Paavola et al. 2000).
3.1.3 Paratendinopathy
The Achilles tendon is surrounded throughout its length by thin gliding membrances, the 
paratenon. The paratenon functions as an elastic sleeve, although probably not as effectively 
as a true tendon sheath, and permits free movement of the tendon within the surrounding 
tissues (Kannus and Jozsa 1991). Under the paratenon, the entire Achilles tendon is 
surrounded by a fine, smooth, connective tissue sheath, the epitenon. On its outer surface, 
the epitenon is in contact with the paratenon. The inner surface of the epitenon is continuous 
with the endotenon, which binds the collagen fibres and fibre bundles together and provides 
the neural, vascular, and lymphatic supply to the tendon (Laszlo G. Jozsa 1997).
The paratenon is richly vascularized and provides the blood supply to the Achilles tendon 
itself. The neural supply to the Achilles tendon and the surrounding paratenon is provided by
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nerves from the attaching muscles and by small fascicule from cutaneous nerves, in 
particular the sural nerve (Stilwell 1957). In patients who have an Achilles tendon overuse 
injury, the sensory nerve endings follow the paratendinous neovascularization and may be a 
cause of Achilles tendon pain (Alfredson et al. 2003).
In the acute phase of Achilles paratendinopathy, inflammatory cell reaction, circulatory 
impairment, and oedema formation occur (Paavola et al. 2002). Crepitus, due to movement 
of the Achilles tendon within a paratenon that is filled with fibrin exudates, may be present. If 
the physiologic healing process fails or is delayed, the fibrin may organize and form 
adhesions that prohibit the normal gliding between the tendon, paratenon, and crural fascia 
(Kvist 1994).
In chronic Achilles paratendinopathy, the paratenon tissue becomes thickened as a result of 
fibrinous exudates; prominent and widespread proliferation of fibroblasts; formation of new 
connective tissue; and adhesions between tendon, paratenon, and crural fascia (Kvist et al. 
1985).
Ultrasonography is a reliable diagnostic method for Achilles paratendinopathy if adhesions 
can be seen around an Achilles tendon. However, US may fail to detect adhesions and 
produce false negative results in patients who have few adhesions (Laine et al. 1987). In 
acute Achilles paratendinopathy, Ultrasonography reveals fluid surrounding the tendon, 
whereas paratendinous adhesions can be seen as a thickening of the hypoechoic paratenon 
with poorly-defined borders in the chronic form of the disorder (yellow arrows in Fig. 3.2).
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Achilles tendon
Fig. 3.2 PDU image of chronic paratendinopathy
MRI has been used extensively to visualize tendon pathology (Pope 1992). However, in 
patients who have pure chronic Achilles paratendinopathy (without tendinopathy of the main 
body of the Achilles tendon), MRI infrequently reveals any pathologic changes around the 
tendon (Paavola and Jarvinen 2005).
3.1.4 Midportion tendinopathy
Chronic tendinopathy of the main body of the Achilles tendon is a condition associated with a 
combination of tendon pain, swelling, and impaired performance ability. Chronic 
tendinopathy has been described as a condition with symptoms that last longer than 6 weeks 
(Maffuili and Kader 2002). Excessive loading of the Achilles tendon during athletic activities 
and work is regarded as the main pathologic stimulus that leads to tendinopathy (Vora et al. 
2005). This is possibly as a result of an imbalance between muscle power and tendon 
elasticity.
Mild Achilles tendinopathy presents as pain in a region 2 to 6 cm proximal to the tendon 
insertion usually after exercise, namely midportion tendinopathy. As the condition progresses,
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pain may occur during exercise, and, in severe cases, the pain interferes with activities of 
daily living (Vora et al. 2005). Changes in training pattern, poor technique, previous lower 
extremity injuries, footwear and environmental factors such as training on hard, slippery or 
slanting surfaces are extrinsic factors which may also predispose the athlete to Achilles 
tendinopathy (Kvist 1994). Several studies have confirmed the occurrence of sensory 
neuropeptides in both animal and human tendons, and Substance P (SP) has been found in 
Achilles tendinopathy (Khan et al. 2000), which is thought to be the cause of pain.
In the acute phase, the tendon is diffusely swollen and oedematous, and on palpation the 
tenderness is usually greatest in the midportion. Crepitation can also be found in 
paratendinopathy. In chronic cases, an exercise-induced pain is still the cardinal symptom, 
but crepitation and oedema diminish. Eventually the tendon becomes thick, firm, and nodular 
(Maffulli et al. 2003).
Most of the studies agree that the ultrasonography diagnosis correlates quite well with 
clinical findings (Zanetti et al. 2003; de Vos et al. 2007a; Richards et al. 2008). Conventional 
ultrasound was used as a primary imaging method to investigate the neovascularization both 
in transverse and longitudinal planes (Fig. 3.3). Thickening of the midportion Achilles tendon 
and Doppler signals are detected easily with this method.
(a) Transverse PDU image
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(b) Longitudinal PDU image
Fig. 3.3 PDU images of midportion tendinopathy
One report concluded that in normal Achilles tendons, blood flow was not detectable on CDU, 
but colour Doppler often reveals blood flow in pathological tendons (Ohberg L 2001). This 
blood flow was linked to greater pain scores, poorer function and long standing symptoms of 
the Achilles tendon (Peers et al. 2003), compared with control participants who had no visible 
flow. However, the long-term clinical importance of blood vessels in a pathological tendon is 
not clear, especially as more refined examinations also demonstrated vascularization in 
non-tendinopathic Achilles tendon (Boesen et al. 2006b; van Snellenberg et al. 2007). One 
study detected arteries in all normal tendons with Doppler after contrast injection (Koenig et 
al. 2007).
MRI is also a helpful diagnostic way to provide extensive information on the internal 
morphology of tendons and its surrounding structures, and is useful in evaluating various 
stages of chronic degeneration and in differentiating between peritendinitis and tendinosis. 
Areas with increased signal intensity seen on MRI correspond to areas of altered collagen 
fibre structure and increased inter-fibrillar ground substance. Signal intensity on MRI has 
also been associated with clinical outcome (Gardin et al. 2006).
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3.1.5 Retrocalcaneal bursitis
The retrocalcaneal bursa is a significant structure that is horseshoe-shaped and measured 4 
mm in width and 8 mm in depth (Schepsis et al. 2002). It is a distinct entity hallmarked by 
pain that is anterior to the Achilles tendon and just superior to its insertion. The retrocalcaneal 
bursa, which lies between the anterior aspect of the tendon and posterior aspect of the 
calcaneus, becomes inflamed, hypertrophied, and adherent to the underlying tendon. This 
may be associated with a prominence of the posterosuperior angle of the calcaneus 
(Schepsis et al. 2002).
Compression of the bursa between the calcaneus and the Achilles tendon occurs every time 
the ankle is dorsiflexed, and in runners the repetitions are countless, particularly with uphill 
running where ankle dorsiflexion is increased. Thus, it is not surprising that long-distance 
runners who use uphill running as a training method frequently develop this clinical entity.
3.1.6 Insertional tendinopathy
The incidence of Achilles insertional tendinopathy is not well established. It was reported as 
the most common form of Achilles tendinopathy in athletes who presented to an outpatient 
clinic (Laszlo G  Jozsa 1997). Conversely, 5% to 20% of the Achilles tendinopathies were of 
the insertional variety (Krishna Sayana and Maffulli 2005). Insertional tendinopathy often is 
diagnosed in older, less athletic, overweight individuals, and in older athletes.
The insertion of the Achilles tendon, the posterior aspect of the calcaneus, the retrocalcaneal 
bursa, and the pretendinous bursa constitute the posterior aspect of the heel. The enthesis, 
the bursa, and the bursal walls form a complex insertional region that protects the Achilles 
tendon and the posterior aspect of the heel (Krishna Sayana and Maffulli 2005).
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Achilles insertional tendinopathy is characterized by early morning stiffness, pain that is 
localized at the insertion of the Achilles tendon that worsens after exercise, climbing stairs, 
running on hard surfaces, or heel running. The pain may become constant. There may also 
be a history of recent increase in training, and poor warm-up or stretching habits. 
Examination reveals tenderness at the Achilles tendon insertion, thickening or nodularity of 
the insertion, and limited dorsiflexion of the ankle (Krishna Sayana and Maffulli 2005).
3.1.7 Conservative treatment
Little reliable experimental or clinical scientific work has been performed on the 
pathophysiology, aetiology, natural course, and management of Achilles tendon overuse 
injuries (Paavola et al. 2002). Without scientific backing and a firm understanding of the 
nature of tendon injuries and other tendon disorders, it is difficult to prescribe a proper 
management regimen for Achilles tendon problems. Conservative and surgical regimens 
vary considerably among countries, clinics, and physicians. Most management regimens are 
based only on what seemed to work empirically, without much scientific support (Paavola et 
al. 2002).
3.1.7.1 Paratendinopathy
Various forms of conservative management are used. Initial nonoperative management aims 
to identify and correct the above described predisposing factors of the chronic Achilles 
tendon problems (Paavola and Jarvinen 2005). Although the use of nonsteroidal 
anti-inflammatory drugs (NSAIDs) did not affect the outcome of Achilles tendinopathy 
positively in a randomized clinical trial, they often are used for early management of pain 
from Achilles paratendinopathy (Sandmeier and Renstrom 1997). Surgical management is 
recommended to those patients who do not respond adequately to 3 to 6 months of 
conservative management (Kvist 1994). In most studies, surgery for Achilles tendon overuse 
injury gave satisfactory results in 75% to 100% of patients; however, most of these reports
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were retrospective and only in a few were the results based on objective evaluations. The 
few studies reported of the endoscopic-assisted surgical release of adhesions around the 
Achilles tendon showed promising preliminary results (Morag et al. 2003), and that the 
endoscopic technique may reduce early postoperative morbidity. No studies have compared 
different operative methods in the treatment of Achilles paratendinopathy (Paavola and 
Jarvinen 2005).
3.1.7.2 Midportion tendinopathy
Traditionally, nonsteroidal anti-inflammatory drugs again have been used in the early phase 
of midportion tendinopathy, and are prescribed occasionally for chronic Achilles tendinopathy 
(Vora et al. 2005). One study recently reported that, patients who had Achilles tendinopathy 
were managed with ultrasound-guided injection of a sclerosing agent (polidocanol) to 
decrease the neovascularization that was detected in chronic midportion Achilles tendinosis 
(Ohberg and Alfredson 2002). Ultrasound and colour Doppler studies have demonstrated the 
presence of neovascularization outside and inside the ventral tendon in areas of 
tendinopathy (Breidahl et al. 1998; Richards et al. 2001; Peers et al. 2003; Boesen et al. 
2006a; de Vos et al. 2007a). Reports (Ohberg L 2001; Ohberg and Alfredson 2003) 
hypothesized that the neovascularization and the nerve fibres that are associated with 
neovessels mediate the pain that is associated with Achilles tendinopathy. Hence, by 
ablation of these neovessels, the underlying pathophysiologic condition is remedied with 
improvement in symptoms including less discomfort (Ohberg and Alfredson 2002). Physical 
therapy has been used extensively. Specific therapy protocols have focused on concentric 
strengthening, eccentric strengthening, stretching based protocols, and other management 
regimens with accompanying modalities. Of all of the modalities, heavy-load eccentric calf 
muscle training program was the only one tested in a scientific manner, with great efficacy in 
multiple studies (Alfredson 2003). These studies found that eccentric training is superior to 
concentric training in decreasing pain in chronic Achilles tendinopathy, with 81% to 89% of
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patients report resolution of symptoms. The mechanism by which improvement occurs may 
be due to an alteration of the tendon’s inherent tensile properties or by lengthening of the 
muscie-tendon unit with stretch.
3.1.7.3 Insertional tendinopathy
Conservative management produces an 85% to 95% success rate with treatment by rest, ice, 
modification of training, heel lift, and orthoses (Krishna Sayana and Maffulli 2005). In athletes, 
nonweight-bearing activities can help to maintain fitness until symptoms improve. 
Immobilization of the ankle in a below-knee wight-bearing cast or a walker boot can be 
counterproductive, although it was suggested as a treatment by some investigators (Krishna 
Sayana and Maffulli 2005). Tendon loading stimulates collagen fibre repair and remodeling. 
Therefore, complete rest of an injured tendon is not advisable. In addition, sclerosing therapy 
in insertional tendinopathy showed promising results in a pilot study (Ohberg and Alfredson
2003). Polidocanol was injected into local neovessels that were localized by ultrasound and 
colour Doppler. Eight of eleven patients experienced good pain relief, and seven of them had 
no neovascularization at a mean follow-up of 8 months.
3.2 Acute Rupture
3.2.1 Aetiology
Achilles tendon ruptures are relatively common. Although the Achilles tendon is the thickest 
and strongest tendon in the human body, it remains susceptible to injury. During the last two 
decades, the incidence of spontaneous ruptures has been rising (C. Niek van Dijk 2008), 
probably because of the increasing keep-fit culture. Approximately 75% of Achilles tendon 
ruptures occur during sports activities.
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There is little agreement on the aetiology of spontaneous Achilles tendon ruptures. 
Inflammatory and autoimmune conditions, genetically inherited collagen abnormalities, 
infectious diseases, and neurological conditions have been implicated in the aetiology of a 
spontaneous rupture (Movin et al. 2005). The blood flow in the tendon decreases with 
increasing age, and the Achilles tendon site typically prone to rupture is relatively avascular 
compared with the rest of the tendon. These site usually is the midportion, some 2 to 6 ,4  to 7, 
or 3 to 5 cm proximal to the calcaneal insertion (Ahmed et al. 1998).
A report compared the histopathology of 397 Achilles tendon ruptures with 220 control 
tendons, using conventional and polarized light microscopy and scanning and transmission 
electron microscopy. A healthy structure was not found in any of the spontaneously ruptured 
tendons. However, only two thirds of the control tendons were structurally healthy. There 
were characteristic histopathologic patterns found in the spontaneously ruptured tendons. 
Most (97%) of the pathologic changes were degenerative, with hypoxic (45%), mucoid (19%), 
tendon-lipomatous (6%), and calcifying tendinopathy (3%), alone or in combination. These 
changes were also found in 31% of the control tendons (Kannus and Jozsa 1991).
The homeostasis of the extracellular matrix components, such as the fibrillar collagens and 
proteoglycans, may be affected and predispose to a rupture. Type I collagen accounts for 
95% of collagen in normal tendons. This parallel arrangement imparts high tensile strength to 
the tendon (Movin et al. 2005). Ruptured tendons contain significantly greater proportions of 
type III collagen and reduced amounts type I collagen, together with significantly higher 
degrees of degeneration, than non-ruptured tendons. Type III collagen is less resistant to 
tensile forces and may predispose the tendon to spontaneous rupture (Movin et al. 2005).
Clinically painful tendinopathy is not a common etiological factor for complete Achilles tendon 
ruptures as most patients have no symptoms before rupture (Magnusson et al. 2002).
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However, another study indicated that 5% of the 176 patients who presented with a rupture 
of the Achilles tendon had previous symptoms (Maffulli 1999). Although clinically painful 
tendinopathy seemingly is a risk factor, patients who had chronic Achilles tendinopathy in 
reported nonsurgical and surgical series had a long duration of symptoms without sustaining 
a rupture (Coutts et al. 2002). Conversely, at the time of Achilles tendon rupture, 
degeneration and necrosis was present in 47 of 50 and 42 of 50 of the contralateral 
asymptomatic Achilles tendons, respectively. Spontaneous rupture of the Achilles tendon 
seems to be preceded by widespread, bilateral damage of the tendon (Coutts et al. 2002). 
Simultaneous bilateral ruptures without preceding factors are rare, whereas subsequent 
ruptures on one side after the other have been reported in up to 6% of patients (Aroen et al.
2004).
The role of genetic background of the patient in Achilles tendon rupture is almost unknown. 
Adverse drug use, for example, local and systemic corticosteroids, fluoroquinolone 
antibiotics, are a risk factor for tendon ruptures (Fisher 2004). There is evidence of a 
relationship between ABO blood groups and spontaneous tendon ruptures. A strong 
association between blood group O and Achilles tendon rupture was identified in a large 
series of patients has been reported (Jozsa et al. 1989).
3.2.2 Epidemiology
Achilles tendon rupture usually occurs in middle-aged men who work in a white-collar 
profession and during sports activities (Moller et al. 2001). Another report showed an 
incidence curve with two peaks (Moller et al. 1996), a larger one in young or middle-aged 
individuals, and a smaller one in patients in their seventies.
The higher proportion of men suffering Achilles tendon rupture is evident in all studies, with a 
male to female ratio of between 2:1 and 12:1. This probably reflects the greater prevalence
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of men who are involved in sports (Movin et al. 2005). Almost all studies report a dominance 
of left-sided Achilles tendon ruptures, 57% of 1823 Achilles tendon ruptures were left-sided, 
probably because of the greater prevalence of right-side-dominant individuals who push off 
with the left lower limb (Arndt 1976).
3.2.3 Diagnosis
Normally, patients presented with sudden intense pain in the distal portion of the Achilles 
tendon, and often state that something or somebody might have struck their heel. The 
immediate pain resolves quickly; but persistent weakness, poor balance, and altered gait are 
common (Movin et al. 2005). On clinical examination, a positive calf squeeze test and a gap 
in the Achilles tendon, most often 3 to 6 cm above the insertion on the calcaneus, is 
consistently found. In a surgical study of 303 patients, the average gap was found to be 4.8 
cm proximal to the insertion (Krueger-Franke et al. 1995). The most striking sign is the 
inability to perform a single heel rise in patients with acute as well as chronic Achilles tendon 
ruptures.
Because the injury may be missed or misjudged by the patient or the doctor especially when 
sports participation is not involved, Achilles tendon ruptures are missed in diagnosis in up to 
25% of patients (Balias et al. 1998). Further difficulties in reaching the correct diagnosis may 
occur in elderly patients or if the patient consults a doctor some days after the injury.
The various clinical tests (and their statistic values) are listed in Table 3.1 (Maffulli 1998) and 
are sufficient for a diagnosis of acute rupture of the Achilles tendon. A more long-standing 
rupture may produce ambiguous clinical findings and may need to be confirmed by imaging. 
Real time high-resolution ultrasonography and MRI provide an adjunct to clinical diagnosis.
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Table 3.1 Physical examination tests of tendon ruptures
Physical tests Descriptions
Palpation
A gap in the Achilles tendon, most often 3 to 6 cm above the 
insertion in the calcaneus (sensitivity 0.73, specificity 0.89).
Single leg heel rise
The patient is asked to perform a single leg heel rise. If the 
patient is able to lift his or her heel against gravity, the Achilles 
tendon is not ruptured.
Calf squeeze test
Also known as the Simmond’s or Thompson’s test. The patient 
lies prone with both feet hanging from the examination table. 
The examiner squeezes the affected calf muscle; if the Achilles 
tendon is intact, the foot will plantarflex. If the Achilles tendon is 
ruptured, the foot will remain in the resting position, or only 
minimal plantarflexion will occur. On the affected side, the calf 
muscle should be squeezed at the level where the largest 
range of motion will be reached on the healthy side (sensitivity 
0.96, specificity 0.93).
Knee flexion test
The patient lies prone, and is asked to flex both knee to 
90°.during this movement, the position of both ankles is 
observed. An Achilles tendon rupture is diagnosed if the foot of 
the affected limb falls into neutral or dorsiflexion. If the tendon 
is intact, the foot will remain slightly plantarflexed (sensitivity 
0.88, specificity 0.85).
Sphygmomanometer
test
The patient lies prone with both feet extending the examination 
table. The ankle is passively plantarflexed; a 
sphygmomanometer cuff is placed halfway up the calf, and 
inflated to lOOmmHg. Subsequently, the examiner dorsiflexes 
the ankle. No pressure rise will be seen if the tendon is
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ruptured. If the Achilles tendon is intact, however, a pressure 
rise of 35-60 mmHg is measured (sensitivity 0.78).
Needle test
The patient lies prone with both feet hanging from the 
examination table. Insert a needle 10 cm proximal to the 
calcaneal insertion of the Achilles tendon. With passive 
dorsiflexion of the foot, the hub of the needle will tilt rostrally 
when the Achilles tendon is intact.
High-frequency ultrasound probes improve resolution therefore the imaging capacity of the 
degenerative changes, but for a rupture a 5-7.5 MHz probe is sufficient (C. Niek van Dijk 
2008). The tendon should be examined in both longitudinal and axial planes. An acute 
tendon rupture mostly appears as a focal lucency in the tendon, with a small amount of fluid 
in and surrounding the tendon. The frayed ends of the tendons can be detected, and they 
separate in dorsiflexion.
Ultrasound can be of additional value in localizing the tendon ends where surgery is planned. 
This might assist the surgical procedure when small incisions are used in case of where 
there is a large haematoma. The precise location of the tendon ends at a given position of 
flexion of the ankle should be noted in relation to the posterior-superior corner of the 
calcaneus (Deangelis et al. 2009).
3.2.4 Management
The goals of management of Achilles tendon ruptures are to minimize the morbidity of the 
injury, optimized rapid return to full function, and prevent complications (Movin et al. 2005). 
Several treatment methods and procedures have been described for the management of 
Achilles tendon rupture (Fig. 3.4). Despite the developments of the last decades, there is no 
consensus on the best way to heal Achilles tendon ruptures. The modalities of management
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can be divided widely into surgical and nonsurgical treatments (Movin et al. 2005). The 
surgical treatment methods can be subdivided into open operative repair and percutaneous 
repair.
Open
repair
Immobilization 
in plaster
Functional
rehabilitation
Tendon
augmentation
Immobilization 
in plaster
Functional
rehabilitation
Percutaneous
repair
End to end 
sutureshoe
• Brace or splint or
Nonsurgical treatment Surgical treatment
• Full-leg or below 
the knee plaster
• With or without 
early weightbearing
• In equines and/or 
neural
Fig. 3.4 Several treatment methods and procedures for the management of Achilles tendon
rupture
3.2.4.1 Nonsurgical treatment
Immobilization in a below-knee plaster cast in a gravity equines position for four weeks is 
considered to be the most common management protocol. For a further four weeks after that, 
the limb is placed into a more neutral position (Worth et al. 2007). After a following 1 to 3 
weeks of immobilization, braces, splints, or shoes with limitation of dorsiflexion and increased 
heel height have been used for functional rehabilitation (McComis et al. 1997).
3.2.4.2 Surgical treatment
The preferred method for early diagnosed ruptures has been simple end-to-end suture with 
Bunnell- or Kessler-type sutures placed 2 to 4 cm from the frayed tendon ends at the rupture 
site. Because of the reported sural nerve injuries and wound complications, many surgeons 
prefer a medial incision (Movin et al. 2005). End-to-end suturing can be performed under
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local anesthesia, and the tendon can be sutured through a 6- to 8-cm long medial approach 
with low complications rates. Augmentation is reserved commonly for late-presenting 
ruptures, neglected cased, or reruptures. The augmentation is the second step of the 
operation and adds extra strength to the end-to-end suture (Movin et al. 2005). 
Percutaneous repair uses six stab incisions, three lateral and three medial to the Achilles 
tendon. A suture is criss-crossed through the tendon and tied on the tendon surface. 
Arthroscopy has been applied as an adjunct to percutaneous techniques to allow direct 
visualization of the sural nerve and rupture site (Halasi et al. 2003).
3.3 Shockwave Therapy
Extracorporeal shock wave therapy (ESWT) has emerged as a popular and effective 
treatment for many orthopedic conditions including plantar fasciitis, Achilles tendinopathy, 
lateral epicondylitis, calcific tendinitis of the shoulder, tendinosis of the supraspinatus tendon 
and patella tendinopathy (Rompe et al. 2007). Numerous clinical trials have shown that 
ESWT is safe, well tolerated, and yields few side effects. Significant complications are rare 
(Furia 2008). However, the treatment algorithms vary from clinic to clinic and from country to 
country. There are device-specific and disease-specific protocols. Terminology can be 
confusing. There are ‘high energy’ single treatments, ‘low energy’ multiple treatments, and 
combinations of both. Some devices use imaging to guide shock wave delivery while others 
rely on ‘clinical focusing’. The treatment parameters such as the total amount of energy 
delivered, frequency of shock wave delivery, and method of focusing the shock wave have 
not been standardized. For that reason it is difficult to compare data from different clinical 
trials (Furia and Rompe 2007).
3.3.1 Principles
Shock waves are acoustic sound waves that propagate rapidly as a pressure disturbance
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through a medium. Shock waves are characterized by a high peak pressure (500 bar) with 
rise times of less than 10 ns, a short life cycle (less than 10 ms), and a broad frequency 
spectrum (16-20 MHz) (Sems et al. 2006). The rapid rise in pressure is followed by periods 
of pressure dissipation and of negative pressure before gradually returning to ambient 
pressure.
Shock waves entering tissue may be absorbed, reflected, or dissipated depending upon the 
properties of the tissue (Seil et al. 2006). Shock waves have two basic effects on tissue, the 
direct or primary effect is the result of shock waves propagating through and impacting a 
direct mechanical efFect on targeted tissues. The indirect or secondary effect is the result of 
cavitation. Shock wave propagation produces cavitation bubbles in targeted tissues. The 
cavitation bubbles expand and collide, thereby imparting additional energy to the treated 
tissue (Seil et al. 2006).
3.3.2 Physics
ESWT is traditionally categorized by low (<0.2 mJ/mm2) and high (>0.2 mJ/mm2) energy. 
Low-energy treatment is generally well tolerated, with mild to moderate discomfort and does 
not require anesthesia. High-energy applications are generally more painful and usually 
require some local or regional anesthesia (Furia and Rompe 2007). ESWT can be given in 
single or multiple treatment sessions. Single sessions usually are high energy and performed 
in either a surgical center or hospital. Multiple treatment sessions are commonly used in low 
energy treatments. These treatments typically occur in a clinic without the use of anesthesia.
The total amount of energy delivered in one session is simply a concentration of total shock 
wave energy per unit of area. The calculation of the total energy is the multiplication of the 
energy per pulse with the number of pulses given in one session. It is postulated that the 
threshold value of energy density has to be exceeded in order to stimulate a biological
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response (Seil et al. 2006).
In our research, a patient was given low-energy ESWT, with the shock wave frequency of 8 
Hz. The total number of shocks applied during each treatment session was 2000 impulses. 
The amount of energy per shock totaled 2.5 bar in all sessions.
3.3.3 Bio-effects
A portion of the energy is absorbed by the tissue, and a portion is reflected, when a shock 
wave hits a material with altered acoustic impedance (Seil et al. 2006). The ratio of the 
absorption to reflection varies depending on the specific tissue properties.
One report indicated that the ESWT altered neural activity. It was found that the number of 
afferent sensory fibres decreased significantly following shock wave applications (Ohtori et al. 
2001), which suggested a neuroinhibitory effect of ESWT and helped to explain the clinically 
observed pain reduction in the treated patients.
In addition, the low-energy ESWT enhances angiogenesis. Another study reported on the 
effect of ESWT on neovascularization at the OTJ (in rabbits) (Wang et al. 2003). It found that 
tendons treated with low-energy ESWT had a higher number of neo-vessels and 
angiogenesis-related markers, including endothelial nitric oxide synthase, vessel endothelial 
growth factor and proliferating cell nuclear antigens than the untreated controls (Wang et al. 
2003).
3.3.4 ESWT and neovascularization in Achilles tendon
In clinical application, ESWT has been shown to be effective in the treatment of Achilles 
tendinopathy. Despite the success in clinics, the exact mechanism of how ESWT affects 
Achilles tendinopathies remains unclear. It was speculated that ESWT produces
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micro-fracture which in turn causes hematoma formation and subsequent callus formation 
and eventual fracture healing (Wang et al. 2003).
For tendinopathy, it was postulated that ESWT provokes a painful level of stimulation and 
relieves the pain due to tendinopathy at the osteotendinous junction by hyper-stimulation 
analgesia (Maier et al. 2002). Others have hypothesized the theoretical mechanism of ESWT 
in bone healing including micro-disruption of avascular or minimally vascular tissue to 
encourage revascularization and the recruitment of appropriate stem cells conclusive to 
more normal bone tissue healing (Wang et al. 2002b). The results of studies on dog Achilles 
tendon demonstrated that ESWT enhances neovascularization at the osteotendinous 
junction (Wang et al. 2002a).
Neovascularization is found to be close to the area of tendinopathy that corresponded to the 
pain in Achilles tendon. The result of a study (Wang et al. 2003) reported that ESWT induces 
in-growth of neo-vessels and tissue proliferation associated with the early release of 
angiogenesis-related factors including VEGF at the osteotendinous junction (in rabbits). The 
neovascularization may lead to improvement of blood supply and play a role in tissue 
regeneration at the osteotendinous junction.
In summary, ESWT appears to promote early release of angiogenic factors, and 
subsequently induce cell proliferation and in-growth of neo-vessels that in turn may stimulate 
stromal cell growth and differentiation.
3.4 Other Conservative Treatments
There are numerous different types of treatment used in the management of tendon 
disorders is summarized below. Unfortunately, few have a strong evidence base (Rees et al.
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2006).
3.4.1 Non-steroidal anti-inflammatory drugs (NSAIDs)
NSAIDs are used as in the treatment of tendinopathy both in the acute and chronic situations. 
However, animal studies on the use of NSAIDs in tendon injuries have demonstrated 
conflicting results, with some studies suggesting increased tendon tensile strength whilst a 
primate study suggested a reduction in breaking point (Rees et al. 2006).
3.4.2 Cryotherapy
Particularly in sports, the use of cryotherapy in the treatment of acute injury of a tendon is 
widespread. Cryotherapy is believed to reduce blood flow and tendon metabolic rate and 
hence reduce swelling and inflammation in an acute injury (Hamilton and Purdam 2004). 
There is the potential benefit of analgesia, which may help explain the popularity of this 
treatment.
3.4.3 Manual therapy
There are several manual therapies popular in the treatment of tendon disorders. The two 
most common are friction massage and soft tissue mobilization.
3.4.4 Eccentric training
Eccentric training or ‘loading’ regimens have been popularized following successful 
randomized controlled trials in the treatment of Achilles tendinopathy (Alfredson et al. 1998). 
Both the initial results and a statistically significant reduction in tendon thickening (from 8.8 
mm average to 7.6 mm average) were confirmed in the subsequent long-term follow-up 
study (Ohberg et al. 2004). Doppler examinations showed that neovascularization also 
resolved in the responders.
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It has been proposed that possible explanations for the positive effects of eccentric training 
on tendinopathies might be either an effect of stretching, with a “lengthening” of the 
muscle-tendon unit and consequently less strain during ankle joint motion, or effects of 
loading within the muscle-tendon unit, with hypertrophy and increased tensile strength in the 
tendon (Stanish et al. 1986). Thus remodeling of the tendon is induced from eccentric 
training.
3.4.5 Sclerosant injection
The injection of a sclerosant agent around the neovascularization area in both midportion 
and insertional Achilles tendinopathy was found to effectively reduce the levels of pain 
(Ohberg and Alfredson 2002; Ohberg and Alfredson 2003), presumably due to the sclerosant 
injection being toxic to both the neovascularization and localized sensory nerves.
3.5 Clinical Evaluation
3.5.1 VISA-A questionnaire
Clinically, patients were evaluated using the Victorian Institute of Sport Assessment Achilles 
(VISA-A) questionnaire (Robinson et al. 2001), which is shown in the following pages. This 
questionnaire, specifically designed to serve as an index of severity of Achilles tendinopathy, 
contains eight questions measuring the domains of pain, function in daily living and sporting 
activity. Scores range from 0 to 100 points, with 100 points representing a perfect score.
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VISA-A
A questionnaire based instrument that serves as 
an index of severity of Achilles tendinopathy
IN THIS QUESTIONNAIRE, THE TERM PAIN REFERS SPECIFICALLY TO PAIN IN THE 
ACHILLES TENDON REGION
1. For how many minutes do you have stiffness in the Achilles region on first getting up?
100
mins
10
mins
2. Once you are warmed up for the day, do you have pain when stretching the Achilles 
tendon fully over the edge of a step? (keeping the knee straight)
Strong
severe
pain
O
No
pain
10
3. After walking on flat ground for 30 minutes, do you have pain within the next 2 hours? (If  
unable to walk on flat ground for 30 minutes because of pain, score 0 for this question).
4. Do you have pain walking downstairs with a normal gait cycle?
Strong ....................    No
severe 1 I I I I I I I ! I pain
pain 0 1 2 3 4 5 6 7 8 9  10
5. Do you have pain during or immediately after doing 10 (single leg) heel raises from a flat 
surface?
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6. How severe of your pain after 10 single leg hop?
Strong __________ _________________________________________
severe [""
Pain/
Unable 0 1 2 3 4 5 6 7 8 9
7. Are you currently undertaking sport or other physical activity?
0 E D  Not at all
4 Q  Modified training ± modified competition
7 Q  Full training ± competition but not at same level as when symptoms
began
10 Q  Competing at the same or higher level as when symptoms began
symptoms began
8. Please complete E ITH E R  A, B or C in this question.
• I f  you have no pain w hile undertaking sport please complete Q8a only.
• I f  you have pain while undertaking sport but it does not stop you from completing the 
activity, please complete Q8b only.
• I f  you have pain w hich stops you from completing sporting activities, please complete Q8c 
only.
A. I f  you have no pain while undertaking sport, for how long can you train/practise?
NIL 1-10mins 11-:□ □
0 7
OR
B. I f  you have some pain while undertaking sport, but it does not stop you from completing 
your training/practice for how long can you train/practise?
NIL 1-10mins 11-1□ □
0 4
OR
C. I f  you have pain that stops you from completing your training/practice, for how long can 
you train/practise?
NIL 1-10mins 11-20mins 21-30mins□ □ □ □
0 2 5 7
Omins□
10
20mins 21-30mins >30mins □ □ □
10 14 20
Official use□
20mins 21-30mins >30mins □ □ □
14 21 30
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Official use
Signature:
Date:
3.5.2 VAS assessment
A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a 
characteristic or attitude that is believed to range across a continuum of values and cannot 
easily be directly measured. For example, the amount of pain that a patient feels ranges 
across a continuum from none to an extreme amount of pain. From the patient's perspective 
this spectrum appears continuous - their pain does not take discrete jumps, as a 
categorization of none, mild, moderate and severe would suggest. It was to capture this idea 
of an underlying continuum that the VAS was devised.
Operationally a VAS is usually a horizontal line, 100 mm in length, anchored by word 
descriptors at each end, as illustrated in Fig. 3.5 below. The patient marks on the line the 
point that they feel represents their perception of their current state. The VAS score is 
determined by measuring in millimeters from the left hand end of the line to the point that the 
patient marks.
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Visual
Analogue
Scale
(VAS)
How severe is your pain this morning? Place a 
vertical mark on the line below to indicate how 
bad you feel your pain is now.
■S '
4 /
Unbearable
Distress
§<p
I
/ /
1 • J . 1 ;I _____
L .  i
I |
1 1 
5 7 t
- 1 1
3 ‘5 <
1 l
I 3 2
1 1 1
1
> 1 0 
I |
1 1 1 1 “
No
Distress
Signature:
Date:
Fig. 3.5 Visual analog scale (VAS) example
3.6 Conclusions
Achilles tendon disorders are common found among athletes and the general public. 
Two-thirds of Achilles tendon injuries in competitive athletes are paratendinopathy and 
one-fifth are insertional complaints (bursitis and insertion tendinitis). As described in this 
chapter, the remaining afflictions consist of pain syndromes of the MTJ and tendinopathy. 
Achilles tendon injuries have been split into overuse injuries and spontaneous ruptures. 
Many factors contribute to the development of tendinopathy: extrinsic factors, such as 
training errors and environmental conditions, as well as intrinsic factors, such as 
malalignments, age, and gender. ESWT is considered to be an effective and safe treatment 
for Achilles tendinopathy. In order to obtain the undergoing condition of Achilles tendinopathy, 
VISA-A and VAS are commonly used to evaluate the clinical severity. The next chapter will 
focus on the fundamentals of ultrasound which is commonly used in the diagnosis of Achilles 
tendinopathy.
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4. Ultrasound
Ultrasound providing high-resolution images without the use of ionizing radiation is one of the 
most widely used modalities in medical imaging. Ultrasound imaging is regularly used in 
cardiology, obstetrics, gynecology, abdominal imaging, etc. It is also mostly non-invasive, 
although an invasive technique like intra-vascular imaging is also possible. Non-diagnostic 
use of ultrasound is finding increased use in clinical applications, (e.g., in guiding 
interventional procedures). There are also novel non-imaging uses of ultrasound like bone 
densitometer where the ultrasound speed difference is used to measure the depth or width of 
bones non-invasively.
4.1 Basic Ultrasound Physics
4.1.1 Introduction
Sound waves above a frequency of 20 kHz are termed “ultrasound”. Like all sound waves, 
ultrasound propagates through various media in the form of a pulsating pressure wave. 
Waves are basically of two types -  longitudinal and transverse. Longitudinal waves are those 
in which particle motion is along the direction of propagation of the wave energy. Sound 
waves are longitudinal. Transverse waves are perpendicular to the direction of propagation 
of the wave energy (Hennerici and Neuerburg-Heusler 2006).
4.1.2 Properties of waves
When particle displacement is plotted against distance, the wavelength (A) of a wave is the 
distance from crest to crest, or from trough to trough. A wave cycle is a sequence of changes
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in the amplitude that recur at regular intervals. The frequency (/) of a wave is the number of 
cycles passing a given point in one unit of time (usually one second). The unit of frequency is 
the herts (Hz; one cycle per second).
The speed of wave propagation through a medium is known as the acoustic velocity, c. This 
speed depends on the density and compressibility of a medium to be present. In addition, the 
medium also has to be compressible-that is, it must be able to deform temporarily and then 
return back to its original shape (Fish 1990).
The speed of ultrasound:
m/s 
Where
p = density (kg/m3)
K  = elastic modulus (stiffness) = stress/strain (kgm 'V2)
4.1.3 Reflection
Ultrasound reflections occur when there is an interface between two media with differing 
levels of resistance to ultrasound. Such interfaces are known as “specular reflectors”. 
Resistance to ultrasound is termed acoustic impedance. Acoustic impedance depends on 
the speed of ultrasound propagation in tissue and on the density of the tissue concerned. 
The greater the difference in impedance, the stronger the reflection. Mathematically, acoustic 
impedance (Z) is given by:
Z - p c
Where
p = density (kg/m3)
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c is the speed of ultrasound
Acoustic impedance is thus a measure of the resistance to sound passing through a medium. 
High density materials are associated with high sound velocities and therefore high acoustic 
impedances. Similarly, low density media such as gases have low acoustic impedances. It is 
not important which impedance is larger or smaller for two media forming an interface; the 
same reflection occurs whether sound is propagating from high impedance tissue to low 
impedance tissue or vice versa (Shutilov 1988).
4.1.4 Refraction
If a sound beam strikes an interface at an angle other than 90°, the part of the beam that is 
transmitted further is refracted or bent away from the straight path that would have been 
expected. This refraction takes place in accordance with Snell’s law of optics, which relates 
the angle of transmission to the relative velocities of sound in the two media. Then bending 
occurs because the portion of the wavefront in the second medium travels at a different 
velocity compared with that in the first medium. As may be expected, the amount of deviation 
from the expected path changes with the angle of incidence and with the velocities in the 
associated media. If the velocity of sound is the same in both media, then there will be no 
refraction, even though there may be different acoustic impedances (Fish 1990).
4.1.5 Scattering
Tissue particles that are relatively small in relation to the wavelength (e.g., blood cells), and 
particles with differing impedance that lie very close to one another, cause scattering or 
speckling. Reflecting media that lie at an angle to the ultrasound propagation axis can only 
be recognized due to these scattering phenomena, which are accompanied by an 
attenuation in the echo intensity (Hennerici and Neuerburg-Heusler 2006).
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4.1.6 Attenuation
The stronger the reflections are at the interfaces, the less ultrasound energy is available to 
reach deeper tissue. If a total reflection occurs at an interface to air, bone, or 
calcium-containing tissue, then an ultrasound shadow results. Most of the ultrasound energy 
is converted into kinetic energy within the tissue. The term attenuation characterizes the 
reduction in the amplitude of an ultrasound wave as it propagates through a medium, due to 
both scattering and absorption. Attenuation is described by an exponential function. The 
attenuation coefficient is given by:
A /
a =   m
I  Ax
Where A l  is the loss of intensity from incident intensity I  during passage through a thin 
layer of thickness Ax and where AI  / 1 «  1 (small change of intensity).
The coefficients quantitate the respective fractional loss in amplitude per unit length from 
absorption, scattering, and both processes together. The special unit used for these 
coefficients is the neper (Np) per centimeter. The attenuation coefficients at 1 MHz for 
various tissue types are shown as below (Fish 1990):
Table 4.1 Attenuation of various human tissues at 1 MHz
Tissue Np/cm
Blood 0.021
Fat 0.069
Brain 0.098
Liver 0.103
Kidney 0.115
Skull bone 2.3
Lung 4.6
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4.1.7 The Doppler effect
The flow velocity of corpuscular elements in the blood can be detected with ultrasound by 
using a principle named after Christian Andreas Doppler (1803-1852). When using this 
principle to investigate blood flow, it refers correspondingly to a change in frequency called 
the Doppler shift, f d (Hz), which is proportional to the flow velocity of blood, V  (cm/s), and 
to the transmission frequency of ultrasound, f 0 (MHz) (Hennerici and Neuerburg-Heusler 
2006).
Exact measurement of the Doppler shift requires that the angle 0  between the ultrasound
beam and the longitudinal axis of the blood vessel is known:
r  -2 F /Ocos(0)
J d ~
c
Where
V  = scatterer velocity 
/ 0 = transmitted frequency 
c = speed of ultrasound
0 -  angle between the bisector of the transmitter and receiver beams and the direction of 
movement
When blood vessels are examined, the reflection caused by the blood’s corpuscular 
elements, mainly erythrocytes, plays a major role. Since the flow velocity through the 
different areas of any given cross-section of a blood vessel varies, the Doppler signal itself 
does not correspond to a single frequency, but contains a broad frequency spectrum (Fish 
1990).
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4.2 Ultrasound Technology
4.2.1 Introduction
Ultrasound waves are produced by a vibrating crystal using a piezoelectric effect. This effect 
involves the characteristic that certain materials have of changing their form when subjected 
to an electric current -  or vice versa, of producing an electric current due to changes in their 
form. These piezoelectric crystals are placed in a specific arrangement within the ultrasound 
probe.
In order to improve the acoustic coupling (impedance match), a gel is applied between the 
crystal and the surface of the skin.
4.2.2 A-mode and B-mode ultrasound
4.2.2.1 A-mode
A-mode (Amplitude) displays the amplitude of a sampled voltage signal for a single sound 
wave as a function of time. This mode is considered 1D and used to measure the distance 
between two objects by dividing the speed of sound by half of the measured time between 
the peaks in the A-mode plot, which represents the two objects in question. This mode is no 
longer used in ultrasound systems (Fish 1990).
4.2.2.2 B-mode
B-mode (Brightness) imaging is the same as A-mode, except that brightness is used to 
represent the amplitude of the sampled signal. B-mode imaging is performed by sweeping 
the transmitted sound wave over the plane to produce a 2D image. Typically, multiple sets of 
pulses are generated to produce sound waves for each scan line, each set of pulses are
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intended for a unique focal point along the scan line (Murtaza Ali 2008).
4.2.3 Doppler systems
4.2.2.1 Continuous-wave Doppler ultrasound
Continuous-wave (CW) Doppler equipment uses two piezoelectric elements with overlapping 
ultrasound fields, which serve as the transmitter and the receiver (Fig. 4.1). The transmitter 
(T) is connected to an oscillator and transmits ultrasound continuously. The ultrasound 
reflected and scattered from tissue structures is picked up by the receiver (R) mounted in the 
same probe. The electrical output from this transducer is amplified and fed to the Doppler 
demodulator where it is mixed with a signal (the reference signal) from the transmitter 
oscillator (Fish 1990).
Fig. 4.1 The principle of continuous-wave Doppler ultrasound
Due to the continuous and simultaneous emission and reflection of ultrasound waves, no 
exact information about depth can be obtained with this equipment (Murtaza Ali 2008).
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4.2.2.2 Pulsed-wave Doppler ultrasound
Pulsed-wave (PW) Doppler ultrasound is used to detect blood flow at a specifically defined 
depth. Using a single piezoelectric element, these systems function alternatingly as the 
transmitter and receiver (Fig. 4.2). The transducer is driven during transmission by a short 
burst of voltage from the oscillator when the timing circuits open the gate between the 
oscillator and the transducer. Ultrasound is backscattered to the receiving transducer, as CW 
Doppler, amplified and passed to the Doppler demodulator but in this case the output of the 
demodulator is not monitored continuously but sampled by opening a gate after a delay 
following the transmitter pulse (Fish 1990).
Fig. 4.2 The principle of pulsed-wave Doppler ultrasound
PW Doppler overcomes the range ambiguity inherent in CW Doppler. PW Doppler sends 
pulses of a certain length to a target at a certain range. The received pulses are dilated (or 
contracted) due to Doppler, and hence, the delay in the arrival of the pulse also provides 
velocity information. In CW Doppler, the received frequency is compared to the transmitted 
frequency but in PW Doppler each received echo is compared to a similar echo from a
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previous transmission (Hennerici and Neuerburg-Heusler 2006).
4.2.4 Colour Doppler imaging
Grey-scale B-mode image with superimposed colour indicating blood-flow velocity and 
direction is termed colour Doppler ultrasound (CDU). Unlike PW Doppler techniques, which 
acquire Doppler signals at restricted predetermined depths only, CDU acquires Doppler 
information at multiple locations along each scan line, i.e. at each position of the ultrasound 
beam during scanning.
A commonly used method for measuring blood-flow velocity in CDU is autocorrelation, which 
involves repeating the pulse-echo-sequence several times (typically 4 -8 ) along the same 
scan line, and comparing the phase of the echo signal at each depth from one pulse - echo 
sequence to the next. For stationary reflectors, the phase is the same from one echo to the 
next. For moving reflectors, like red blood cells, the phase of the signal will vary from echo to 
echo according to the flow velocity and direction. The autocorrelation technique estimates 
the mean velocity and variance at each depth location and places this information in a colour 
image memory, a process which provides data for a single scan line. The ultrasound beam is 
then moved to the next scan line position, and the procedure repeated. In the final image, 
each pixel containing flow information is colour-coded according to blood flow direction and 
mean velocity. To obtain more exact flow information such as Doppler wave form, maximum 
velocity, spectral broadening, resistance index etc., CDU must be combined with PW  
Doppler. Since CDU requires multiple pulse-echo sequences at each scan line, the scanning 
frame rate is lower than in standard B-mode imaging. To improve time resolution, the 
colour-coded field may be restricted to only a part of the entire image (Murtaza Ali 2008).
4.2.5 Power Doppler imaging
PDU is an option in CDU instruments, and just as in CDU, the Doppler signal is sampled at
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multiple locations along each scan line. The technique differs from conventional CDU in the 
way the Doppler signals are processed; instead of estimating mean frequency and variance 
through autocorrelation, the integral of the power spectrum is estimated and colour coded. 
The colours in the PDU indicate only that blood flow is present; they contain no information 
on flow velocity (Murtaza Ali 2008).
The colour and brightness of the signals on PDU are related to the number of blood cells 
producing the Doppler shift. The greater sensitivity of PDU for detecting blood flow in 
comparison with CDU is due to several factors. Noise can be assigned to a homogeneous 
background, thus allowing the gain to be increased over the level of CDU. Moreover, in PDU 
more of the dynamic range of the Doppler signal can be used to increase sensitivity. PDU is 
also less angle-dependent than CDU, thus allowing better display of curving or tortuous 
vessels. Finally, relying on the Doppler amplitude means there is no aliasing; this improves 
the display of vessel wall pathology in areas of turbulent flow. Reports on the clinical value of 
power Doppler imaging have demonstrated distinct advantages with this technique in 
assessing the surface structures of atherosclerotic plaque (Griewing et al. 1996).
4.2.6 Transducer/Probe
There are three different types of images obtained by multi-element array transducers, i.e. 
linear, convex, and phased (Fig. 4.3). The linear array transducer selects the region of 
investigation by firing a set of elements situated over the region. The beam is moved over the 
imaging region by firing sets of contiguous elements. Focusing in transmission is achieved 
by delaying the excitation of the individual elements, so a concave beam shape is emitted.
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elements— 7*
Active
Linear array transducer Curved array transducer
Beam profile
Image
area
Active
Beam
elements
Phased array transducer Sector scan transducer
Active elements x  Active element
Beam profile
Fig. 4.3 Ultrasound transducers
The linear arrays acquire a rectangular image, and the arrays can be quite large to cover a 
sufficient ROI. A larger area can be scanned with a smaller array if the elements are placed 
on a convex surface as shown in Fig. 4.3. A sector scan is then obtained. The method of 
focusing and beam sweeping during transmission and reception is the same as for the linear 
array, and a substantial number of elements (often 128 or 256) is employed (Jensen 2007).
4.2.7 3D ultrasound
3D imaging with ultrasound was first described in 1956 for stereoscopic observation of body 
structure (Howry et al. 1956). This technique has been continuously developed in the last 
decades. It obtained serial parallel ultrasound images and then created a 3D display by 
stacking sequential photographic plates of the images. Although rapid developments in 
ultrasound scanning equipment and in computer hardware and software have occurred, the 
basic requirements of producing 3D ultrasonographic reconstructions have not changed:
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adequate two-dimensional images, a known spatial relationship, and orientation of each 
two-dimensional image to a common external reference point, as well as techniques for 
volume reconstruction and visualization (Hennerici and Neuerburg-Heusler 2006).
3D ultrasound is most commonly acquired in one of three ways (Fig. 4.4). The most obvious 
approach, although the most difficult to achieve, is to have a 2D array of transducer elements 
in contact with the object to be scanned (Fig. 4.4(b)). This can record 3D data directly by 
firing and receiving with different combinations of elements. Because dense arrays of 2D 
transducers are difficult to build, alternative approaches have been developed using 1D 
transducer arrays to produce 2D B-scan images at known locations in 3D space. The second 
group of acquisition strategies involves sweeping the 1D transducer array through a known 
trajectory using a mechanical device (Fig. 4.4(a)). The third group of acquisition strategies 
involves letting the clinician sweep the 1D transducer array manually across the subject and 
using some sort of tracking device to measure its trajectory (Fig. 4.4(c)) (Prager et al. 2009).oo
(b) (c)
Fig. 4.4 3D ultrasonographic imaging acquisitions
There are some advantages offered by 3D US. Firstly, the 3D US contributes to eliminating 
operator dependence in the scanning process. 2D ultrasound requires the clinician to sweep 
the probe back and forth across the subject while mentally visualizing the anatomy from 
multiple 2D images. 3D, on the other hand, often requires only the acquisition of a single 
volume. Once this has been acquired it can be visualized using slices at any angle and a 
variety of measurements may be taken from it (Prager et al. 2009). Secondly, quantitative
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estimates in 2D ultrasound are based on heuristic formulae with strong prior assumptions 
which are prone to error. 3D US provides a more accurate and repeatable way of evaluating 
anatomic structures and disease entities (Pauletzki et al. 1996).
4.2.8 3D power Doppler
Images of vascular anatomy can be produced using conventional angiography, computed 
tomography angiography, Doppler ultrasound or magnetic resonance angiography. 
Angiograms established using these techniques are clinically useful because they allow for 
the identification of stenoses and aneurysms (Ritchie et al. 1996). Each of these techniques 
can be applied to investigate the large (greater than 2 or 3 mm diameter) vessels in the head, 
neck, thorax, abdomen and extremities. Conventional angiography and Doppler ultrasound 
can also be used to image vessels with diameters on the order of 1 mm or smaller (Ritchie et 
al. 1996).
Visualizing lower velocity flows in small vessels is a necessary first step for assessing 
perfusion in parenchymal organs such as the kidney or placenta. The second step is to 
assess qualitatively, and potentially quantitatively, the perfusion of parenchymal organs by 
the way of visualizing low-velocity flows in small vessels. Furthermore, the method must also 
allow for visualization of flow throughout the volume of the organ. Conventional angiography 
meets these criteria; however, the techniques is invasive and complications are possible 
during catheterization, and the exposure of pregnant women and others to ionizing radiation 
should be avoided (Ritchie et al. 1996).
Doppler ultrasound, using transducer frequency from 3 to 12 MHz can resolve small vessels 
and is able to display low-velocity flows. Some investigators (Ritchie et al. 1996; Porter et al. 
2001; Vlaisavljevic et al. 2003) described an ultrasonic angiography system that is able to 
create 3D images of parenchymal vasculature from 2D power-mode Doppler images. This
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system allows for the imaging of low-velocity flows in small vessels.
3D PDU can be applied in all fields of medicine where quantification of vascularization, 
neovascularization or revascularization is of potential importance in clinical decision making 
(Schulten-Wijman et al. 2008). Several reports have used 3D PDU to create the visualization 
of blood flow in the carotid artery, the fetal heart, the breast, the kidney, the placenta, the 
prostate, the feto-placental vasculature, and the endometrial vasculature (Fenster and 
Downey 1996; Ritchie et al. 1996; Nelson and Pretorius 1998; Welsh et al. 2001; Merce et al. 
2006).
4.3 Conclusions
This chapter briefly introduced the physics and fundamentals of ultrasonography. Ultrasound 
imaging is a non-invasive, inexpensive tool used in cardiology, obstetrics, etc. Recently, 
B-mode ultrasound imaging and Doppler systems have been widely applied in daily 
diagnosis. 3D Doppler ultrasound can be used in quantifying the vascularization, which is 
prospectively used to measure the volume of the neovascularity in Achilles tendinopathy 
from chapter 6. The next chapter will describe the previous studies in the investigation of pain 
and neovascularization in Achilles tendinopathy, as well as the optimized machine settings 
we recommended.
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5. Achilles Tendinopathy and Ultrasound
Ultrasonography, which is regarded as a readily available, quick, safe, and inexpensive test, 
has been widely used in the diagnosis of Achilles tendinopathy (Maffulli et al. 1987). The 
normal Achilles tendon should have an echogenic pattern of parallel fibrillar lines in the 
longitudinal plane and an echogenic round-to-ovoid shape in the transverse plane. The 
number of echogenic lines that is visible in the tendon with ultrasound is simply a correlate of 
the ultrasound probe frequency (Martinoli et al. 1993). Focal hypo-echogenic or diffuse 
thickening of the Achilles tendon is seen most commonly in association with tendinopathy 
(Astrom et al. 1996; Ohberg L 2001), the tendon thickness may range from 7 to 16 mm 
(Fornage 1986).
5.1 Achilles Tendon Neovascularization
5.1.1 Pain and neovascularization
The cause of pain in Achilles tendinopathy is thought to be related to the presence of 
neovascularization in the tendon as seen on colour and PDU. A research group suggested 
that all painful tendons demonstrate neovascularization (Ohberg L 2001; Ohberg and 
Alfredson 2002; Alfredson et al. 2003). When these neo-vessels are sclerosed, in a 
middle-aged population, the pain has been shown to be remarkably reduced in both a 
population with mid-tendon and a population with enthesis pain.
5.1.2 Neovascularization and Doppler ultrasound
Much attention has been given in assessing the distribution of neovascularization on colour
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and PDU of the Achilles tendon in tendinopathy, and to look for any relationship between 
tendon morphology and symptoms (Boesen et al. 2006a; de Vos et al. 2007a; Knobloch 
2008).
Power Doppler, unlike colour Doppler, is not dependent on the probe being directionally 
aligned to the flow and therefore will identify all flow independent of velocity, theoretically 
improving sensitivity over colour Doppler (Rubin et al. 1994). In vitro validation found power 
Doppler up to 4 times more sensitive than colour Doppler for the detection of micro-vessels 
with flow detection in tubes as small as 0.3 mm, where flow may sludge and no flow is seen 
on colour Doppler (Weskott 1997).
With the use of PDU, a retrospective observational study (Richards et al. 2005) suggested a 
non-linear relationship between the number of vessels seen on power Doppler and Achilles 
tendon size. They also conclude the following: (1) power Doppler shows more tendon 
microvascularity than colour Doppler in Achilles tendinopathy; (2) all micro-vessels arise on 
the ventral side of the Achilles tendon; (3) there is a nonlinear relationship between 
tendinopathy, Achilles tendon size, and the amount of microvascularity, but not between 
power Doppler and duration of symptoms; and (4) morphologically abnormal adult Achilles 
tendons were larger than 5.9 mm, and power Doppler flow was only seen in Achilles tendons 
above 6.5 mm.
Another study (de Vos et al. 2007a) reported the same results at baseline, with 58 patients 
with 63 symptomatic tendons. They used the Ohberg score (Ohberg and Alfredson 2002), 
with 0 for no vessels visible, 1+ for 1 vessel mostly in the anterior part, 2+ for 2 vessels 
throughout the tendon, 3+ for 3 vessels throughout the tendon, and 4+ for >3 vessels 
throughout the tendon, with no correlation of the degree of neovascularization (0-4+) and 
pain on the visual analog scale. After a 12-week treatment with heavy-load eccentric training
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with or without an additional night splint, a significant correlation of the level of 
neovascularization and the visual analog scale score was evident (r=.43, p<.001).
Another scoring system was used in the evaluation of Achilles tendon neovascularization 
(Richards et al. 2005). The use of many different scoring systems, none of which have been 
validated, makes comparing results from different research groups difficult. The lack of 
validated scoring system means that any changes in score must also be interpreted with 
caution and is a major weakness in the field of tendinopathy research.
Another research group (de Vos et al. 2007b) performed their study to examine whether the 
degree of neovascularization detected with power Doppler is correlated with clinical severity 
before and after conservative treatment. They concluded there was no significant correlation 
before treatment, yet after treatment, a correlation was found. The role of neovascularization 
in Achilles tendinopathy is still unclear. The exact origin of the pain in chronic tendinopathies 
is debatable. A study gave a possible explanation upon the source of pain. It might due to the 
in-growth of neo-vessels and their accompanying nerves in the tendinopathic part of the 
tendon (Alfredson 2003).
Eccentric training might decrease the amount of neovascularization. A recent report found 
(Alfredson and Ohberg 2006) an increase in neovascularization in every patient in the first 3 
weeks after treatment with sclerosing injections. After this period, less pain was reported in 
patients, with a decrease of neovessels; patients with a high neovascularization score 
reported high pain scores.
One study (Reiter et al. 2004) reported the presence of neovascularization in symptomatic 
Achilles tendons and this was associated with a low Victorian Institute of Sport 
Assessment-Achilles (VISA-A) score (Robinson et al. 2001), which is used to assess the
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Achilles tendon clinical outcomes. However, another study (Sengkerij et al. 2009) found no 
correlation between VISA-A score and neovascularization score.
5.1.3 Reliability of power Doppler in the investigation
A recent study (Sengkerij et al. 2009) reported the excellence of the interobserver reliability 
of determining the neovascularization score using PDU. Neovascularization was present in 
70% (23/33) of symptomatic tendons and 29% (5/17) of asymptomatic tendons. The 
prevalence of neovascularization in symptomatic tendons using PDU was within the range 
from 47% to 88% reported by several other investigators (Peers et al. 2003; Zanetti et al. 
2003; Reiter et al. 2004; de Vos et al. 2007a; Leung and Griffith 2008). On the contrary, some 
studies (Ohberg L 2001; Ohberg and Alfredson 2002; Lind et al. 2006) demonstrated 
neovascularization in all symptomatic tendons. Besides examining the prevalence of 
neovascularization in symptomatic tendons, about 30% of asymptomatic tendons had a 
degree of neovascularization (Boesen et al. 2006b).
Although analyzing Achilles tendons with PDU is reliable the conflicting results about the 
presence of neovascularization and correlation between the degree of neovascularization 
and pain or discomfort do not help to clarify the significance of neovascularization in Achilles 
tendinopathy. At present, there is insufficient evidence to be able to clearly state the role of 
neovascularization in chronic tendinopathies. Therefore, this thesis will quantify 
microcirculatory mapping in the Achilles tendinopathy to detect a potential correlation of 
patient symptoms with VON.
5.1.4 Summary of the recent studies
Studies regarding the correlation between the neovascularization detected using Doppler 
ultrasonography and Achilles tendinopathy are summarized in Table 5.1. Some studies 
(Ohberg L 2001; Ohberg and Alfredson 2002; Alfredson et al. 2003; Zanetti et al. 2003;
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Reiter et al. 2004) agree there is a potential or possible correlation between the 
neovascularization and symptoms, while others (Peers et al. 2003) (Richards et al. 2005; 
Boesen et al. 2006b; de Vos et al. 2007a; Koenig et al. 2007; van Snellenberg et al. 2007; 
Sengkerij et al. 2009) disagree.
Table 5.1 Summary of studies investigating the correlation between the Doppler 
ultrasonography and Achilles tendinopathy
Study
N um ber o f 
sym ptom atic  
tendons  
exam ined
C olour or 
pow er 
D oppler used 
(m achine  
used)
U ltrasound
m achine
settings
D opp ler  
s ignal fou nd  
in
tend inop ath y
Conclusion
(Ohberg L 
2001)
28
Colour
(ACUSON
Sequoia
C512)
Frequency: 
8-13 MHz. 
PRF & CG 
not 
mentioned
100%
Neovascularization is not 
seen in pain-free tendons but 
it might be involved in painful 
chronic Achilles tendinopathy.
(Ohberg
and
Alfredson
2002)
10
Colour
(ACUSON
Sequoia
C512)
Frequency: 
8-13 MHz. 
PRF & CG 
not 
mentioned
100%
Neovascularization is a 
potential cause of tendon 
pain, the probable importance 
of neovascularization in 
midportion tendinosis was 
confirmed.
(Zanetti et 
al. 2003)
55
Power
(Elegra,
Siemens)
Frequency: 
7.5-9.0 MHz. 
PRF= 
1.25kHz
55%
Neovascularization of Achilles 
tendons seems to be 
associated with pain but not 
with an unfavorable outcome.
(Alfredson 
et al. 
2003)
25
Colour
(ACUSON
Sequoia
C512)
Frequency: 
8-13 MHz. 
PRF & CG 
not 
mentioned
100%
There is a vasculo-neural 
ingrowth in the structurally 
changed part of the tendon 
that possibly can explain the 
pain suffered from chronic 
painful Achilles tendinosis 
tendons.
(Peers et 
al. 2003)
25
Power 
(HDI 5000, 
ATL-Philips)
Frequency: 
5-12 MHz. 
PRF=1kHz, 
CG=81%
88%
Power Doppler signal does 
not strictly relate to pain or 
symptoms but possibly 
represents an additional risk 
adding to the clinical 
information on Achilles
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tendinopathy.
(Reiter et 
al. 2004)
19
Both 
(GE LOGIQ 
9)
Frequency: 
14 MHz 
CG was 
optimized to 
see on flow 
in the 
contralateral 
asymptomati 
c Achilles 
tendon.
74%
Neovascularization within the 
Achilles tendon can be an 
important condition 
associated with pain in 
chronic Achilles tendinopathy.
(Ohberg
and
Alfredson
2004)
41
Colour
(ACUSON
Sequoia
C512)
Frequency: 
8-13 MHz. 
PRF & CG 
not 
mentioned
100%
Action on the area with 
neovascularization during the 
eccentric training regimen 
might possibly be responsible 
for the good clinical results.
(Richards 
et al. 
2005)
55
Power 
(ATL HDI 
3000 
Philips)
Frequency: 
5-12 MHz. 
PRF = 0.8 to 
1kHz,
CG adjusted 
to no colour 
signal was 
present 
deep to the 
cortical 
bone.
82%
Power Doppler shows more 
microvascularity than colour 
Doppler. There was non-linear 
relationship between 
tendinopathy, Achilles tendon 
size and the amount of 
microvascularity, but not 
between power Doppler and 
duration of symptoms.
Colour 
(ATL HDI 
3000 
Philips)
44%
(Boesen 
et al. 
2006c)
11
Colour
(Mountainview,
California)
Frequency: 
14 MHz. 
PRF & CG 
not 
mentioned
100%
No effect on the 
intratendinous Doppler signal 
could be detected, suggesting 
that the effect is independent 
of changes in blood flow.
(Koenig et 
al. 2007)
22
Colour
(Mountainview,
California)
Frequency: 
14 MHz. 
Optimized 
for low flow 
with a gain 
setting just 
below the 
level that 
produces 
random 
noise.
12%
The mere presence of some 
Doppler signal cannot be 
regarded as pathological 
since they found it in 
asymptomatic individuals.
(van 128 Colour Frequency & 4% There was low prevalence of
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Snellenbe 
rg et al. 
2007)
(HDI 5000 
SonoCT 
Philips)
PRF & CG 
not 
mentioned
Achilles tendinopathy in the 
subjects. Neovascularization 
was rare and was observed 
regardless of the presence of 
pain, swelling or tenderness.
(Boesen 
et al. 
2006b)
11
Colour
(Mountainview,
California)
Frequency: 
14 MHz. 
Gain setting 
just below 
the level that 
produces 
random 
noise.
100%
Mere presence of Doppler in 
the Achilles tendon does not 
per se indicate disease. 
Without defined thresholds for 
the amount of Doppler signal, 
pathologic and physiologic 
perfusion cannot be 
distinguished in all cases.
(de Vos et 
al. 2007a)
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Power
(Elegra,
Siemens)
Frequency: 
8-13 MHz. 
PRF & CG 
not 
mentioned
63%
There was no correlation 
between neovascularization 
and VISA-A or VAS at 
baseline, but at follow-up, a 
higher neovascularization 
score was significantly 
correlated with a worse 
VISA-A and a higher VAS.
(Sengkerij 
et al. 
2009)
50
Power
(Elegra,
Siemens)
Frequency: 
8-13 MHz. 
PRF=868Hz
70%
An excellent interobserver 
reliability (ICC 0.85) was 
found. No correlation was 
found between VISA-A score 
and neovascularization score.
5.2 Optimizations in Achilles tendinopathy Studies
5.2.1 The use of power and colour Doppler ultrasound
CDU and PDU have been applied to investigate the role of neovascularization in Achilles 
tendinopathy. Although CDU and PDU provided equal findings in the detection of blood flow 
within the Achilles tendons (Reiter et al. 2004), more support was given to power Doppler 
because it varies from colour Doppler in that the imaging is relatively independent of the 
angle of incident beam (Zanetti et al. 2003). Another advantage of power Doppler is that it is 
more sensitive than colour Doppler to detect flow in vessels as small as 0.3 mm in diameter
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(Weskott 1997), that is an area of 7.065x104 pm2. However, from Table 5.1, colour Doppler 
was applied more often than power Doppler in the evaluation of Achilles tendinopathy.
In certain circumstances power Doppler is preferred over colour Doppler for examination of 
blood flow (Richards et al. 2005); the former could demonstrate a greater number and extent 
of vessels. Therefore, power Doppler ultrasound was applied in all the patients in this thesis.
5.2.2 The importance for settings optimization
Some researchers in Table 5.1 (Ohberg L 2001; Ohberg and Alfredson 2002; Alfredson 2003; 
Ohberg et al. 2004; Boesen et al. 2006b; Boesen et al. 2006c; Lind et al. 2006) reported 
neovascularization was noted in all symptomatic tendons, whilst another studies (Peers et al. 
2003; Koenig et al. 2007; van Snellenberg et al. 2007) showed that in chronic Achilles 
tendinopathy tendon blood flow measured by power Doppler did not directly correlate to pain 
or symptom evaluation.
Part of the difference may result from the fact that neovascularization is a dynamic finding 
that may be most pronounced during acute exacerbation of pain and then disappear at 
inconstant rates (Zanetti et al. 2003). Another reason that might cause these contradictory 
conclusions may be due to the difference of performing Doppler ultrasound examination, in 
terms of the transducer frequency, settings of ultrasound machine (Yang et al. 2010). The 
PRF values listed in Table 5.1 range from 868 to 1250 Hz. There are no comparative studies 
between the set value or using a range of values for the PRF. The colour gain (CG) settings 
are not clearly indicated in most studies. The standard settings are essential to distinguish 
between physiological (slight) Doppler signals and possible pathological signal (Boesen et al. 
2006a). The optimization of machine settings is of importance for reproducing results and 
allowing comparison among studies. Specifying settings will assist in standardization 
(Joshua et al. 2006). Therefore, the possible parameters were investigated on ultrasound
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machine to achieve the optimization of examination conditions prior to scan any Achilles 
tendon.
5.2.3 The pulse repetition frequency
The settings of pulse repetition frequency (PRF) are potential factors affecting the Doppler 
signal which have not been widely discussed in the examinations of Achilles tendons. PRF 
setting determines the sensitivity of both colour and power Doppler; high-velocity flow is able 
to be detected by high PRF, and therefore filters that remove low flow to remove noise are 
applied (so-called linked controls) (Torp-Pedersen and Terslev 2008).
It has been reported that the area of the intratendinous vessels ranges from 6.99x104 |jm2 to 
14.97x104 pm2 (the radius ranges from 149.2 pm to 218.4 pm.) (Carr and Norris 1989), 
Another study by Wescott reported that the detectable flow velocity for colour Doppler under 
this range is no less than 0.7 cm/sec (Weskott 1997). They concluded that in order to 
reasonably investigate the blood flow of 0.7 cm/sec, the PRF should be adjusted to 1 kHz 
with the measuring angle between the probe and the flow of 45° (Weskott 1997). However, to 
test these settings, a Toshiba Aplio machine was used with the PRF of 1.1 kHz to ultrasound 
the radial artery (Fig. 5.1a). At these values, the “flash” artifacts caused by moving soft tissue 
were very pronounced. This is because the intensity echo signal from moving soft tissue has 
much higher amplitude than intensity echo signal from flowing blood (Campbell et al. 2004), 
whereas the study by Wescott looked at blood flow detection in a flow phantom. It is found 
that at a PRF of 2.1 kHz with the blood flow scale of 1.5 cm/sec, most of the ‘flash’ artifacts 
were eliminated (Fig. 5.1b).
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(b)
Fig. 5.1 Colour Doppler image of radial artery (a) with PRF of 1.1 kHz and scale of 0.7 
cm/sec, (b) with PRF of 2.1 kHz and scale of 1.5 cm/sec
During the test, the PRF was found to be synchronically altered with the adjustment of either 
the sensitivity, depth, or the width of the Doppler box. For example, when increasing the 
width of the Doppler box, the PRF also automatically goes up while changes on the height of 
the Doppler box have no variance on PRF. The change of PRF and the hue on the Doppler 
image may differ between machines and between different manufacturers. Thus it is 
recommended to find a threshold for the PRF under specific settings of sensitivity, depth, and 
width of the Doppler box for a particular machine that just eliminates the ‘flash’ artifacts. Also, 
to reduce tissue motion the motion artifact eliminator (MAE), on the ultrasound machine, is 
suggested to set to the highest position.
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5.2.4 Machine settings optimization
If it is agreed the neovascularization is essential in evaluation of Achilles tendinopathy, the 
goal in the ultrasound investigation must be to detect as much flow as possible, thus, the 
machines settings should be adjusted to allow the machine to achieve its highest sensitivity 
without noise.
The lower PRF, the more ‘flash’ artifacts were noted. However, with higher the PRF, the 
scatterer with low Doppler frequency shift may be ignored. The PRF must therefore be 
chosen carefully, based on a tradeoff between maximum velocity resolution and the 
reduction of velocity aliasing and range ambiguity problems. To find out the optimized PRF 
value, the same ultrasound machine with a 12 MHz linear array probe was used to examine 
six healthy Achilles tendons. At the same transverse plane, subjects were observed with 
different sensitivity settings, 0.4(PRF=3.1 kHz), 0.8(PRF=6.1 kHz), 1.1(PRF=7.6 kHz), 
1.7(PRF=12.1 kHz), 2.6(PRF=18.9 kHz), 3.4(PRF=16.4 kHz), respectively (Fig. 5.2). All 
tendons showed ‘flash’ artifacts with the sensitivity settings below 1.1. Therefore, with a 
Doppler box of constant width, a PRF was deduced to 7.6 kHz in our examinations, which 
was suitable to remove “flash” artifact and detect flow.
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Sensitivity=0.4
insertion
f ;
Sensitivity=3.4Sensitivity=2.6
Sensitivity=0.8 Sensitivity=1.1
Sensitivity=1.7
Fig. 5.2 Achilles tendon transverse ultrasonography planes with different sensitivity 
settings at 6 cm from the calcaneal insertion
When I turned the sensitivity scale knob, the PRF increases up to a certain level, then jumps 
down, decreases to a similar maximum to previously, as indicated by the PRF difference 
between the sensitivity of 2.6 and 3.4. What is almost certainly happening is that the machine 
is re-setting to avoid range ambiguity. That is, if the PRF exceeds a certain value, the echoes 
returning from the maximum depth will reach the transducer after having sent out the next 
pulse. The machine will interpret it as being a shallow echo from the second pulse, rather 
than a deep echo from the first. I am not sure what, then, it is adjusting to allow the scale to 
increase even if the PRF is lower - it is presumably that there is an allowable window. It 
may involve coded excitation, or any number of complex processes in the machine.
The second parameter should be optimized is CG. The CG setting determines the sensitivity 
of the system to flow (Torp-Pedersen and Terslev 2008), weak flow signals are undetected 
and motion artefacts may be prevented by lowering the CG (Martinoli and Derchi 1997). So 
the settings on ultrasound machine were adjusted to the threshold to noise.
Obtaining the maximized spatial resolution and have good blood flow is affected by another
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important machine setting, Doppler frequency, which is not generally specified in the 
literature listed in Table 5.1. Higher Doppler frequency gives better spatial resolution i.e. a 
more detailed image of the blood vessels but at the expense of penetration (Torp-Pedersen 
and Terslev 2008). Frequency effects are much more important in Doppler than in B-mode 
grayscale imaging because the echo intensity from the moving scatters are much weaker 
than echoes used to create grayscale images. So there needs to be a trade-off between 
having a Doppler frequency low enough to detect the blood flow (penetration) and high 
enough to maximize spatial resolution. The more superficial the structure scanned, the 
higher the frequency can be used. Increasing Doppler frequency improves spatial resolution 
which decreases pixel size. The Doppler frequency was therefore chosen as highest as 
possible to maximize spatial resolution.
The machine settings under the preset of MSK mode are given in Table 5.2.
Table 5.2 Other parameters under the preset of MSK mode on the ultrasound machine
2DR 80 DR 55
CG 40 PRF 17.3kHz
Filter 5 Probe 14LX7
CF 8.8 DiftT 13.0
FR 12fps ApliPure 2
2D-Post Process 5 2D-AGC 0
2D-Time Smooth 4 2D-Edge enhance 1
2D-Psel 5 Focal No. 1
2D-Map 2 CDI-Map 6
Data No. 1 M.A.E. 2
CDI-Focal Position 50 Frame Interpolate 2
Cut-off 4 CDI-Time Smooth 4
Spatial Smooth 1 Power DR 20
CDI-Frequency 8.8MHz
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5.2.5 Inclusion criteria
On B-mode gray-scale ultrasonography, it is generally considered that a fibrillar pattern must 
be present without localized hypoechoic areas or calcifications in the normal tendons 
(Fornage 1986; Martinoli et al. 2002), while hyperaemia has been regarded to signify 
abnormality (Ohberg L 2001; Martinoli et al. 2002). The inclusion criteria for normality and 
abnormality still remain to be defined in longitudinal studies of an age-stratified reference 
material (Koenig et al. 2007). To our knowledge, two previous studies offered a similar 
inclusion criteria table during the investigations (de Vos et al. 2007a; Sengkerij et al. 2009). 
Without the reasonable inclusion criteria, discrepancy in individual studies may not be 
confidentially explained, therefore, an inclusion and exclusion criteria were developed, as 
shown in Table 5.3, to define the patients in the study group.
Table 5.3 Inclusion and exclusion criteria
Inclusion Criteria Exclusion Criteria
Aged 18 to 70 years (de Vos et al. 2007a)
Previous eccentric loading exercise 
programme just prior to scanning (de Vos et 
al. 2007a)
Have symptoms in the Achilles tendon 
more than 6 weeks (el Hawary et al. 1997)
Previous Achilles tendon surgery or rupture 
on the symptomatic lower limb (Munteanu 
etal. 2009)
Be able to complete the VISA-A and VAS 
questionnaire (Robinson et al. 2001)
Previous lower limb trauma which may 
have caused structural changes in the 
Achilles tendon (Munteanu et al. 2009)
Score less than 80 on VISA (el Hawary et 
al. 1997) and VAS not equal to 0 on VAS
Pathology at insertional location (de Vos et 
al. 2007a), bilateral tendinopathy and 
bursitis (Knobloch et al. 2008)
Pain and swelling positioned at 2 to 6 cm 
proximal to the calcaneal insertion(Vora et 
al. 2005)
Injection of local sclerotic or other 
anaesthetic effect agents into the Achilles 
tendon or surrounding area (Ohberg and 
Alfredson 2002)
B-mode ultrasound detects a local 
thickening and/or irregular fibre orientation 
and/or irregular tendon structure with 
hypoechoic areas (Alfredson et al. 2003; 
Zanetti et al. 2003)
Other systemic disorders
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5.2.6 Physical activity and other factors
Prior physical activity can influence the neovascularization score in the Doppler investigation 
(de Vos et al. 2007a). Blood flow, oxygen demand and the level of collagen synthesis 
increase with mechanical loading of the tendon (Boushel et al. 2000), thus the tendon should 
not be evaluated immediately after activity or eccentric training, which may create a 
physiological response (Boesen et al. 2006b). Standardization of physical activity before the 
Doppler scan is necessary. A study (de Vos et al. 2007a) recommended 24 hours’ abstinence 
from heavy-load eccentric training, sporting activity, or physical exertion.
Other factors including the degree of ankle plantar flexion, probe pressure impacted onto the 
skin during the examinations also needed to be validated and standardized in future studies.
5.3 Conclusions
This chapter focuses on the ultrasonic investigation of Achilles tendinopathy, specially the 
observation of neovascularization in Achilles tendon. In the experiment, the amount of 
neovascularization denoted by Doppler signals was found to be associated with the 
ultrasound machine settings. Optimized machine settings including PRF and CG were 
recommended, as well as inclusion criteria, physical activity, and other factors. The next 
chapter will describe a novel 3D Doppler ultrasound system to be used in the measurement 
of VON.
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6. Methods to Quantify Neovascularization
In PDU imaging, the integral of the power spectrum of the local blood flow is estimated and 
encoded in colour and superimposed over the 2D B-mode image. Power Doppler imaging 
therefore provides a spatial distribution of flow in relation to the associated anatomic 
structure, thus depicting the flow field. Currently, power Doppler imaging is therefore used 
mainly for qualitative analysis of blood flow, especially where blood flow volume is low. In this 
thesis, a new modality of ultrasound imaging, 3D power Doppler imaging, was applied to 
depict directly the VON for Achilles tendinopathy.
Figure 6.1 is a block diagram of our experimental system. The 3D power Doppler imaging 
system, developed in our laboratory, includes a Toshiba Apilo ultrasound machine with a 
12-MHz high resolution linear array probe, a specially constructed motor-driven translation 
assembly controlled by a custom-controller, and a Toshiba laptop workstation. The 
workstation is capable of image acquisition, reconstruction and display of 3D images in 
surface rendering and texture mapping modes. The linear array ultrasound probe was 
mounted on the translation assembly with the transducer axis parallel to the Achilles tendon 
(patients at prone position). Aset of planar 2D power Doppler images, transverse to the 
Achilles tendon, was acquired while translating the probe along the Achilles tendon at a fixed 
interval. These 2D images were digitized in a form of video clips in the ultrasound machine. 
After acquisition, a frame from each video clip was selected based on its maximal Doppler 
signal using a specially developed computer program. With the representative frames 
selected, they were reformatted into a 3D volume image to compensate for the intervals and 
recover the correct geometry using the commercial software. The resulting 3D volume image 
was viewed on the same workstation using the some software also. The software allowed
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rotation of the 3D image and interactive slicing into the volume in any plane in real-time with 
a computer mouse. A detailed technical description of the 3D power Doppler imaging system 
will be introduced as below.
Ultrasound
machine
1
► Workstation
Transducer
Achilles tendon
Motor
driver
4 .
Controller
Fig. 6.1 Block diagram of system
6.1 Ultrasound Machine and Probe
For this study, a Toshiba Apilo ultrasound machine (Fig. 6.2) with a 12-MHz high resolution 
linear array probe was used. The features of the machine are below.
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•  3 transducer ports
•  19” color LCD screen
•  Panoramic Zoom
•  Trapezoidal imaging
•  Dual and Quad screen imaging
•  Duplex / Triplex
•  Advanced Dynamic Flow: Increased color Doppler resolution
•  Micro Flow Imaging: Enables imaging of contrast medium
•  Hard drive
•  STIC: Spatio-Temporal Imaging Correlation
•  Cavity Imaging
•  DVI interfaces
•  Export to JPEG, TIFF, BMP and AVI
•  Patient info easily removed from images for HIPAA compliance
•  Flexible control panel for repositioning
•  2-D, M-Mode, PW, HPRF, Color Doppler, Power Doppler, Directional Power 
Doppler
Fig. 6.2 Toshiba Aplio features
6.1.1 Why power Doppler?
The reason why power Doppler was used in the 3D system is the power Doppler imaging 
has many promising properties for flow field mapping (Guo et al. 1995). It was initially 
developed for the assessment of low velocity flow. Instead of displaying the mean Doppler 
frequency shit, the colour map of power Doppler imaging displays the integrated power of the 
Doppler signal. The background noise is normally white and uniformly distributed and has 
lower power than the flow signal, therefore the noise will be represented as a homogeneous 
background colour even when the gain is increased beyond the level at which the random 
colour noise dominated the conventional colour Doppler image. This increases the sensitivity 
of flow mapping (Guo et al. 1995).
Because power Doppler imaging maps the power of the Doppler signal, it is in some way 
velocity-independent when there is no red cell aggregation or when a blood mimic is used. In 
fact, the Doppler power spectral curve has a wider bandwidth with lower amplitude for 
high-velocity flow and a narrower bandwidth with higher amplitude for low-velocity flow, 
making the integral under the curve almost identical.
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Power Doppler imaging has been used to detect soft-tissue hyperemia and to depict the 
Achilles tendon vasculature. In this study, 3D power Doppler imaging has been used to 
depict the neovascularization of the Achilles tendinopathy. The appearance of the 3D power 
Doppler image, after they have been rendered in 3D, was found to be similar to subtraction 
angiograms.
6.1.2 Settings on machine
In the power mode, the B-mode image in the colour overlay window give the information of 
soft tissue, i.e. Achilles tendon and its surroundings. The power Doppler images itself looks 
like a subtraction angiogram. The geometry of the neo-vessels was well defined and 
provided a reference for locating the examination, determining the colour gain, and the 
region of interest (Fig. 6.3).
The cutoff sensitivity setting in power Doppler mode in the investigation of neovascularization 
in the Achilles tendinopathy had not been widely discussed. In several 2D power Doppler 
examinations, a PRF from 600 to 1000Hz was used in order to obtain maximal sensitivity 
without background noise (Peers et al. 2003; Silvestri et al. 2003; Richards et al. 2005;
DAVID 10 20:- - O 
D OPPLER ULTRASOUND
Fig. 6.3 Transverse image of neovascularization in Achilles tendon
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Sengkerij et al. 2009); however, the wall filter applied in these studies had not been clearly 
indicated. One study (Silvestri et al. 2003) reported that they always adjusted the colour gain 
setting by carrying out a manual elevation of the power Doppler gain knob until the next 
highest signal above the noise baseline began to appear in the power Doppler box. This 
setting was achieved with the scan head directly in contact with air which has not been 
applied in other studies. A 3D power Doppler study to the pulmonary artery however applied 
the medium wall filter with PRF of 2 kHz (Christiaens et al. 1997).
6.1.3 Investigation of the sensitivity
Because of the discrepancy of the sensitivity settings in different examinations of the Achilles 
tendinopathy as well as in other 3D power Doppler studies, five healthy volunteers was first 
investigated to find out the cutoff sensitivity in the power Doppler images. All these 
volunteers have been marked 100 score in the VISA-A assessment which showed they are 
all asymptomatic for any Achilles tendon disease.
The protocol for investigating the sensitivity in power Doppler is to observe the signals with 
six different sensitivities ranged from 0.4 to 3.4 at three different locations between 2 and 8 
cm from the insertion (Fig. 6.4). The results show that the micro-vascularity as well as the 
movement between the ultrasound probe and volunteers were significant with the 
sensitivities lower than 1.1. In some of them noise was still detected with the settings 
between 1.1 and 3.4. Therefore, the settings of 3.8 was used in the following 3D power 
Doppler investigations in order to discriminate the original supply blood vessels and 
movement noise.
102
The Quantification of Achilles Tendon Neovascularity
'insertion
Sensitivity=0.4 Sensitivity=0.8 Sensitivity=1.1
Sensitivity=1.7 Sensitivity=2.6 Sensitivity=3.4
rrmrinsertion
Sensitivity=0.4 Sensitivity=0.8 Sensitivity=1.1
Sensitivity=1.7 Sensitivity=2.6 Sensitivity=3.4
Sensitivity=0.4 Sensitivity=0.7 Sensitivity=1.1
Sensitivity=1.7 Sensitivity=2.6
8CTrr?fOTrr insertion
I "
Sensitivity=3.4
Volunteer 1
103
The Quantification of Achilles Tendon Neovascularity
2TYrHrariT itTsertion
1
;y. r,V|
4T r^Hrcrtrrifreerrtion
Sensitivity=0.4 Sensitivity=0.8 Sensitivity=1.1
SrhTHwfrr ifTSWlior
Sensitivity=0.4 Sensitivity=1.1
Sensitivity=1.7 Sensitivity=3.4Sensitivity=2.6
Volunteer 2
104
The Quantification of Achilles Tendon Neovascularity
2T!Tfr?rOTrr-ifrs e-rt i o n 
‘N
Sensitivity=2.6
TTTirFFom'-ifrsertion
Sensitivity=1.7 Sensitivity=3.4
 ■ ••
Sensitivity=0.8
Sensitivity=3.4Sensitivity=1.7 Sensitivity=2.6
Sensitivity=1.1Sensitivity=0.4
Volunteer 3
105
The Quantification of Achilles Tendon Neovascularity
2CVtT^reriTMfrseT
Sensitivity=0.4
Sensitivity=1.7
Sensitivity=0.8 Sensitivity=1.1
Sensitivity=2.6 Sensitivity=3.4
frsertion
Sensitivity=0.8
Sensitivity=1.7
Sensitivity=1.7 Sensitivity=2.6 Sensitivity=3.4
Sensitivity=0.4
K -
Sensitivity=1.1
Sensitivity=3.4Sensitivity=2.6
Volunteer 4
106
The Quantification of Achilles Tendon Neovascularity
Sensitivity=1.7 Sensitivity=3.4
Sensitivity=1.7
 _________________»ca
Sensitivity=0.8
Sensitivity=2.6 Sensitivity=3.4
•_________________________ » q p
Sensitivity=2.6
Fwnr’-ifrsertion
Sensitivity=0.4 Sensitivity=1.1
Sensitivity=0.4 Sensitivity=1.1
Sensitivity=0.8
Volunteer 5
Fig. 6.4 Images of healthy Achilles tendon in different sensitivity settings
6.1.4 Patient and probe positions
Ultrasound images were taken in the transverse plane. The patient was scanned while prone
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on the ultrasound bench, with the foot stabilized and hanging over the edge of the apparatus 
described below. The patient was asked to keep as still as possible to minimize motion 
artefacts. In order to improve the acoustic coupling (impedance match), a gel is applied 
between the probe and the surface of the skin.
6.2 Computerized Motor-driven Track
To obtain the imaging slices along the Achilles tendon to ultimately form the visualization of 
3D power Doppler neovascularization images, I designed and built a specially constructed 
computerized motor-driven track (Fig. 6.5). The details and structures of the track will be 
introduced in the following sections. A  sequential transverse power Doppler image was 
obtained with the track that moves the ultrasound probe at a controlled, uniform speed. The 
stopping interval was designed to achieve 0.5 mm to 2 mm image spacing. Other operating 
parameters, for example the driving direction and the total step, are able to be adjusted using 
the computerized controller.
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1-base board 2-memory foam pad 3-foot plate stand 4-stepper motor
5-motor shaft 6-driving screw 7-track 8-slider
9-carriage 10-bridge 11-probe clamp 12-foot hole
13-adjustable top 14-computerized controller
Fig. 6.5 Motor driven track
6.2.1 Anthropometry
Anthropometry plays an important role in industrial design, clothing design, ergonomics and 
architecture where statistical data about the distribution of body dimensions in the population 
are used to optimize products. The dimensions of the rig were designed according to the leg 
data from an anthropometric data for men at the 97.5, 50, and 2.5 percentiles (Fig. 6.6) 
(Diffrient etal. 1974).
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Fig. 6.6 Anthropometry data
6.2.2 Probe clamp
The most difficult part of the rig was the design of a proper ultrasound probe clamp with
some reasonable flexibility. The initial idea was a simple U-shaped clamp made by
aluminium (Fig 6.6), which was connected to the slider via an aluminium pin. The probe
could be positioned into the clamp and squeezed by the arms using a long screw. The
problem with this simple U-shaped clamp was that it was less stable and flexible since the
no
The Quantification of Achilles Tendon Neovascularity
arms were not fitting the curve of the probe. The second generation of the clamp is illustrated 
in Fig. 6.11. The probe was properly held by the rubber pads fixed at the internal surfaces of 
the clamp arms, one arm was carried by a lift connected to the slider, another arm could 
travel along two long screws to release the clamp and position the ultrasound probe. This 
clamp increased the flexibility but didn't adapt to some patients, especially those with thick 
legs. The final version overcame all the problems by introducing another entity as shown in 
Fig. 6.8 and 6.9. An entity with multiple position holes could further adjust the height and 
swing of the clamp, which eventually adapted to all the patients with different leg sizes and 
shapes.
The probe used in the studies was a linear array transducer with the dimensions of 125 mm 
(length) X 55 mm (width) X 25 mm (thickness) (Fig. 6.7). The probe clamp (Fig. 6.8) is 
able to be adjusted to hold the probe firmly during the translation along the Achilles tendon.
125 mm
55 mm
Fig. 6.7 Probe dimensions
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Positions
Bridge
Screw
Probe held inside
Probe clamp
Screw Nut lock
Fig. 6.8 Probe mounting schematic
To clamp the probe, release the nut locks (Fig. 6.8) to separate the probe clamp, stick the 
ultrasound probe between the soft pads. Rotate the nut lock back to clamp the mid-part of 
the probe. The probe clamp can be shifted up and down or swung using the lift and knob lock 
to achieve a proper altitude and angle, more degrees and flexibilities can be achieved by 
altering the clamp in five position holes distributed along the element whose end is fixed on 
the bridge. Figure 6.9 demonstrated the probe in the clamp which is locked at the top hole.
Fig. 6.9 Probe mounting
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6.2.3 Track
The entire entity in Figure 6.9 is mounted on a slider, which can freely run on a metal rail (Fig. 
6.10). Both the slider and track were provided as a linear guide system product from RS. The 
slider, whose clearance can be adjusted and trimmed to level the carriage by loosening or 
tightening three locknuts (Fig. 6.11), is driven on a screw connected to the shaft of a stepper 
motor.
Stepper motor
Slider
Fig. 6.10 Probe mounting attachment
Locknuts for clearance 
adjustment
Fig. 6.11 Clearance adjusting locknuts
The rail is 300 mm in length and 31 mm in width which is sufficient for the translation of the
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Handles
probe (100 mm as maximum). The stepper motor as well as the rail is mounted on an L 
shape aluminium block whose clearance to the top of the stand can be altered by locknuts 
(Fig. 6.12). This will further compensate the slope of the limb during scanning.
300mm
Stepper motor
Screw
Lockout
Fig. 6.12 Stepper motor mounting
6.2.4 Motor
Computer-controlled stepper motors are one of the most versatile forms of positioning 
systems. They are typically digitally controlled as part of an open loop system, and are 
simpler and more rugged than closed loop servo systems. Industrial applications are in high 
speed pick and place equipment and multi-axis machine CNC machines often directly driving 
lead screws or ballscrews. In the field of lasers and optics they are frequently used in 
precision positioning equipment such as linear actuators, linear stages, rotation stages, 
goniometers, and mirror mounts. Other uses are in packaging machinery, and positioning of 
valve pilot stages for fluid control systems.
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Stepper motors operate differently from DC brush motors, which rotate when voltage is 
applied to their terminals. Stepper motors, on the other hand, effectively have multiple 
"toothed" electromagnets arranged around a central gear-shaped piece of iron. Stepper 
motors can be accurately control to rotate in an angle known range, which is able to drive the 
ultrasound probe in a controllable distance and intervals.
Two phase stepper motors are widely used in industries. There are two basic winding 
arrangements for the electromagnetic coils in a two phase stepper motor: bipolar and 
unipolar. The stepper motor (RS no. 332-953) used to drive the carriage is a general 7.5° 
unipolar-driven device with four 12V DC windings (coils) and permanent magnet rotor 
construction (Fig. 6.13, Appendix A has more details of the motor). The cable of the stepper 
motor is connected to a circular socket which is coupled to the computerized controller (Fig. 
6.14).
Unipolar 7.5 deg stepper motor 
12V5.3W
Size 2 Units
Power consumption ot m otor only 5.3 W
Maximum working torque 57 mNm
Holding torque 85 mNm
Torque derating -0.4 %/° C
Maximum pull-in rate 130 steps/s
Resistance per phase at +20°C 47 O
Inductance per phase 400 mH
Current per phase 240 mA
Perm issible ambient tem perature range -20 to +70 °C
Permissible storage tem perature range -40 t o +100 »c
Permissible m otor temperature 120 °C
Insulation resistance at 500V  (CEE 10) >2 MO
Step angle 7° 3 0 '
Step angle tolerance, not cumulative ±20 '
Number of steps per revolution 48
Direction of rotation reversible
Rotor inertia 45 gmc2
Mass 300 g
Maximum radial force 10 N
Maximum axle force 1.5 N
Bearings Slide 
(sintered bronze)
Fig. 6.13 Stepper motor and its specifications
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Stepper motor
Circular socket
Cable
Fig. 6.14 Motor construction
The reason for using a unipolar stepper motor in the track is it has two windings per phase, 
one for each direction of magnetic field (Fig. 6.15). Since in this arrangement a magnetic 
pole can be reversed without switching the direction of current, the commutation circuit can 
be made very simple for each winding. Typically, given a phase, one end of each winding is 
made common: giving three leads per phase and six leads for a typical two phase motor. 
Often, these two phase commons are internally joined, so the motor has only five leads.
Rotator
Fig. 6.15 Structure of a unipolar stepper motor
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6.2.5 Driver
Stepper motor performance is strongly dependent on the drive circuit. A stepper motor 
controller must be used to activate the drive in the right order in order to perform accurate 
controls. The driver used to energize the stepper motor above is a 2A unipolar stepper motor 
drive board (RS no. 217-3611, Fig. 6.16). The drive board above is designed for stand-alone 
operation. It is a standard Euroboard size complete with a 32-way (DIN 41612) plug 
connector for plugging into any Eurocard compatible racking system.
•  Compatible with any stepper motors up to 2A
•  4-phase unipolar motor drive up to 2N  30Vdc 
per phase
•  Full step and half step drive modes
•  Higher resolution, greater performance stability 
and faster stepping rates)
•  External control inputs are C -M O S and open 
collector TTL logic compatible
•  Pre-set control for setting predetermined motor 
phase excitation pattern
•  On-board 12Vdc, 50m A output for external use
•  Drive board and the motor can share the same  
dc. power supply
•  Provision for assembly of on-board oscillator (if 
external clock not available) having dock pulse 
output, base speed, top speed and stop/run 
control inputs
Fig. 6.16 Driver board
The plug connector is connected to controller and stepper motor using the connection 
schematics in Fig. 6.17. The winding of the stepper motor are connected to the K part of the 
board according to Fig. 6.17. The rest of the pins are connected to the controller for speed, 
interval, step, direction controls (Technical details in Appendix B).
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N
A. External connections
B. Full / half step
C. Clock
D. Direction
E. Preset
F. Auxiliary output 12VDC,50ma
G. Board supply (15-30VDC)
H. Board and motor may share the same supply
I. +V motor (30DC max)
J. All board connections are to the ‘A’ side
of the DIN connector 
K. Motor windings 01 - 0 4  
L. Oscillator control inputs 
M.On-board oscillator (when assembled)
N. (See oscillator section)
0 .„ p _  +VMotor - Rated winding voltage
Rated winding current
Fig. 6.17 Connection schematic
6.2.6 Controller
The controller (Fig. 6.18) was specially designed for the scanning rig above, which provides 
man-machine interface for scanning functions settings and communications with the drive 
board. The core of the controller is a generic microcontroller, AT89S51, which is a widely 
used model in 8051 series microcontroller from Atmel. The signals used to communicate the 
drive board are created according to the user inputs through buttons and a joystick. The 
system block diagram is in Fig. 6.19.
The schematic diagram of the controller is shown in Figure 6.20, as well as the printed circuit 
board (PCB) in Figure 6.21. Details for each part will be described below.
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Status
Stepper motor port 
Fig. 6.18 Stepper motor controller
Programming 
circuitry
7-segment
Indicators display
AT89S51 buffer
I
‘ I
Drive boardJoystick circuitry
I
“ I
Power supply Stepper motor
Fig. 6.19 Controller block diagram
Function buttons
Power switch
Power supply 
Programming port
Number display 
indicators
Joystick adjustment
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Fig. 6.20 Schematic diagram of the stepper m otor controller
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Fig. 6.21 PCB of the stepper motor controller
6 .2 .6 .1AT89S51 m icrocontroller
The AT89S51 (Fig. 6.22) is a low-power, high-performance CMOS 8-bit microcontroller with 
4K bytes of In-System Programmable Flash memory. The device is manufactured using 
Atmel’s high-density nonvolatile memory technology and is compatible with the 
industry-standard 80C51 instruction set and pinout. The on-chip Flash allows the program 
memory to be reprogrammed in-system or by a conventional nonvolatile memory 
programmer. By combining a versatile 8-bit CPU with In-System Programmable Flash on a 
monolithic chip, the Atmel AT89S51 is a powerful microcontroller which provides a 
highly-flexible and cost-effective solution to many embedded control applications. The 
AT89S51 provides some standard features (Fig. 6.22). In addition, the AT89S51 is designed 
with static logic for operation down to zero frequency and supports two software selectable 
power saving modes. The Idle Mode stops the CPU while allowing the RAM, timer/counters, 
serial port, and interrupt system to continue functioning. The Power-down mode saves the 
RAM con-tents but freezes the oscillator, disabling all other chip functions until the next 
external interrupt or hardware reset.
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4K Bytes of In-System Programmable (ISP) Flash
Memory -  Endurance: 10,000 Write/Erase Cycles
4.0V to 5.5V Operating Range
Fully Static Operation: 0 Hz to 33 MHz
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(Byte and Page Mode) • Green (Pb/Halide-free) 
Packaging Option
Fig. 6.22 AT89S51 microcontroller and its features
6.2.6.2 Reset circuitry
Reset is an active High input in AT89S51, when RST pin is set to high, the chip goes back to 
the power on state. The AT89S51 is reset by holding the RST pin high for at least two 
machine cycles and then returning it low. The capacitor C9 is conducted in a very short 
period when the power is supplied, the short pulse is enough to reset the microcontroller and 
start the system. After the reset, the RST pin of AT89S51 stays low until the manual reset 
switch S10 is pressed.
6.2.6.3 Oscillator
XTAL1 and XTAL2 are the input and output, respectively, of an inverting amplifier that can be 
configured for use as an on-chip oscillator, as shown in Fig. 6.20. A 12MHz quartz crystal (Y1) 
is used.
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6.2.6.4 Buffers
In order to match the logic levels, SN5417J buffers (U7) are used to couple the signals 
between the I/O ports of the AT89S51 and the drive board. SN5417J buffers feature 
high-voltage open-collector outputs for interfacing with high-level circuits (such as MOS) or 
for driving high-current loads (such as lamps or relays) and also are characterized for use as 
buffers for driving TTL inputs.
6.2.6.5 Buttons
Two push button switches (S4 & S5) are used to confirm or cancel the setting respectively, a 
joystick (S1 & S3) is applied to set the steps, direction, and interval.
6.2.6.6 Display
Two digits seven-segment display (DS1 & DS2) and four LEDs (D1 -  D4) are used to 
indicate the system status. Two decoders SN74LS47D (U1 & U6) convert the BCD to 
seven-segment display indicators. The SN74LS47 are Low Power Schottky Decoder, 
offering active low, high sink current outputs for driving indicators directly.
6.2.6.7 Programmer
The AT89S51 microcontroller is an in-system programmable device, in order to use the 
download the codes into the microcontroller, an in-system programmer cable (Fig. 6.23) was 
also designed and made, which communicates serially with the AT89S51 and reprograms it 
in the circuit without removal. The software to download the codes into the cable is Atmel 
Microcontroller ISP Software®. The Atmel Microcontroller ISP Software is the primary means 
for performing in-system programming (ISP) for the Atmel devices. It provides an intuitive 
interface for in-system programming that can be run from a personal computer. The Atmel
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ISP Software has a comprehensive set of features and allows the user to view, program, and 
erase data from an Atmel ISP device.
Fig. 6.23 ISP cable and schematic diagram
6.2.6.8 Assembly
Programming socket
The controller box is an ABS plastic 7.013 x 5.015 inch enclosure (dimensions in Appendix 
C). According to the positions and dimensions of the joystick, push buttons, indicators, 
seven-segment display, and sockets, the plastic enclosure was constructed in the workshop 
in School of Engineering, Cardiff University. The controller printed circuit board, drive board, 
peripheral devices, and necessary connections are assembled into the enclosure as shown 
in Fig. 6.24.
Stepper motor port
Power supply
Connections between 
controller and drive board
Drive board
Joystick—
Controller printed circuit board Plastic enclosure
Fig. 6.24 The assembly of the controller
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6.2.6.9 Software
The controller driver is written entirely in assembly language and compiles under Keil C51 
(from Keil™). The flowchart of the software is shown in Fig. 6.25. There entire codes are
attached in Appendix G.
Start
System test ---------
T- - - - - - -
Manual drive
Step setting 
Interval settings
I
Direction settings
F  -  -  - T -
 ► Trigger Cancel
? ? T  Tl
Pulse output
——  Steps finished — -------------
?
Fig. 6.25 Flowchart of the stepper motor controller
6.3 Scanning and Image Processing
After the conventional PDU examination, both the patient and control group were scanned
while prone on the couch with the limb placed on the scanning constructed apparatus,
consisting of a motorized track driving the same linear array transducer at a controlled, 
uniform step along the length of the Achilles tendon (Fig. 6.26).
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The patient was asked to keep as still as possible to minimize motion artefacts. Sufficient 
acoustic coupling gel was spread on the skin to couple the transducer and the subject. The 
tendon was scanned in the transverse plane in all cases. The transducer was stopped at 
consecutive positions with an interval of 1 mm, typically over a length of 6 cm from the 
calcaneal insertion. At each 1 mm position, 38 frames of images were saved as a 2 second 
AVI file on the ultrasound machine. For a scan of 6 cm, 60 slices were produced, to allow the 
entire neovascularization in midportion, where the tendon is most susceptible to 
degeneration and injury (Schweitzer and Karasick 2000), to be registered.
All the AVI files in the ultrasound machine were subsequently burned into a CD-ROM and 
transferred to a commercially available laptop computer (Toshiba Satellite Pro) with a T2400 
1.83 GHz CPU. In the specially developed pixel analysis program (Fig. 6.27, developed in 
Microsoft Visual Basic 6.0 with the flowchart shown in Fig. 6.28, the entire codes are 
attached in Appendix D), images were recalled on the computer screen.
At the beginning, the programme could only create an ovoid superimposition on the region of 
Achilles tendon. This worked well on the images where Achilles tendons are regular, as 
shown in Fig. 8.2. However, in the majority the Achilles tendons showed non-ovoid 
transverse slices (Fig. 3.2). To match the borders of the Achilles tendon on the transverse 
slice, I updated the programme to be able to manually outline a polygon to follow the trend of 
the borders. By doing this, a region of interest (ROI) was manually marked by the edges of 
polygon based on the boundary between the Achilles tendon and surrounding tissue.
Then a region of interest (ROI) was manually marked by the edges of polygon based on the 
boundary between the Achilles tendon and surrounding tissue. This ROI outline ensured that 
only the Doppler signals within the Achilles tendon were statistically evaluated and that
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surrounding signals were excluded. Since the ROIs on each slice contained the entire 
section through the desired structure, the visualization of the Achilles tendon was obtained 
after the 3D reconstruction.
Fig. 6.26 Data acquisition setup
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Fig. 6.27 Program interface
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Another function of the program was to present a frame with maximal power Doppler signal 
and another with minimal. For each position, there were 38 frames extracted from each video 
clip (Fig. 6.29). Our technique treated power Doppler images as binary images by 
considering all colour pixels as foreground pixels. This simple threshold step resulted in a 
complex shaped binary object that consists of the distribution of neovascularization. Only the 
pixels with colour-coding bytes were retained and the grey-scale information was eliminated. 
For each frame, the program performed an automated contour extraction of the colour data. 
The total amount of the pixels on the colour-coding objects on each frame was stored in an 
array (Fig. 6.30). A comparison of the amount of the pixels was performed to find the frame 
with maximal power Doppler signal, which then be used in the 3D reconstruction.
The program then created 60 representative maximum (systolic) frames and 60 
representative minimum (diastolic) frames, which were both reconstructed to form two 3D 
images of the neovascularization in both phases, using a commercial 3D reconstruction and 
analysis software. The maximum and minimum volumes of neovascularity (VON) were also 
computed in the software.
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CDs
Ultrasound
machine
WMV- "AVI 
WinAVI Video 
Converter 8.0I
Load AVIs 
Extract frames
Select ROI
T
Pixel analysis
Representative 
frame selected 
and stored
3D reconstruction
Fig. 6.28 Acquisition flowchart
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Frame 1 Frame 2 Frame 3 Frame 4
Frame 5 Frame 6 Frame 7 Frame 8
Frame 9 Frame 10 Frame 11 Frame 12
Frame 13 Frame 14 Frame 15 Frame 16
Frame 17 Frame 18 Frame 19 Frame 20
Frame 21 Frame 22 Frame 23 Frame 24
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Frame 25 Frame 26 Frame 27
Frame 29 Frame 31 Frame 32Frame 30
Frame 34 Frame 35Frame 33
Fig. 6.29 Example of frames extracted from video clip
Fig. 6.30 Example of flow extracted
6.4 3D Reconstruction and Volume Measurement
After the representative frames were acquired from the last procedure, a 3D volume
reconstruction of the Doppler signal was performed in a commercial 3D imaging analysis
software 3D-DOCTOR® (Able Software Corp.)
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3D-DOCTOR® is an advanced 3D image rendering, processing, and analysis software, 
which is approved for medical imaging and 3D visualization applications by US FDA (US 
Food and Drug Administration). It is developed to provide a complete set of tools for 
visualizing 3D volume image data, including CT, MRI, Microscopy, ultrasound, and other 
types of imaging. The software works by extracting object boundaries using 3D image 
segmentation functions, and creating both 3D surface and volume rendering for visualization, 
object measurement, and quantitative analysis. It includes all these functions in a single 
integrated easy-to-use package.
Transverse images in DICOM, TIFF, BMP, JPEG, Interfile, PNG, PGM, GIF, Raw Image Data, 
and other uncompressed image formats are accepted in 3D-DOCTOR®. Image files in 
various vendor specific formats can be easily read using SD-DOCTOR^s universal image 
configuration and input function. Both grayscale (8-bit and 16-bit) and colour images are 
supported. Scanned CT/MRI films can easily be cropped using the template-based function 
for 3D imaging applications.
The fully automatic texture-based segmentation for grayscale and colour images works with 
most images. The threshold-based Interactive Segmentation is perfect for processing 
different images. The region-based Object Segmentation allows quick segmentation of local 
areas, such as a tumour. The easy-to-use polygon-based manual tracing method provides 
the flexibility of segmenting tissues with weak edges.
From segmented boundary data, a 3D surface mesh model is created quickly using one of 
the vector-based surface rendering commands. 3D models of multiple tissue objects are 
supported for realistic 3D display and quantitative analysis. The surface area, volume, 
distance, angle, profile and image region histogram are easily measured in 3D-DOCTOR®.
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Detailed reports can be produced for quantitative analysis of tissue areas and volumes.
6.5 Subjects
The ethical approval for the current study was given by two ethical committees, Engineering 
School Research Committee, Cardiff University and South East Wales Research Ethics 
Committee panel D. The examinations were divided into two sections, system validation and 
correlation investigation.
In order to investigate whether the quantitative evaluation system was capable of 
determining the healthy and symptomatic Achilles tendon, I conducted an initial experiment 
to scan control and patient groups. With the optimized machine settings and other criteria 
described in Chapter 5, the evaluation system should be able to identify whether an Achilles 
tendon was undergoing tendinopathy by the VON. If the system showed the capability to pick 
up the Achilles tendon with pathology, a following clinical trial would be performed to 
investigate the correlation between the VON and clinical severity. Therefore, the 
examinations were divided into two sections, system validation and correlation investigation.
6.5.1 Subjects in system validation
Twelve tendons from 10 subjects (9 men and 1 woman) with a mean age of 45 years (range 
from 23 to 57) with a chronic painful Achilles tendon, and twenty tendons from 10 controls (8 
men and 2 women) with a mean age of 41 years (range from 28 to 49) with no history of an 
Achilles tendinopathy, were prospectively enrolled in the validation of the scanning and 
reconstruction system. The patients and controls provided written informed consent. 
Diagnosis of Achilles tendinopathy was confirmed by a consultant orthopaedic surgeon and a 
conventional ultrasonographic examination.
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6.5.2 Subjects in correlation investigation
Forty tendons from 30 patients (16 men and 14 women) with a mean age of 49.7 years 
(range from 37 to 79) with a chronic painful Achilles tendon were enrolled in the study. 
Inclusion and exclusion criteria are reported in Table 5.3. The patients provided written 
informed consent. Diagnosis of Achilles tendinopathy was confirmed by a consultant 
orthopaedic surgeon and the conventional ultrasonographic examination. After patients had 
been selected for inclusion by the Trauma Clinic at the University Hospital of Wales, 
appointments were made for ultrasound examinations. All patients were examined by a 
single researcher using a standard protocol.
6.6 Reliability
All ultrasound examinations were performed using the system above, which had been 
calibrated by scanning a known volume gel cube, in which the ultrasound speed (1610 m/s) 
is similar to that in the soft tissue (1540 m/s). The variation between the real and 
reconstructed volume was found to be not statistically significant (p < 0.05).
To assess reproducibility, all the control and symptomatic subjects were scanned twice on 
the same apparatus. Afterwards, two experienced researchers performed independent 
evaluations of the maximum and minimum VON twice for each subject. Images were 
processed in the same specially developed pixel analysis program to produce 60 
representative maximum vascularity frames and 60 representative minimum vascularity 
frames. Afterwards, the data in a given subject including two sets of maximum and minimum 
slices were visualized and reconstructed in the same 3D reconstruction software. Thereby, 
two maximum VONs, sVON1 and sVON2, and two minimum VONs, dVON1 and dVON2, 
were calculated. The mean maximum VON, derived from (sVON1+ sVON2)/2, and the mean
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minimum VON, derived from (dVON1+ dVON2)/2, were used to denote the amounts of 
neovascularity at maximum (representing the systolic) and minimum (representing the 
diastolic) phases for each subject, respectively.
Inter-observer variability was evaluated by comparing the mean of the first and the second 
measurement of each researcher. The assessment of intra-observer variability was based on 
comparison between the first and the second set of measurements of each researcher. The 
intra-class correlation coefficient (ICC) was used to evaluate the inter- and intra-observer 
variability (Shrout and Fleiss 1979). The reliability is excellent if ICC is greater than 0.75, fair 
to good if ICC is 0.75 to 0.4, and poor if ICC is less than 0.4 (Fleiss 1986).
6.7 Statistical Evaluation
For the statistical analysis in system validation, the SPSS13.0 software (SPSS Inc., Chicago, 
IL, USA) was used. Inter- and intra-observer variability were analyzed with a one-way 
random model. A Q-Q plot for the VONs in the system validation and the following clinical 
trial were obtained in SPSS13.0, which is a graph that can decide whether the data are 
Normally distributed or not. The G-Q plot of the VONs in controls, patients were shown in Fig. 
6.31, which show that all the data were not normally distributed since the points did not follow 
the line well. Therefore, all the statistical analysis was performed with non-parametric tests.
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Fig. 6.31 Q-Q plots of the VONs in controls and patients
The non-parametric Mann-Whitney U and Wilcoxon tests were applied to compare the
difference between the volume of vascularity between control and patient group, and the
136
The Quantification of Achilles Tendon Neovascularity
difference of the volume at maximum and minimum phases within both the control and 
patient group, respectively. In addition, descriptive statistics were used to characterize the 
data. In the case of a statistically significant result, the probability value (p value) less than 
0.05 was considered to be significant.
For the statistical analysis in correlation investigation, the SPSS 13.0 software (SPSS Inc., 
Chicago, IL, USA) was used as well. G*Power 3 (Franz Faul, University of Kiel, Germany) 
was applied for power analysis. Spearman correlation was used to evaluate the degree of 
association between VON and the scores of VAS and VISA-A. Two tail post-hoc power 
analysis was performed after the study to find out the significant effects of the VON in 
predicting the level of pain and the clinical severity.
6.8 Conclusions
This chapter described the designs and structures of the experimental system used in the 
quantification of the VON in Achilles tendinopathy. A computerized motor-driven track was 
built to hold the conventional ultrasound probe to scan at a controlled step. A specially 
developed program was used to retrieve the frame with maximum and minimum Doppler 
signals. Then the visualization and measurement were performed in a commercial available 
software 3D-DOCTOR. Subjects were examined both in the system validation, including the 
investigation of reliability, and in correlation investigation in the novel 3D Doppler ultrasound 
system. The experimental results will be reported in the next chapter.
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7. Results
This thesis focused on the quantification of the VON in Achilles tendinopathy and correlation 
between VON and the clinical severity of the disease. The VONs in both control and patients 
with the maximum and minimum values due to the cardiac cycle were first reported. In the 
following clinical trial, VONs were collected among 40 symptomatic Achilles tendons, as well 
as the assessment of VAS and VISA-A.
7.1 Intra- and Inter-Observer Variability
The results of the mean VON for both control and patient groups obtained by two 
researchers are summarized in Table 7.1. The mean maximum VON in control group ranged 
between 0.3 mm3 and 0.6 mm3, The ICC for intra-observer variability was close to 1 for each 
of the 2 researchers with values of 0.974 and 0.943, respectively. The ICC value derived 
between the 2 researchers was 0.404 indicating that the inter-observer variability was 
medium (in the ‘fair to good’ range).
The mean minimum VON in control group was close to 0 mm3, The ICC for intra-observer 
variability was 0.556 and 0.940, respectively, between 2 researchers. The ICC for the 
inter-observer variability in minimum VON was 0.404.
The mean maximum VON in patient group ranged between 158.2 mm3 and 165.6 mm3, The 
ICC for intra-observer variability was also closed to 1 for each of the 2 researchers with 
values of 0.986 and 0.964, respectively. The inter-observer variability was small, with an ICC 
value of 0.964.
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The mean minimum VON in patient group ranged between 61.4 mm3 and 82.1 mm3. The 
intra-observer variability was similar to the maximum phase, with the ICC values of 0.986 
and 0.964 for the 2 researchers. A small variance was found between 2 researchers, with an 
ICC value of 0.984.
Table 7.1 Inter- and intra-observer variability for VON in both control and patient groups
Researcher 1 Researcher 2
Intra-observer variability
Mean maximum VON in control 1 ('mm3') 
Mean maximum VON in control 2 (mm3) 
ICC
0.5(1.1) 
0.6(1.5) 
0.974
0.3(0.8)
0.3(0.6)
0.943
Inter-observer variability
Mean maximum VON in control (mm3) 
ICC
0.5(1.3)
0.404
0.3(0.7)
lntra-observer variability
Mean minimum VON in control 1 (mm3) 
Mean minimum VON in control 2 (mm3) 
ICC
0(0.1)
0(0)
0.556
0(0.1)
0(0.1)
0.940
Inter-observer variability
Mean minimum VON in control (mm3') 
ICC
0(0.1)
0.404
0(0.1)
Intra-observer variability
Mean maximum VON in patient 1 (mm3) 
Mean maximum VON in patient 2 (mm3') 
ICC
163.6(175.0)
158.2(173.2)
0.986
165.6(161.5)
159.2(189.8)
0.964
Inter-observer variability
Mean maximum VON in patient (mm3) 
ICC
160.9(172.9)
0.964
162.4(173.1)
Intra-observer variability
Mean minimum VON in patient 1 (mm3) 
Mean minimum VON in patient 2 (mm3) 
ICC
68.2(106.8)
69.3(104.4)
0.986
82.1(145.4)
61.4(89.7)
0.964
Inter-observer variability
Mean minimum VON in patient (mm3) 
ICC
68.8(105.3)
0.984
71.7(117.2)
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7.2 Control Group in Validation
All the healthy subjects were given the identical scanning procedures using the apparatus 
and off-line analysis described in Chapter 6. Twenty normal Achilles tendons including any 
vascularity were reconstructed with volume information attached for each case. In control 
group, the maximum VON ranged from 0 mm3 to 3 mm3 with the mean of 0.41 mm3 
(SD=0.8), while the minimum VON ranged from 0 mm3 to 0.2 mm3 with the mean of 0.02 
mm3 (SD=0.1), which indicates that, the VON at both the maximum and minimum were 
very small (Fig. 7.1). Fig. 7.2 shows 10 normal tendons with the volume of vascularity 
ranged from 0 mm3 to 3 mm3, which indicate that, in general terms, the vascularity does not 
notablely exist in healthy Achilles tendon using ultrasound examinations with optimized 
machine settings.
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Fig. 7.1 The mean VON at maximum and minimum phases in control group.
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(a) Subject 1L -  volume = 0.2 mm3
(b) Subject 1R -  volume = 0.8 mm3
(c) Subject 2L -  volume = 1.7 mm3
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(d) Subject 2R -  volume = 2.3 mm3
(e) Subject 3L -  volume = 0.4 mm
(f) Subject 3R -  volume = 2.6 mm
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(g) Subject 4L -  volume = 0.2 mm3
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(i) Subject 5L -  volume = 0 mm3
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(a) Subject 5R -  volume = 0 mm3
Fig. 7.2 20 normal Achilles tendon reconstruction results with the volume of the 
vascularity. Green entity in the model is the manually added Achilles tendon, Blue 'foot' is 
another manual entity used to give the spatial information.
7.3 Patients in Validation
In the patient group, transverse slices were reconstructed (Fig. 7.3), neovascularization 
was noted in all 12 symptomatic Achilles tendons in 10 patients. The maximum and 
minimum VON were ranging from 3 mm3 to 589 mm3 with the mean of 161.7 mm3 
(SD=171.5) and 0 mm3 to 380 mm3 with the mean of 70.3 mm3 (SD=110.5), respectively 
(Fig. 7.4), among which two patients were recorded as bilateral Achilles tendinopathy.
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(a) Patient 1 -  mean volume = 316 mm3
(b) Patient 2 -  mean volume = 589 mm3
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(e) Patient 5 -  mean volume = 144 mm3
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(f) Patient 6L -  mean volume = 28 mm3
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(g) Patient 6R -  mean volume = 292 mm3
(h) Patient 7L -  mean volume = 189 mm 3
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(i) Patient 7R -  mean volume = 57 mm3
Fig. 7.3 3D reconstruction of nine Achilles tendon from seven patients. The blue 
neo-vessels are the vascularity found in Achilles tendon, the oranges are the blood vessels
surrounding the Achilles tendon.
■ Patient Maximum 
VON
■ Patient Minimum 
VON
Patient Group
Fig. 7.4 The mean VON at maximum and minimum phases in patient group.
For both control and patient groups in system validation, the mean VON at maximum
phase (p<0.01) was greater than that in the minimum phase (p<0.01).
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For both maximum and minimum phases, the mean VON of the patient group was notably 
greater than the mean volume of vascularity of the control group in Wilcoxon test, 
reporting a p value of 0.002, and 0.018, respectively. The difference of the VON between 
maximum and minimum was greater in the patient group than that in the control group.
7.4 Patients in Correlation Investigation
In the following clinical trial, neovascularization was noted in 97.5% (n = 39) of 
symptomatic subjects among 40 Achilles tendons in the 30 patients. The VON ranged 
from 0 mm3 to 618 mm3 (mean 111 mm3, SD=161). VAS score ranged from 0 to 100 
(mean 41, SD=20), VISA-A score ranged from 2 to 87 (mean 44, SD=17).
A positive Spearman correlation was detected between VAS and VON, while a negative 
correlation was noted between VISA-A and VON, as shown in Fig. 7.5 and Fig. 7.6, 
respectively. Calculated Spearman correlation coefficients are given in Table 7.2, which 
indicates that only the VAS score denoted a significant correlation with the level of VON. A 
higher VAS score was associated with more neovascularization, while either VISA-A and 
age was not correlated with the degree of VON. Some subjects with the visualization of 
neovascularization in Achilles tendon with the VON values were given in Fig. 7.7.
The VON appeared to be associated with the degree of pain, post-hoc tests (Cohen 1988) 
showed that the power of the correlation between VAS and VON, VISA-A and VON were 
0.89 (effect size |p|=0.46, total sample size=40) and 0.75 (effect size |p|=0.39, total 
sample size=40), respectively. The statistical power value, also known as Type II error 
rate, should be greater than 0.80, to detect a reasonable departure from the null 
hypothesis (Cohen 1988). Therefore, the probability of correctly rejecting the null
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hypothesis of the correlation between VAS and VON is greater than that of the correlation 
between VISA-A and VON. In addition, the small, medium, and large effect size is defined 
to be |p|= 0.1, |p|= 0.3, and |p|= 0.5, respectively, this could therefore be more safely to 
conclude from this thesis that with an effect size between medium and large, the volume 
of neovascularity (VON) has a potential effect on pain (VAS) in a symptomatic Achilles 
tendon.
Fig. 7.5 Scatter plot of VAS and VON (r = 0.326, p  = 0.04)
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Fig. 7.6 Scatter plot of VISA-A and VON (r = -0.246,p  = 0.127)
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Table 7.2 The Spearman Correlation between different variables and VON
Variable Spearmen Correlation p-value
VAS 0.326 0.04
VISA-A -0.246 0.127
Age -0.058 0.723
VON=10mmVON=158mm
VON=Omm3 VON=309mm3
VON=257mm3
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VON=24m nr VON=22mrrr
VON=429mm3 VON=179mm3
VON=6mm3 VON=238mm3
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VON=11mm3 
Fig. 7.7 Subjects with the visualization
VON=145mm3
of neovascularization in Achilles tendon with the VON 
values
7.5 Conclusions
Initial data including the intra- and inter- observer variability, control and symptomatic 
subjects in system validation, and patients in correlation investigation were reported in this 
chapter. The ICC values indicated that the system works efficiently in the definition of 
symptomatic and asymptomatic subjects. The VONs found in controls were not higher than 3 
mm3 (mean = 0.41 mm3) in this study, while patients showed distinct greater VONs with a 
mean value of 161.7 mm3. To correlate the VON and clinical severity, another 40 Achilles 
tendons were scanned. The results show that the VON was associated with the degree of 
pain (VAS) but not the severity (VISA-A). The next chapter will discuss and conclude this 
study further.
160
The Quantification of Achilles Tendon Neovascularity
8. Discussion and Conclusion
In this thesis, a novel system for quantitatively analyzing neovascularization in Achilles 
tendon from 3D PDU scans was described. In addition, the analysis system has been also 
developed as the first step towards in-vivo correlation between the neovascularization and 
clinical severity in Achilles tendinopathy.
8.1 Discussion
8.1.1 Power or colour Doppler ultrasound?
To establish information of the low-speed flows and tiny vessels in the Achilles tendon, PDU 
was used. PDU is more able to display small vessel flow than CDU because PDU displays 
the integrated power of the Doppler signal, while CDU displays the mean Doppler frequency 
shift. Therefore, because noise has a low power, the gain in a PDU can be increased to a 
point at which low-speed flows in small vessels are visible.
8.1.2 Why was a commercial 3D probe not used?
Currently, the most common type of commercial 3D US scanner is that based on a 
mechanically swept probe. A 1 D  transducer array, similar to that in a conventional probe, is 
mounted inside an enclosure and moved mechanically through a known trajectory. This 
enables the acquisition of a regular pattern of 2D scans covering a fixed 3D volume. Figure 
8.1 shows the internal structure of a classic 3D probe (the RSP6-12, Kretztechnik) working 
from 6 MHz to 12 MHz with 192 transducer elements. A stepper motor drives a gearbox. The 
yoke with the array of transducer elements is mounted on the output of the gearbox. The
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black bag joins onto the scanning window that forms the probe face. The space between the 
bag and the probe face contains the transducer array, mounted on the end of the yoke, and 
is filled with an oily substance (Prager et al. 2009).
Main probe cable---------------
Motor Gearbox Motor axle
Motor axle
sensor
Scanning window
Motion of transducer array
Bag of oil to 
couple 
transducer 
array to 
scanning 
window
Yoke on 
which 
transducer 
array is 
mounted
Yoke sensor
Fig. 8.1 The inter-structure of a 3D mechanically swept probe (Prager et al. 2009)
The structure of a common commercial 3D ultrasound probe (Fig. 8.1) will cause artifacts 
include those related to acquisition, rendering or editing.
The ultrasound system used in this study was a commercially available scanner with the 
probe mounted onto a specially constructed scanning apparatus, so that the translation 
axis was perpendicular to the imaging plane. The probe slider was driven by a stepper 
motor under a control box in a step- and interval-programmable movement. The probe 
was held stationary during the image acquisition period, which lasted for 2 seconds, and 
then moved automatically to the next recording location. Less than 1 second was 
necessary to translate the probe between two image positions on the apparatus. The time 
consumed in storing the AVI file on ultrasound machine was less than 1 second. The
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specially constructed scanning apparatus was designed to overcome some potential 
artifacts in the commercial available, mechanically swept 3D ultrasonographic scanners, 
which have been widely used to date. The main problems encountered when using the 
mechanically swept 3D systems relate to field of view and motion artifacts. The normal 
dimension of the active window of the 3D linear array transducer, are not much greater 
than 5 cm *  5 cm, which is not sufficient to scan of an entire Achilles tendon in most of 
patients. 3D ultrasound is also particularly susceptible to the motion artifacts induced due 
to the mechanical movement of the transducer head (Nelson et al. 2000). In addition, 
when using a commercially available 3D ultrasound, there are timing problems with the 
display of the ultrasound images. The images are consecutively acquired, with no 
synchronization to the cardiac cycle and therefore maximum vascularity will only be 
represented in some parts of the resulting 3D image. This may cause an ambiguous 3D 
visualization and VON of Achilles tendinopathy.
8.1.3 Conflicting results in previous studies
Previous studies have suggested that the presence of neovascularization, as obtained by 
both CDU and PDU, gives an important indication to the degree of pain suffered during a 
bout of Achilles tendinopathy (Ohberg L 2001; Ohberg and Alfredson 2002; Alfredson et al. 
2003; Ohberg and Alfredson 2004; Boesen et al. 2006b). Other studies have reported 
some conflicting results (Koenig et al. 2007; van Snellenberg et al. 2007). One of the 
possible reasons for this may be due to the blood flow of neovascularization in the Achilles 
tendon being too slow to be detected; any flow slower than 4-6 mm/sec is unable to be 
detected by Doppler ultrasound (Peers et al. 2003). Another reason that might cause 
these contradictory conclusions may be due to the difference of performing Doppler 
ultrasound examination, in terms of the transducer frequency, settings of ultrasound 
machine (Yang et al. 2010). The standard settings are essential to distinguish between 
physiological (slight) Doppler signals and possible pathological signal (Boesen et al.
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2006a). Cutoff values of PRF and CG must be defined. Despite uniform optimized 
machine settings, too few studies have been performed the test of reliability and 
reproducibility. In addition, the small changes in direction and positioning of the hand-held 
probe, may make a quantitative calculation of Doppler changes (based on Ohberg’s and 
similar grading systems) difficult in the oblique Achilles tendon (Boesen et al. 2006a). It is 
also of importance to optimize the degree of plantar flexion and pressure of the ultrasound 
probe (Alfredson and Ohberg 2005), which may influence of the presence of small vessels 
on Doppler ultrasound examination (Boesen et al. 2006b). Prior physical activity to the 
Doppler ultrasound examination could influence the level of neovascularization. A study 
(de Vos et al. 2007a) recommended 24 hours’ abstinence from heavy-load eccentric 
training, sporting activity, or physical exertion.
8.1.4 Manually added boundary in reconstructions
To clarify the boundary between the intra-neovascularization and the feeder vessels, the 
border of the Achilles tendon was outlined for each transverse slice before 3D reconstruction. 
An outlined example is demonstrated in Fig. 8.2. 3D models with outlined Achilles tendon 
were created for the patient in order to find out the potential existence of the feeder vessels. 
With the appearance of the outlined Achilles tendon in the 3D view of four scans (Fig. 8.3), it 
was able to distinguish the vascularity within and surrounding the Achilles tendon.
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Fig. 8.2 Manually added boundary of Achilles tendon
1st scan
Fig. 8.3 3D reconstruction with manual Achilles tendon
8.1.5 The influence of cardiac cycle
The influence of systolic and diastolic phases on the appearance of vascularity during the 
Doppler ultrasound examination is an unattended issue. To our knowledge, the difference 
in the presence of neovascularization during the corresponding phases of the cardiac
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cycle on Doppler ultrasound appearance has not been investigated in the previous studies 
of Achilles tendinopathy. The present study has shown a significant difference in the VON  
measured during maximum vascularity, compared to that measured during minimum 
vascularity, in both the control and symptomatic groups. In the present study, we did not 
cardiac gate the signals and therefore it cannot be sure it was measuring the absolute 
systolic and diastolic values corresponding to the maximum and minimum vascularity 
recorded. However, at each position during the scan, a 2 second AVI file consisting of 38 
frames was saved by the ultrasound machine. In patients with normal sinus rhythm, more 
than one entire cardiac cycle is recorded during the 2 second period. This allows the 38 
frames to contain sufficient information of the patient’s systolic and diastolic flow 
components. The lumen of neovascularization in transverse images was found to change 
with the cardiac cycle.
To study the variance of the VON at systole and diastole, the slices with both the minimal 
and maximal Doppler signals were reconstructed for control and patient group. In the 
control group (Fig. 8.4), the mean maximum and minimum VON was 0.41 mm3 (range 
from 0 mm3 to 3 mm3), and 0.02 mm3 (range from 0 mm3to 0.2 mm3), respectively. In the 
patient group (Fig. 8.5), the mean maximum and minimum VON were 161.7 mm3 (range 
from 3 mm3 to 589 mm3) and 70.3 mm3 (range from 0 mm3 to 380 mm3), respectively. For 
both control and patient groups, the VON at maximum phase was notably greater than 
that in the minimum phase (p<0.05).
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Fig. 8.4 The maximum and minimum VON in control group
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Fig. 8.5 The maximum and minimum VON in patient group
One example of 12 symptomatic Achilles tendons indicating the variance between 
maximum and minimum VON is given in Fig. 8.6. Both the intra-tendinous vascularity and 
surrounding blood vessels are notably change between the maximum and minimum 
phases. The connections of the neovascularization were apparently weakened or 
disappeared in minimum phase. In all 12 symptomatic Achilles tendons, the average 
volume variation at minimum phase was 43.4% (70.3/161.7) of maximum, which denotes 
the cardiac cycle a key factor when quantifying the amount of neovascularization using
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either 2D or 3D Doppler ultrasound, which was rarely reported in previous studies.
By examining the 38 frames of image in each scanning site, as two frames in an example 
shown in Fig. 8.7, the colour pixels in these two frames were found to be 583 (left, 
minimum among the 38 frames) and 614 (right, maximum among the 38 frames). The 
maximum frames were noted giving more Doppler signals, which denoted its capability to 
visualize more neo-vessels (white circles). Therefore, the maximum frames were always 
used as the representative image for a specific slice, in the 3D reconstruction. The 
reconstructed volumes of the neovascularity were considered as maximum VONs.
Fig. 8.6 The neovascularity at minimum (left) and maximum phases (right)
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Fig. 8.7 Two of 38 frames from an AVI file with the Doppler signal
8.1.6 Correlations
The positive correlation between VAS and VON found in 40 symptomatic tendons was in 
accordance with a previous study where the neovascularization seemed to be associated 
with pain (Zanetti et al. 2003), with a correlation coefficient of 0.326 (p = 0.04). This 
indicated a medium correlation was found between VAS and VON, the level of VON may 
be able to predict the score of pain. On the other hand, the Spearman correlation between 
VISA-A and VON was -0.246 (p = 0.127) in the current study, which indicated a weak 
correlation between the level of VON and clinical severity, supporting the hypothesis that 
the clinical outcome was not correlated with neovascularization, which is consistent with 
some recent studies (de Vos et al. 2007a; Sengkerij et al. 2009). Taken together, these 
results may indicate that via quantitative PDU measured neovascularity is an expression 
of the degree of pain but not necessarily a general indication of clinical symptoms.
Because the level of VAS reflects the degree of pain in symptomatic Achilles tendon, while
the VON shows the degree of lesions (neovascularity), the positive correlation between
them could hypothesize that the in-growth of neovascularity cause the pain. This supports
that some studies (Ohberg and Alfredson 2002; Alfredson et al. 2003) by sclerosing the
neovascularity in patients with painful chronic mid-portion Achilles tendinosis, the tendon
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pain was significantly diminished during activity. Studies using sclerosing agents 
demonstrated that patients with no remaining neovascularization in the Achilles tendon 
had no pain during activity, but patients with unchanged neovascularization still 
demonstrated pain (Ohberg and Alfredson 2002). Combining the results in these studies,
It is supposed that the blood flow within the Achilles tendon was significantly correlated 
with severity of pain, which is associated with the accompanying nerves in neovascularity 
(Ohberg L 2001).
The continuous numerical result of the VISA-A questionnaire is ideal for comparing 
symptom progress in the clinical setting (Robinson et al. 2001). The VISA-A questionnaire 
is a valid, reliable and easy-to-administer measure of the severity of Achilles tendinopathy 
and appears suitable for both clinical rating and quantitative research. However, the score 
of VISA-A doesn’t seem to correlate with the VON in our samples. This may due to that 
the VISA-A questionnaire is an index of the severity of a clinically diagnosed condition but 
not a diagnostic tool (Robinson et al. 2001). Furthermore, limitation of function limits the 
subject’s ability to score well in some questions, especially question 8, even though the 
Achilles tendon may be uninjured (Robinson et al. 2001). Therefore, the weak Spearman 
correlation between VISA-A and VON, with the coefficient o f -0.246 (p = 0.127), indicated 
the level of VON couldn’t be confidently used to predict the clinical severity.
8.1.7 Future work
A grading system based on the ratio of Doppler signal in the ROI has been used in many 
previous studies including studies on the role of neovascularization, the effectiveness of 
extracorporeal shockwave therapy, eccentric training, and sclerosing in Achilles 
tendinopathy (Ohberg and Alfredson 2002; Boesen et al. 2006a). The grading system is a 
feasible and easy way to measure the amount or change of neovascularization. 
Comparing the grading systems, the current study could involve sketching a quantitative
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neovascularization map in painful Achilles tendon.
More work is needed to establish the role of neovascularization in Achilles tendinopathy, 
either by the evaluation of VON or conventional PDU scans. Whether neovascularization 
is related to symptoms is still uncertain. The current study firstly investigated the VON in 
both control and symptomatic Achilles tendons to quantify the neovascularity. Large 
prospective studies on the value of VON are needed to confirm the results here. Our study 
hopefully will provide an additional tool towards understanding the role of 
neovascularization in Achilles tendinopathy and help in clinical practice.
8.2 Conclusion
In this thesis, the 3D vascularity map of the neovascularization in Achilles tendinopathy 
was first created from continuous PDU image transverse slices. The intra- and 
inter-observer reliability of the system was tested. The high ICCs indicated that the 
present system was capable to eliminate the artifact yielded from the patient movement 
during the scan, as well as its capability minimizing the error when determining the 
amount of neovascularity within the border of Achilles tendon, by manually ROI marking 
on each slice.
We also optimized protocols for the study of neovascularization in Achilles tendinopathy as 
the suggestion in Table 8.1.
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Table 8.1 Suggested protocol for studying neovascularization in Achilles tendinopathy
Protocol Description
Ultrasound machine settings
Parameter Settings
PRF
Lowest possible where ‘flash’ 
artefacts are eliminated
CG On the threshold to noise
Doppler frequency
Highest possible to 
maximize spatial resolution 
and have good blood flow
Patient selection criteria
Inclusion criteria Exclusion criteria
Aged 18 to 70 years
Previous eccentric loading 
exercise program just prior to 
scanning
Have symptoms in the 
Achilles tendon more than 6 
weeks
Previous Achilles tendon 
surgery or rupture in the 
symptomatic lower limb
Be able to complete the 
VISA-A and VAS 
questionnaire
Previous lower limb trauma 
which may have structural 
changes on the Achilles 
tendon
Score less than 80 on VISA  
and VAS not equal to 0 on 
VAS
Pathology at insertional 
location, bilateral 
tendinopathy and bursitis
Pain and swelling 
positioned at 2 to 6 cm 
proximal to the calcaneal 
insertion
Injection of local sclerosis or 
other anaesthetic effect 
agents into the Achilles 
tendon or surrounding area
B-mode ultrasound detects 
a local thickening and/or 
irregular fibre orientation 
and/or irregular tendon 
structure with hypoechoic 
areas
Other systemic disorders
Pre-physical activity
24 hours’ abstinence from heavy-load eccentric training, 
sporting activity, or physical exertion.
Severity assessment Using VISA-A and VAS questionnaire
Degree of ankle plantar 
flexion
90 degree
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In the validation of the novel system, the volumetric information of neovascularization and 
pattern were established both in control group and patients. The mean maximum and 
minimum volumes of the vascularity in control group were 0.41 mm3 and 0.02 mm3, 
respectively. The mean maximum and minimum VONs in patients with painful Achilles 
tendon were 380 mm3 and 70.3 mm3, respectively, which were distinctly greater than that 
in controls. In patients, the maximum VONs were notably greater than the minimum VONs. 
Therefore, it is proposed using the maximum VON as the indicator of choice in evaluating 
neovascularity of Achilles tendon.
In the investigation of the correlation between VON and clinical severity, the mean VON was 
definitely greater than that in healthy Achilles tendon. Neovascularization was noted in 
97.5% (n = 39) symptomatic Achilles tendons in 30 patients. The VAS showed a positive 
correlation with VON with a Spearman correlation coefficient of 0.326 (p = 0.04, power = 
0.89), while no significant correlation was found between VISA-A score and VON. Further 
studies examining the correlations are needed.
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Appendix A-Stepping Motor
7.5° Stepping Motors
Stock Nos. 332-947 and 332-953
7.5° stepper motor
size 1 (RS stock no. 332-947)
and size 2 (RS stock no. 332-953)
Two 7.5° stepper motors each with four 12V ~  windings 
(coils) and permanent magnet rotor construction. 
Designed for unipolar drive, these motors are easily 
interlaced to simple and relatively low power electronics 
thus providing economical means of motion and speed 
control. Due to their permanent magnet rotors these 
motors have a braking torque even when not energised. 
This is the detent (residual) torque which is a useful 
feature for positional integrity.
The size 1 motor is ideal for applications requiring low 
torque drive but it can also be used with the RS range 
of synchronous gearboxes (RS stock nos. 336-400 etc.) 
to provide finer step angle and increased torque at 
lower speeds.
The size 2 motor is more powerful general purpose 
motor ideally suited for direct drive applications.
Figure 1. 7.5s Stepper motors
21.S TO
- L
i
Size 1. (RS stock no. 332-947)
563
Size 2. (RS stock no. 332-953)
Technical specification
Size 1 Size 2 Units
Power consumption of motor only 2 5.3 W
Maximum working torque 6 57 mNm
Holding torque 10 85 mNm
Torque derating -0.4 -0.4 % /°C
Maximum pull-in rate 350 130 steps/s
Resistance per phase at +20°C 120 47 Q
Inductance per phase 160 400 mH
Current per phase 100 240 mA
Permissible ambient temperature range -20 to +70 -20 to +70 °C
Permissible storage temperature range -40 to +100 -40 to +100 °C
Permissible motor temperature 120 120 °C
Insulation resistance at 500V (CEE 10) >2 >2 MQ
Step angle 7° 30’ 7s 30'
Step angle tolerance, not cumulative ±40' ±20'
Number of steps per revolution 48 48
Direction of rotation reversible reversible
Rotor inertia 2.6 45 gmc2
Mass 80 300 9
Maximum radial force 2.5 10 N
Maximum axle force 0.75 1.5 N
Bearings Slide Slide
(bronze) (sintered bronze)
RS Components Issued March 1991 8756
188
The Quantification of Achilles Tendon Neovascularity
Appendix B-Stepping Motor Driver
R S S t o c k  N o .
217-3611
Max. power dissipated through R = (rated motor current) 2 x R. If the power 
dissipation is high it is advisable to arrive at the required value of ‘R’ by using 
a network of series or parallel resistors. (The use of higher wattage resistors 
and heat sinks may be required).
Max current consumption (motor & board) = 2 x (current per phase) + 60mA. 
Thus ensure power supply cables used are sufficiently rated.
External control signals e.g. full/half step, direction etc. as well as the 
oscillator (if fitted) stop/run signal can be applied to the circuit in any of the 
methods of Figure B1.
C on nectio n  to RS s te p p e r  m o to rs
When the winding of the RS stepper motors are assigned (01 - 0 4) as shown
in Fig. B 2 . they can be connected to the board according to Figure 42.
If the supply voltage is set to 24Vdc then 'R' values for use with the RS motors 
are given in table 1 below 
T a b le  1
Motor
Rated
Current
(A)
Rated 
Winding 
Voltage (V)
R
( )
Power 
Dissipation 
through R (W)
332-947 0.1 12 120 1.2
332-953 0.24 12 47 3
440-464 2 3 10.5 5
For other details and motors performance refer to RS data sheet on stepper 
motors.
On-board o s c illa to r  a s s e m b ly
If external dock source is not available, on-board oscillator can be assembled 
simply by soldering into place the required RS Components listed below. 
Note : the oscillator dock output must be externally wired to the clock, input- 
pin 24a.
If osdllator remote controls are required (e.g. front panel controls) then plug 
PLI (5-way inter p.c b. RS stock no.467-576) can be added together with 
mating cable shell (RS stock no. 467-627) and crimp terminals (RS stock 
no 467-598)
S tartin g  (b ase ) and runn ing  s p e e d  c o n tro l 
The on-board osdllator can be arranged to start at a fixed frequency (thus a 
fixed motor speed) and then ramp up to a final value (the running motor 
speed). This facility is available to start the motor within its pull-in performance 
region and then accelerate the motor through so that it can operate within the 
pull-out mode On switch-off the motor decelerates automatically 
Three parameters need to be determined for any application :
a) The starting speed: this should be below the pull-in speed for the motor 
(with any additional load).
b) The running (final) speed: this should be within the pull-out capability of 
the motor (with any additional load).
c) The acceleration and deceleration rate between starting and running 
speeds: this is limited by motor capability to accelerate through its own 
(plus any load) inertia
O s c illa to r co n tro ls  (e x te r n a l)
Note : Oscillator frequency corresponds directly to motor speed in step/s or 
half step/s depending on motor drive mode.
For a 1 .8 ' s te p p e r m o to r :
speed in revs / min = 60 x speed in step/s 
200
or
speed in revs / min = _60_ x speed in 'half step/s 
400
T e c h n ic a l s p e c ific a tio n  
Size __________________________
Mating edge connector.
Supply (board and motor)
Current consumption: 
Board only_
 standard Euro card (168 x 100 x 15)
. standard 32-way DIN41612socket eg
 (RS stock no. 471-503 or 467-453)
 15-30Vdc + 10% max.
unregulated smoothed
Motor winding
_____________________60mA
 dependent on the motor
_used-up to 2A per phase max. 
l2Vdc 50mA max. regulatedOn-board auxiliary output 
Switching logic control (CMOS and open collector T.T.L. compatible): 
Level 0’ .
Level ‘1’
Inputs pins:
0V
25. Full / half step 
23 Direction____
24 Clock
__________ Level'T full step / Level '0' half step
..Connecting this pin to Zero volts will change the 
direction of the motor. 
_1Hz-25kHz, 10ps min. pulse
width negative edge triggered.
22. Preset Active Level ‘0’ set motor drive states to Q1. & Q3 'OFF',
Q2 & 04  'ON' (full step mode) Q1. 
Q2 & Q3 OFF', 04  ON'(Half step mode)-see Figure42.
Automatic preset at switch-on
RS Components shall not be liable for any liability or loss of any nature (howsoever 
caused and whether or not due to RS Components' negligence) which may result 
from the use of any information provided in RS technical literature.
For a 7 .5 ' s te p p e r  m o to r :
speed in revs / min = 60 *  speed in step/s 
48
or
speed in revs / min = 60 x speed in ‘half step/s 
96
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£
B
Y A. Open collector T.T.L.
B. C.M.O.S. (operating I
C. Opto-coupler
D. Simple switch
+12V)
Fig. B1
0 1 k  0 2 k  03 k  04
1
2
3
4
A. Black
B. Orange
C. Red
D. Yellow
E. White / Black
F. White / Orange
G. Red / White
H. Yellow / White
Fig. B2
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Appendix C-Controller Box Dimensions
Fig. C1
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Appendix D-Program Codes
D.l Main body
/ f t * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * p y p £ f j Q p  * * * * * * * * * *  * * * * * * * * * * * * *
Private Declare Function GetPixel Lib "gdi32" (ByVal hdc As Long, ByVal x As Long, _
ByVal y As Long) As Long
Private Declare Function SetPixel Lib "gdi32" (ByVal hdc As Long, ByVal x As Long, _
ByVal y As Long, ByVal crColour As Long) As Long
* * * * * * J * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ******\ /3rjables d e f i n i t i o n s * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Dim pColour As Long
Dim R As Long, G As Long, B As Long
Dim x l As Integer 
Dim y l As Integer 
Dim x2 As Integer 
Dim y2 As Integer
'initial x position 
'initial y position 
'end x position 
'end y position
Dim flag As Boolean 'drawing flag
Dim dopplerpoints As Long 'count the doppler points
Dim numOpenAVIs As Integer 
Dim DateFolder As String
Dim numFrames As Long 'num ber of frames in video stream 
Dim ColourDis As Integer 'threshold
Dim mouseBoxxl, mouseBoxx2, mouseBoxyl, mouseBoxy2 As Integer
Dim lineAch, radCha As Boolean
Dim circenX, circenY As Integer
Dim cirX, cirY As Integer
Dim cirRad, cirR As Integer
Dim cirHei, cirH As Single
Dim dragSen, dragS As Integer
, * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * £ ^ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
load and unload f u n c t i o n s * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Form_Load()
Call AVIFilelnit 7/ opens AVIFile library
Picturel.ScaleMode = 3
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Sliderl.Min = 0 
Sliderl.Max = 37 
Slider2.Value = 20
lineAch = False 
radCha = False
circenX = 417 
circenY = 128 
cirRad = 60 
cirHei = 1 / 3
cirX = circenX 
cirY = circenY 
cirR = cirRad 
cirH = cirHei
Listl.Enabled = False
End Sub
Private Sub Form_Unload(Cancel As Integer)
Call AVIFileExit ' / /  releases AVIFile library
End Sub
/ * *  *  * * * *  *  *  *  * *  *  * * * * * * * *  * * * * * * * * * * *  *  * * * *  * * * * *  *  * * * *  *  * * *  *  * * *  * * * * * * * *  *  * * * * * *  *  * *  *
Private Sub Commandl_Click()
Dim res As Long 'result code
Dim ofd As cFileDlg 'OpenFileDialog class
Dim szFile As String 'filename
Dim pAVIFile As Long 'pointer to AVI file interface (PAVIFILE handle)
Dim pAVIStream As Long 'pointer to AVI stream interface (PAVISTREAM handle)
Dim firstFrame As Long 'position of the first video frame
Dim filelnfo As AVI_FILE_INFO 'file info struct
Dim streamlnfo As AVI_STREAM_INFO 'stream info struct
Dim dib As cDIB
Dim pGetFrameObj As Long 'pointer to GetFrame interface
Dim pDIB As Long 'pointer to packed DIB in memory
Dim bih As BITMAPINFOHEADER 'infoheader to pass to GetFrame functions
Dim i As Long 
Dim j As Long
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DateFolder = "E:\tem p\~$$ D o pp ler" + Format(Time, "h-m-s ") + Format(Date, 
"mmm d yyyy")
MkDir (DateFolder)
MkDir (DateFolder & "\maxlnBo") 'save in and boundary
Labell.Caption = "Processing File "
Label2.Caption = "Creating Slice"
If Listl.List(O) <> "" Then
Do While Listl.List(j) <> ""
LabelB.Caption = (j + 1) & " o f " & numOpenAVIs 
La be 13. Refresh
MkDir (DateFolder & "\" & j)
szFile = Listl.List(j) 'filename pass to res
'Open the AVI File and get a file interface pointer (PAVIFILE) 
res = AVIFileOpen(pAVIFile, szFile, OF_SHARE_DENY_WRITE, 0&)
If res <> AVIERR_OK Then GoTo ErrorOut
'Get the first available video stream (PAVISTREAM)
res = AVIFileGetStream(pAVIFile, pAVIStream, streamtypeVIDEO, 0)
If res <> AVIERR_OK Then GoTo ErrorOut
'get the starting position of the stream (some streams may not start simultaneously) 
firstFrame = AVIStreamStart(pAVIStream)
If firstFrame = -1 Then GoTo ErrorOut 'this function returns -1 on error 
'get the length of video stream in frames 
numFrames = AVIStreamLength(pAVIStream)
If numFrames = -1 Then GoTo E rrorO ut' this function returns -1 on error
'get file info struct (UDT)
res = AVIFilelnfo(pAVIFile, filelnfo, Len(filelnfo))
If res <> AVIERR_OK Then GoTo ErrorOut 
'print file info to Debug W indow  
Call DebugPrintAVIFilelnfo(filelnfo)
'get stream info struct (UDT) 
res = AVIStreamInfo(pAVIStream, streamlnfo, Len(streamInfo))
If res <> AVIERR_OK Then GoTo ErrorOut 
'print stream info to Debug W indow  
Call DebugPrintAVIStreamlnfo(streamlnfo)
MkDir (DateFolder & "\maxAH") 
MkDir (DateFolder & "\maxln")
'save objects including in out and boundary 
'svae in only
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'set bih attributes which we w ant GetFrame functions to return 
W ith bih
.biBitCount = 24 
.biClrlmportant = 0 
.biClrUsed = 0 
.biCompression = BI_RGB
.biHeight = streamlnfo.rcFrame.bottom - streamlnfo.rcFrame.top 
.biPlanes = 1 
.biSize = 40
.biWidth = streamlnfo.rcFrame.right - streamlnfo.rcFrame.left 
.biXPelsPerMeter = 0 
.biYPelsPerMeter = 0
.biSizelmage = (((.biW idth * 3) + 3) And &HFFFC) * .biHeight 'calculate total size of RGBQ.UAD scanlines 
(DWORD aligned)
End With
pGetFrameObj = AVIStreamGetFrameOpen(pAVIStream, bih)
'force function to return 24bit DIBS
If pGetFrameObj = 0 Then
MsgBox "No suitable decompressor found for this video stream!”, vblnformation, App.title 
GoTo ErrorOut 
End If
ProgressBar2.Min = 0 
ProgressBar2.Max = numFrames - 1
'create a DIB class to load the frames into 
Set dib = New cDIB
For i = firstFrame To (numFrames -1 )  + firstFrame
pDIB = AVIStreamGetFrame(pGetFrameObj, i) 'returns "packed DIB"
If dib.CreateFromPackedDIBPointer(pDIB) Then
Call dib.WriteToFile(DateFolder & "\" & j & "\" & i & ".bmp")
Label4.Caption = i + 1 & " o f " & numFrames & " to fo ld er" & j + 1 
La bel4. Refresh 
ProgressBar2.Value = i
Else 
End If
Next
Text3.Text = numFrames 
Set dib = Nothing
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Listl.Enabled = True
ErrorOut:
If pGetFrameObj <> 0 Then
Call AVIStreamGetFrameClose(pGetFrameObj) '//deallocates the GetFrame resources and interface 
End If
If pAVIStream <> 0 Then
Call AVIStreamRelease(pAVIStream) '//closes video stream 
End If
If pAVIFile <> 0 Then
Call AVIFileRelease(pAVIFile)' / /  closes the file 
End If
If (res <> AVIERR_OK) Then 'if  there was an error then show feedback to user
MsgBox "There was an error working with the file:" & vbCrLf & szFile, vblnformation, App.title 
End If
j = j  + l  
Loop 
End If
End Sub
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Command2_Click()
ProgressBar2.Max = Picturel.W idth  
Picturel.AutoRedraw = True 
Const PI = 3.14159265
SavePicture Picturel.Im age, DateFolder & "\m axln\" & Text2.Text & Listl.Listlndex & & Label8.Caption &
".bmp"
For i = 0 To Picturel.W idth  
ProgressBar2 .Value = i 
For j = 0 To Picturel.Height
If i > mouseBoxxl And i < mouseBoxx2 And j > mouseBoxyl And _  
j < mouseBoxy2 Then
pColour = GetPixel(Picturel.hdc, i, j)
R = pColour And &HFF
G = (pColour And 65280) /  256
B = (pColour And &HFF0000) /  65536
If (R > G) And ((Abs(R - G)) > ColourDis Or (Abs(G - B)) > ColourDis _
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Or (Abs(R - B)) > ColourDis) Then
pColour = SetPixel(Picturel.hdc, i, j, vbRed) 
dopplerpoints = dopplerpoints + 1
Else
pColour = SetPixel(Picturel.hdc, i, j, vbBlack)
End If
Else
pColour = SetPixel(Picturel.hdc, i, j, vbBlack)
End If 
Next j 
Next i
SavePicture Picturel.Im age, DateFolder & "\maxlnBo\" & Text2.Text & .  
Listl.Listlndex & & Label8.Caption &  ".bmp"
If Checkl.Value = 1 Then
Picturel.Circle (cirX, cirY), cirR, vbBlue,, ,  cirH 
'outline Achilles bound 
End If
If Checkl.Value = 1 Then
a2 = cirR 
b2 = cirH * cirR 
xc = cirX 
yc = cirY
ProgressBar2.Max = Picturel.W idth  
For x = 0 To Picturel.W idth  
ProgressBar2.Value = x 
For y = 0 To Picturel.Height
pColour = GetPixel(Picturel.hdc, x, y)
R = pColour And &HFF
G = (pColour And 65280) /  256
B = (pColour And &HFF0000) /  65536
'utilize x(t)=Xc+acost y(t) = Yc+bsint
If (((x - xc) /  a2) A 2 + ((y - yc) /  b2) A 2) > 1 Then 
If R > 250 And G < 5 And B < 5 Then
pColour = SetPixel(Picturel.hdc, x, y, vbWhite) 
End If
Elself (((x - xc) /  a2) A 2 + ((y - yc) /  b2) A 2) < 1 Then 
If R < 250 Then
197
The Quantification of Achilles Tendon Neovascularity
pColour = SetPixel(Picturel.hdc, x, y, vbBlue)
End If 
End If 
Next y
Next x
For i = 0 To Picturel.W idth  
ProgressBar2.Value = i 
For j = 0 To Picturel.Height
If i > (mouseBoxxl - 2) And i < (mouseBoxx2 + 2) And j > _  
(mouseBoxyl - 2) And j < (mouseBoxy2 + 2) Then
pColour = GetPixel(Picturel.hdc, i, j)
R = pColour And &HFF
G = (pColour And 65280) /  256
B = (pColour And &HFF0000) /  65536
'pColour = SetPixel(Picturel.hdc, i, j, vbCyan)
If (R = 255 And G = 0) Or (R = 255 And G = 255 And B = 255) Then 
' if found red point, then pset yellow around it
ProgressBarl.Max = 3 
For ax = (i - 1 )  To (i + 1)
ProgressBarl.Value = ax - i + 1 
For ay = (j - 1 )  To (j + 1)
pColour = GetPixel(Picturel.hdc, ax, ay)
B = (pColour And &HFF0000) /  65536 
G = (pColour And 65280) /  256 
R = pColour And &HFF
If (B = 255 And G = 0) Then
' if around area is black or blue
pColour = SetPixel(Picturel.hdc, ax, ay, vbYellow) 
End If
Next ay 
Next ax 
End If
End If 
Next j 
Next i
SavePicture Picturel.lm age, DateFolder &. "\maxAII\" &  Text2.Text & _
Listl.Listlndex & &. Label8.Caption & ".bmp"
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End If
Picturel.AutoRedraw = False
End Sub
' f t * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
' * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
Private Sub Command3_Click()
Dim dopplerpoints As Integer 
dopplerpoints = 0
ProgressBar2.Max = mouseBoxx2 - mouseBoxxl 
For i = mouseBoxxl To mouseBoxx2
ProgressBar2.Value = i - mouseBoxxl 
For j = mouseBoxyl To mouseBoxy2
pColour = GetPixel(Picturel.hdc, i, j) 
R = pColour And &FIFF 
G = (pColour And 65280) /  256 
B = (pColour And &HFF0000) /  65536
If (R > G) And ((Abs(R - G)) > ColourDis Or (Abs(G - B)) > ColourDis Or _ (Abs(R - B)) >
ColourDis) Then
pColour = SetPixel(Picturel.hdc, i, j, vbGreen) 
dopplerpoints = dopplerpoints + 1
End If
Next j 
Next i
Label6.Caption = dopplerpoints
End Sub
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
Private Sub Command4_Click()
SavePicture Picturel.Image, DateFolder & "\m ax\" & Text2.Text & Listl.Listlndex & _
& Label8.Caption &  ".bmp"
End Sub
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
/ * *************************************************************************
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Private Sub Command5_Click()
Const PI = 3.14159265  
Picturel.DrawW idth = 2 
Picturel.CIs
'Picturel.FillStyle = 0
Picturel.FillColour = vbGreen
Picturel.Circle (cirX, cirY), cirR, vbG reen ,, ,  cirH
lineAch = True 
End Sub
' * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
' ♦ I * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Listl_MouseDown(Button As Integer, Shift As Integer, x As Single, y As Single)
If Listl.Listlndex < 0 Then Exit Sub 
If Button = vbLeftButton Then
Label5.Caption = "File " & Listl.Listlndex + 1 & " o f " & numOpenAVIs 
Picturel.Picture = LoadPicture(DateFolder & "\" & Listl.Listlndex & "\0.bmp") 
'Label6.Caption = DateFolder & "\" & Listl.Listlndex & "\0.bmp"
End If
Labell2.Caption = "Current fram e " & Listl.Listlndex 
Textl.Text = 0 
End Sub
(I**************************************************************************
' * * * * * * * * * * * * * * * * * * * * * * * * * * * *  s * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * *
Private Sub open_Click()
On Error Resume Next
CommonDialogl.InitDir = "D :\M y  Docum ents\My music"
CommonDialogl.Flags = cdlOFNAIIowMultiselect Or cdlOFNExplorer 'multiple selection 
CommonDialogl.Filter = "All Support Files(*.AVI) | *.AVI | All F iles(*.*)| * . *  | " 
CommonDialogl.filename = ""
CommonDialogl.DialogTitle = "AVI files"
CommonDialogl.ShowOpen
If Len(CommonDialogl.filename) = 0 Then 
Exit Sub 
End If
filemanyaddress = Com m onDialogl.filenam e
Files = Split(filemanyaddress, Chr(O)) 'load multi-files
numOpenAVIs = UBound(Files)
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For i = 1 To UBound(Files) Step 1 
Files(i) = Files(O) & " \ "  & Files(i)
Next i
For i = 1 To UBound(Files) Step 1 
strfilename = Files(i)
Listl.Addltem strfilename 
Next i
Dim Message, title, Default, MyValue 
Message = "Enter a pre-number" 
title = "Slice order"
Default =
MyValue = lnputBox(Message, title, Default, 4500, 4500)
Text2.Text = MyValue
If Err.Number = cdlCancel Then Exit Sub 
VarMore = 0 
VarM3u = 19 
VarVCD = 19
End Sub
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Picturel_MouseDown(Button As Integer, Shift As Integer, x As Single, y As Single) 
'Picturel.AutoRedraw = True 
'Picturel.CIs 
'Picturel.SetFocus 
flag = True 
x l = x 
y l = y
Picturel.DrawW idth = 3 
Picturel.ForeColour = vbYellow 
End Sub
<**************************************************************************
/ ************************************************************************ **  
Private Sub Picturel_MouseMove(Button As Integer, Shift As Integer, x As Single, y As Single) 
If flag = True Then 
Picturel.Refresh 
x2 = x 
y2 = y
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Picturel.Line (x l, y l)-S tep(x2  - x l ,  y2 - y l ) , , B 
End If 
End Sub
/ I * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
' * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Picturel_M ouseUp(Button As Integer, Shift As Integer, x As Single, y As Single) 
flag = False 
Dim i, j As Long 
Dim lastPoints As Long 
Dim maxNum As Integer 
Dim fromFrame As Integer 
Dim ToFrame As Integer
ColourDis = Slider2.Value
dopplerpoints = 0 
lastPoints = 0 
maxNum = 0
If x l  >x2 Then 
a = x l  
x l = x2 
x2 = a 
End If
If y l  > y2 Then 
a = y l  
y l  = y2 
y2 = a 
End If
ProgressBar2.Min = 0 
ProgressBar2.Max = x2 - x l
P icturel.DrawW idth = 2 
Picturel.ForeColour = vbRed
fromFrame = Clnt(Textl.Text)
mouseBoxxl = x l  
mouseBoxx2 = x2 
mouseBoxyl = y l  
mouseBoxy2 = y2
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For p = fromFrame To Clnt(Text3.Text) - 1
Picturel.Picture = LoadPicture(DateFolder & "\" & Listl.Listlndex & "\" & p & ".bmp")
For i = x l  To x2
ProgressBar2.Value = i - x l  
For j = y l  To y2
pColour = GetPixel(Picturel.hdc, i, j)
R = pColour And &HFF
G = (pColour And 65280) /  256
B = (pColour And &HFF0000) /  65536
If (R > G )T h e n
If (Abs(R - G)) > ColourDis Or (Abs(G - B)) > ColourDis Or _
(Abs(R - B)) > ColourDis Then
pColour = SetPixel(Picturel.hdc, i, j, vbYellow) 
dopplerpoints = dopplerpoints + 1 
End If
'pColour = SetPixel(Picturel.hdc, i, j, vbWhite)
End If 
Next j 
Next i
Label6 .Caption = dopplerpoints 
La bel6 .Refresh
Label7.Caption = "Comparing Slice " & p 
La be 17. Refresh
If dopplerpoints > lastPoints Then 
maxNum = p
lastPoints = dopplerpoints 
End If
Label8 .Caption = maxNum  
La bel8 .Refresh
dopplerpoints = 0
Next p
Label6.Caption = maxNum
Picturel.Picture = LoadPicture(DateFolder &  "\" & Listl.Listlndex & "\" & maxNum &_ ".bmp")
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Call Command5_Click 
End Sub
< * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Sliderl_MouseM ove(Button As Integer, Shift As Integer, x As Single, y As _  Single)
On Error Resume Next
Label7.Caption = "Current Slice " & Sliderl.Value
Picturel.Picture = LoadPicture(DateFolder & "\" & Listl.Listlndex & "\" & Sliderl.Value _ & ".bmp") 
End Sub
' * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
' * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Slider2_MouseMove(Button As Integer, Shift As Integer, x As Single, y As _  Single) 
LabellO.Caption = Slider2.Value 
End Sub
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Slider3_MouseDown(Button As Integer, Shift As Integer, x As Single, y As _ Single) 
radCha = True 
End Sub
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Slider3_MouseMove(Button As Integer, Shift As Integer, x As Single, y As _  Single)
If radCha And lineAch Then 
Picturel.CIs
Picturel.Circle (cirX, cirY), Slider3.Value, vbG reen,, ,  cirH 
cirR = Slider3.Value 
End If 
End Sub
/ * ************************************************** ***********************
Private Sub Slider3_MouseUp(Button As Integer, Shift As Integer, x As Single, y As Single) 
radCha = False 
End Sub
z * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Slider4_MouseDown(Button As Integer, Shift As Integer, x As Single, y As _ Single) 
radCha = True
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End Sub
' f t * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
' * *************************************************************************
Private Sub Slider4_MouseMove(Button As Integer, Shift As Integer, x As Single, y As _  Single) 
If radCha And lineAch Then 
Picturel.Cls
Picturel.Circle (Slider4.Value, cirY), cirR, vbG reen,, ,  cirH 
cirX = Slider4.Value 
End If 
End Sub
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Slider4_MouseUp(Button As Integer, Shift As Integer, x As Single, y As Single) 
radCha = False 
End Sub
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Slider5_MouseDown(Button As Integer, Shift As Integer, x As Single, y As _  Single) 
radCha = True 
End Sub
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
Private Sub Slider5_MouseMove(Button As Integer, Shift As Integer, x As Single, y As _ Single) 
If radCha And lineAch Then 
Picturel.Cls
Picturel.Circle (cirX, Slider5.Value), cirR, vbG reen,, ,  cirH 
cirY = Slider5.Value 
End If 
End Sub
/ i t ! * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * *  
Private Sub Slider5_MouseUp(Button As Integer, Shift As Integer, x As Single, y As Single) 
radCha = False 
End Sub
/ **************************************************************************  
Private Sub Slider6_MouseDown(Button As Integer, Shift As Integer, x As Single, y As _  Single) 
radCha = True
205
The Quantification of Achilles Tendon Neovascularity
End Sub
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
<**************************************************************************  
Private Sub Slider6_MouseMove(Button As Integer, Shift As Integer, x As Single, y As _ Single) 
If radCha And lineAch Then 
Picturel.Cls
Picturel.Circle (cirX, cirY), cirR, vbG reen,, ,  Slider6.Value /  120 
cirH = Slider6 .Value /  120 
End If 
End Sub
I * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
' * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Private Sub Slider6_MouseUp(Button As Integer, Shift As Integer, x As Single, y As Single) 
radCha = False 
End Sub
' * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ♦ * * * * * * * * * * * *
D.2 Module-mAVIDecs.bas
Option Explicit
Public Declare Function mmioStringToFOURCC Lib "winmm.dM" Alias "mmioStringToFOURCCA" (ByVal sz As String, 
ByVal uFlags As Long) As Long 'returns fourcc
Public Declare Function VideoForWindowsVersion Lib "msvfw32.dMM () As Long 
Public Declare Sub AVIFilelnit Lib "avifil32.dll" ()
Public Declare Function AVIFileOpen Lib "avifil32.dll" (ByRef ppfile As Long, ByVal szFile As String, ByVal uMode 
As Long, ByVal pcIsidHandler As Long) As Long 'HRESULT
Public Declare Function AVIFilelnfo Lib "avifil32.dll" (ByVal pfile As Long, pfi As AVI_FILE_INFO, ByVal ISize As Long) 
As Long'HRESULT
Public Declare Function AVIFileCreateStream Lib "avifil32.dll" Alias "AVIFileCreateStreamA" _
(ByVal pfile As Long, ByRef ppavi As Long, ByRef psi As
AVI_STREAM JN FO ) As Long
Public Declare Function AVISaveOptions Lib "avifil32.dll" (ByVal hWnd As Long, _
ByVal uiFlags As Long, _
ByVal nStreams As Long, _
ByRef ppavi As Long, _
ByRef ppOptions As Long) As Long 'TRUE if
user pressed OK, False if cancel, or error if error
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Public Declare Function AVISave Lib "avifil32.dll" Alias "AVISaveVA" (ByVal szFile As String, _
ByVal pcIsidHandler As
Long, _
ByVal IpfnCallback As
Long, _
ByVal nStreams As Long, 
ByRef ppaviStream As
Long, _
ByRef ppCompOptions
As Long) As Long
Public Declare Function AVISaveOptionsFree Lib "avifil32.dll" (ByVal nStreams As Long, _
ByRef ppOptions As Long) As Long
Public Declare Function AVIMakeCompressedStream Lib "avifil32.dll" (ByRef ppsCompressed As Long, _
ByVal psSource As Long, _
ByRef IpOptions As
AVI_COMPRESS_OPTIONS, _
ByVal pcIsidHandler As Long) As
Long'
Public Declare Function AVIStreamSetFormat Lib "avifil32.dM” (ByVal pavi As Long, _
ByVal IPos As Long, _
ByRef IpFormat As Any, _
ByVal cbFormat As Long) As Long
Public Declare Function AVIStreamWrite Lib "avifil32.dll" (ByVal pavi As Long, _
ByVal IStart As Long, _
ByVal ISamples As Long, _
ByVal IpBuffer As Long, _
ByVal cbBuffer As Long, _
ByVal dwFlags As Long, _
ByRef pISampWritten As Long, _
ByRef plBytesWritten As Long) As Long 
Public Declare Function AVIStreamReadFormat Lib "avifil32.dH" (ByVal pAVIStream As Long, _
ByVal IPos As Long, _
ByVal IpFormatBuf As Long, _
ByRef sizeBuf As Long) As Long
Public Declare Function AVIStreamRead Lib "avifil32.dll" (ByVal pAVIStream As Long, _
ByVal IStart As Long, _
ByVal ISamples As Long, _
ByVal IpBuffer As Long, _
207
The Quantification of Achilles Tendon Neovascularity
ByVal cbBuffer As Long, _
ByRef pBytesWritten As Long, _
ByRef pSamplesWritten As Long) As
Long
Public Declare Function AVIStreamGetFrameOpen Lib "avifil32.dM" (ByVal pAVIStream As Long, _
ByRef bih As Any) As Long 'returns
pointer to GETFRAME object on success (or NULL on error)
Public Declare Function AVIStreamGetFrame Lib "avifil32.dll" (ByVal pGetFrameObj As Long, _
ByVal IPos As Long) As Long
'returns pointer to packed DIB on success (or NULL on error)
Public Declare Function AVIStreamGetFrameClose Lib "avifil32.dll" (ByVal pGetFrameObj As Long) As Long ' 
returns zero on success (error number) after calling this function the GETFRAME object pointer is invalid
Public Declare Function AVIFileGetStream Lib "avifil32.dll" (ByVal pfile As Long, ByRef ppaviStream As Long, ByVal 
fccType As Long, ByVal iParam As Long) As Long
Public Declare Function AVIMakeFileFromStreams Lib "avifil32.dll" (ByRef ppfile As Long, ByVal nStreams As Long, 
ByVal pAVIStreamArray As Long) As Long
Public Declare Function AVIStreamlnfo Lib "avifil32.dll" (ByVal pAVIStream As Long, ByRef psi As 
AVI_STREAM_INFO, ByVal ISize As Long) As Long
Public Declare Function AVIStreamStart Lib "avifil32.dll" (ByVal pavi As Long) As Long
Public Declare Function AVIStreamLength Lib "avifil32.dll" (ByVal pavi As Long) As Long
Public Declare Function AVIStreamRelease Lib "avifil32.dll" (ByVal pavi As Long) As Long 'ULONG
Public Declare Function AVIStreamClose Lib "avifil32.dll" Alias "AVIStreamRelease" (ByVal pavi As Long) As Long
'ULONG
Public Declare Function AVIFileRelease Lib "avifil32.dll" (ByVal pfile As Long) As Long
Public Declare Function AVIFileClose Lib "avifil32.dll" Alias "AVIFileRelease" (ByVal pfile As Long) As Long
Public Declare Sub AVIFileExit Lib "avifil32.dll" ()
i * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * *  * * * * * *  * * * * * * * * * ^
Public Declare Function AVIMakeStreamFromClipboard Lib "avifil32.dll" (ByVal cfFormat As Long, ByVal hGlobal 
As Long, ByRef ppstream As Long) As Long
Public Declare Function AVIPutFileOnClipboard Lib "avifil32.dll" (ByVal pAVIFile As Long) As Long 
Public Declare Function AVIGetFromClipboard Lib "avifil32.dll" (ByRef ppAVIFile As Long) As Long 
Public Declare Function AVICIearClipboard Lib "avifil32.dll" () As Long
Private Const BMP_MAGIC_COOKIE As Integer = 19778 ’this is equivalent to ascii string "BM"
Public Type BITMAPFILEHEADER ’14 bytes
bfType As Integer ’"magic cookie" - must be "BM" (19778)
bfSize As Long
bfReservedl As Integer
bfReserved2 As Integer
bfOffBits As Long
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End Type
'//BITMAP DEFINES (from mmsystem.h)
Public Type BITMAPINFOHEADER '40 bytes 
biSize As Long 
biWidth As Long 
biHeight As Long 
biPlanes As Integer 
biBitCount As Integer 
biCompression As Long 
biSizelmage As Long 
biXPelsPerMeter As Long 
biYPelsPerMeter As Long 
biClrUsed As Long 
biClrlmportant As Long 
End Type
Public Type BITMAPINFOHEADER_MJPEG '68 bytes 
biSize As Long 
biWidth As Long 
biHeight As Long 
biPlanes As Integer 
biBitCount As Integer 
biCompression As Long 
biSizelmage As Long 
biXPelsPerMeter As Long 
biYPelsPerMeter As Long 
biClrUsed As Long 
biClrlmportant As Long 
' / *  extended BITMAPINFOHEADER fields * /  
biExtDataOffset As Long 
'/ *  compression-specific fields * /
'/*  these fields are defined for 'JPEG' and 'MJPG' * /
JPEGSize As Long
JPEGProcess As Long
'/*  Process specific fields * /
JPEGColourSpacelD As Long 
JPEGBitsPerSample As Long 
JPEGHSubSampling As Long 
JPEGVSubSampling As Long 
End Type
Public Type AVI_RECT 
left As Long 
top As Long
209
The Quantification of Achilles Tendon Neovascularity
right As Long 
bottom As Long 
End Type
Public Type AVI_STREAM_INFO 
fccType As Long 
fccHandler As Long 
dwFlags As Long 
dwCaps As Long 
wPriority As Integer 
wLanguage As Integer 
dwScale As Long 
dwRate As Long 
dwStart As Long 
dwLength As Long 
dwInitialFrames As Long 
dwSuggestedBufferSize As Long 
dwQuality As Long 
dwSampleSize As Long 
rcFrame As AVI_RECT 
dwEditCount As Long 
dwFormatChangeCount As Long 
szName As String * 64  
End Type
'for use with AVIFIIelnfo 
Public Type AVI_FILE_INFO '108 bytes? 
dwMaxBytesPerSecond As Long 
dwFlags As Long 
dwCaps As Long 
dwStreams As Long 
dwSuggestedBufferSize As Long 
dwW idth As Long 
dwHeight As Long 
dwScale As Long 
dwRate As Long 
dwLength As Long 
dwEditCount As Long 
szFileType As String *  64 
End Type
Public Type AVI_COMPRESS_OPTIONS
fccType As Long ' / *  stream type, for consistency * /
fccHandler As Long ' / *  compressor * /
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dwKeyFrameEvery As Long 
dwQuality As Long 
dwBytesPerSecond As Long 
dwFlags As Long 
IpFormat As Long 
cbFormat As Long 
IpParms As Long 
cbParms As Long 
dwInterleaveEvery As Long 
End Type
'/ *  keyframe rate * /
' / *  compress quality 0-10,000 * /  
’/ *  bytes per second * /
' / *  flags... see below * /
' / *  save format * /
’/ *  compressor options * /
' / *  for non-video streams only * /
Global Const AVIERR_OK As Long = 0&
Private Const SEVERITY_ERROR As Long = &H80000000
Private Const FACILITY_ITF As Long = &H40000
Private Const AVIERR_BASE As Long = &H4000
Global Const AVIERR_BADFLAGS As Long = SEVERITY_ERROR Or FACILITYJTF Or (AVIERR_BASE + 105)
’-2147205015
Global Const AVIERR BADPARAM As Long = SEVERITY_ERROR Or FACILITYJTF Or (AVIERR_BASE + 106) 
’-2147205014
Global Const AVIERR_BADSIZE As Long = SEVERITY_ERROR Or FACILITYJTF Or (AVIERR_BASE + 107)
'-2147205013
Global Const AVIERR_USERABORT As Long = SEVERITY_ERROR Or FACILITYJTF Or (AVIERR_BASE + 198) 
’-2147204922
' / /  Flags for dwFlags
Global Const AVIFILEINFOJHASINDEX As Long = &H10
Global Const AVIFILEINFO_MUSTUSEINDEX As Long = &H20
Global Const AVIFILEINFOJSINTERLEAVED As Long = &H100 
Global Const AVIFILEINFO_WASCAPTUREFILE As Long = &H10000
Global Const AVIFILEINFO_COPYRIGHTED As Long = &H20000
' / /  Flags for dwCaps
Global Const AVIFILECAPS_CANREAD As Long = &H1
Global Const AVIFILECAPS_CANWRITE As Long = &H2
Global Const AVIFILECAPS_ALLKEYFRAMES As Long = &H10
Global Const AVIFILECAPS NOCOMPRESSION As Long = &H20
Global Const AVICOMPRESSFJNTERLEAVE As Long = &H1
Global Const AVICOMPRESSF_DATARATE As Long = &H2
Global Const AVICOMPRESSF_KEYFRAMES As Long = &H4
Global Const AVICOMPRESSF VALID As Long = &H8
' / /  interleave 
' / /  use a data rate 
' / /  use keyframes 
' / /  has valid data?
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Global Const OF_READ As Long = &H0  
Global Const OF_WRITE As Long = &H1
Global Const OF_SHARE_DENY_WRITE As Long = &FI20 
Global Const OF_CREATE As Long = &H1000
Global Const AVIIF_KEYFRAME As Long = &H10
'/*  DIB colour table identifiers * /
Global Const DIB_RGB_COLOURS As Long = 0 ' / *  colour table in RGBs * /
Global Const DIB_PAL_COLOURS As Long = 1 ' / *  colour table in palette indices * /
'/ *  constants for the biCompression field * /  
Global Const BI RGB As Long = 0
Global Const BI_RLE8 As Long = 1
Global Const BI_RLE4 As Long = 2
Global Const BI_BITFIELDS As Long = 3
'Stream types for use in VB (translated from C macros)
Global Const streamtypeVIDEO As Long = 1935960438 'equivalent to: mmioStringToFOURCC("vids", 0&)
Global Const streamtypeAUDIO As Long = 1935963489 'equivalent to: mmioStringToFOURCC("auds", 0&)
Global Const streamtypeMIDI As Long = 1935960429 'equivalent to: mmioStringToFOURCC("mids", 0&)
Global Const streamtypeTEXT As Long = 1937012852 'equivalent to: mmioStringToFOURCC("txts", 0&)
' / /  For GetFrame::SetFormat - use the best form at for the display 
Global Const AVIGETFRAMEF_BESTDISPLAYFMT As Long = 1
' / /  defines for uiFlags (AVISaveOptions)
Global Const ICMF_CHOOSE_KEYFRAME As Long = &H1
Global Const ICMF_CHOOSE_DATARATE As Long = &H2
Global Const ICMF_CHOOSE_PREVIEW As Long = &H4
Global Const ICMF_CHOOSE_ALLCOMPRESSORS As Long = &H8
' / /  show KeyFrame Every box 
' / /  show DataRate box 
' / /  allow expanded preview dialog 
' / /  don't only show those that 
' / /  can handle the input format 
' / /  or input data
7 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
1 * 'STANDARD W IN32 API DECLARES, UDTs and Constants
i * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * y
Private Declare Function SetRect Lib "user32.dll" _
(ByRef Iprc As AVI_RECT, ByVal xLeft As Long, ByVal yTop As Long, ByVal xRight As Long, ByVal yBottom As 
Long) As Long 'BOOL
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Private Declare Function GetProcessHeap Lib "kernel32.dH" () As Long 'handle
Private Declare Function HeapAlloc Lib "kernel32.dN" (ByVal hHeap As Long, ByVal dwFlags As Long, ByVal 
dwBytes As Long) As Long 'Pointer to mem
Private Declare Function HeapFree Lib "kernel32.dll" (ByVal hHeap As Long, ByVal dwFlags As Long, ByVal IpMem  
As Long) As Long 'BOOL
Private Declare Sub CopyMemory Lib "kernel32.dll" Alias "RtlMoveMemory" (ByRef dest As Any, ByRef src As Any, 
ByVal dwLen As Long)
Private Const HEAP_ZERO_MEMORY As Long = &H8
Global gfAbort As Boolean 'allows user to abort an AVI Save operation (see Callback function below)
Public Function AVISaveCallback(ByVal nPercent As Long) As Long 'should return C BOOL 
End Function
i *
' * 'UTILITY FUNCTIONS FOR WORKING WITH AVI FILES 
■ *
i * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * y
Public Sub DebugPrintAVIStreamlnfo(asi As AVI_STREAM_INFO)
Debug.Print""
Debug.Print " * * * *  AVI_STREAM_INFO (START) * * * * "
W ith a si
Debug.Print "fccType = " & .fccType
Debug.Print "fccHandler = " & .fccHandler
Debug.Print "dwFlags = " & .dwFlags
Debug.Print "dwCaps = " & .dwCaps
Debug.Print "wPriority = " & .wPriority
Debug.Print "wLanguage = " & .wLanguage
Debug.Print "dwScale = " & .dwScale
Debug.Print "dwRate = " & .dwRate
Debug.Print "dwStart = " & .dwStart
Debug.Print "dwLength = " &  .dwLength
Debug.Print "dwInitialFrames = " & .dwInitialFrames
Debug.Print "dwSuggestedBufferSize = " & .dwSuggestedBufferSize
Debug.Print "dwQuality = " & .dwQuality
Debug.Print "dwSampleSize = " & .dwSampleSize
Debug.Print "rcFrame.left = " & .rcFrame.left
Debug.Print "rcFrame.top = " & .rcFrame.top
Debug.Print "rcFrame.right = " & .rcFrame.right
Debug.Print "rcFrame.bottom = " & .rcFrame.bottom
Debug.Print "dwEditCount = " & .dwEditCount
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Debug.Print "dwFormatChangeCount = " & .dwFormatChangeCount 
Debug.Print "szName = " & .szName 
End W ith
Debug.Print " * * * *  AVI_STREAM_INFO (END) * * * * "
Debug.Print""
End Sub
Public Sub DebugPrintAVIFilelnfo(afi As AVI_FILE_INFO)
Debug.Print " * * * *  AVI_FILE_INFO (START) * * * * ’’
With afi
Debug.Print 'dwMaxBytesPerSecond = " & .dwMaxBytesPerSecond
Debug.Print 'dwFlags = " &  .dwFlags
Debug.Print 'dwCaps = " & .dwCaps
Debug.Print 'dwStreams = " &  .dwStreams
Debug.Print 'dwSuggestedBufferSize = " & .dwSuggestedBufferSize
Debug.Print 'dwW idth = " &  .dw W idth
Debug.Print 'dwHeight = " &  .dwHeight
Debug.Print 'dwScale = " &  .dwScale
Debug.Print 'dwRate = " & .dwRate
Debug.Print 'dwLength = " &  .dwLength
Debug.Print 'dwEditCount = " & .dwEditCount
Debug.Print 'szFileType = " & .szFileType
End With
Debug.Print " * * * *  AVI_FILE_INFO (END) * * * * ’’
Debug.Print""
End Sub
D.3 Class Module-cDIB.cls
Option Explicit
Private Const BMP_MAGIC_COOKIE As Integer = 19778 'this is equivalent to ascii string "BM"
'//BITMAP DEFINES (from mmsystem.h)
Private Type BITMAPFILEHEADER '14 bytes
bfType As Integer "'magic cookie" - must be "BM"
bfSize As Long
bfReserved 1 As Integer
bfReserved2 As Integer
bfOffBits As Long
End Type
Private Type BITMAPINFOHEADER '40 bytes 
biSize As Long
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biWidth As Long 
biHeight As Long 
biPlanes As Integer 
biBitCount As Integer 
biCompression As Long 
biSizelmage As Long 
biXPelsPerMeter As Long 
biYPelsPerMeter As Long 
biClrUsed As Long 
biClrlmportant As Long 
End Type
Private Type RGBQUAD 
Red As Byte 
Green As Byte 
Blue As Byte 
Reserved As Byte 
End Type
Private Type BITMAP 
bmType As Long 
bmWidth As Long 
bmHeight As Long 
bmWidthBytes As Long 
bmPlanes As Integer 
bmBitsPixel As Integer 
bmBits As Long 
End Type
'/*  constants for the biCompression field * /
Private Const BI_RGB As Long = 0&
Private Declare Function GetProcessHeap Lib Hkernel32.dH" () As Long 'handle
Private Declare Function HeapAlloc Lib "kernel32.dll" (ByVal hHeap As Long, ByVal dwFlags As Long, ByVal 
dwBytes As Long) As Long 'Pointer to mem
Private Declare Function HeapFree Lib "kernel32.dll" (ByVal hHeap As Long, ByVal dwFlags As Long, ByVal IpMem  
As Long) As Long 'BOOL
Private Declare Sub CopyMemory Lib "kernel32.dll" Alias "RtlMoveMemory" (ByRef dest As Any, ByRef src As Any, 
ByVal dwLen As Long)
Private Const HEAP_ZERO_MEMORY As Long = &H8
Private m_memBits() As Byte 
Private m_memBitmaplnfo() As Byte
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Private m_bih As BITMAPINFOHEADER 
Private m_bfh As BITMAPFILEHEADER
Public Function CreateFromFile(ByVal filename As String) As Boolean 
Dim hFile As Long
If Not ExistFile(filename) Then
MsgBox "File does not exist:" & vbCrLf & filename, vbCritical, App.title 
Exit Function 
End If
hFile = FreeFile()
'<====ERROR TRAP ON 
On Error Resume Next
Open filename For Binary Access Read As #hFile 
If Err Then
If Err.Number = 70 Then
MsgBox "File is locked - cannot access:" & vbCrLf & filename, vbCritical, App.title
Else
MsgBox Err.Description, vblnformation, App.title 
End If
Exit Function 'assume file was not opened 
End If
On Error GoTo 0 
'====>ERROR TRAP OFF
'OK, file is opened - now for the real algorithm...
Get #hF ile ,, m_bfh 'get the BITMAPFILEHEADER this identifies the bitmap
If m_bfh.bfType <> BMP_MAGIC_COOKIE Then 'this is not a BMP file
MsgBox "File is not a supported bitmap format:" & vbCrLf & filename, vblnformation, App.title 
Close #hFile 
Exit Function
Else
'now get the info header
Get #hFile, Len(m_bfh) + 1, m_bih 'start at the 15th byte
'now get the bitmap bits
ReDim m_memBits(0 To m_bih.biSizelmage -1 )
Get #hFile, m_bfh.bfOffBits + 1, m_memBits
'and Bitmaplnfo variable-length UDT
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ReDim m_memBitmaplnfo(0 To m_bfh.bf Off Bits -1 4 ) 'don't need first 14 bytes (fileinfo) 
Get #hFile, Len(m_bfh) + 1, m_memBitmaplnfo
Close #hFile 'Close file 
End If
CreateFromFile = True 'indicate success 
End Function
Public Function CreateFromPackedDIBPointer(ByRef pDIB As Long) As Boolean 
Debug.Assert pDIB <> 0
'Creates a full-colour (no palette) DIB from a pointer to a full-colour memory DIB 
'get the BitmaplnfoHeader
Call CopyMemory(ByVal VarPtr(m_bih.biSize), ByVal pDIB, Len(m_bih))
If m_bih.biBitCount < 16 Then
Debug.Print "Error! DIB was less than 16 colours."
Exit Function 'only supports high-colour or full-colour dibs 
End If
'now get the bitmap bits
If m_bih.biSizelmage < 1 Then Exit Function 'return False 
ReDim m_memBits(0 To m_bih.biSizelmage -1 )
Call CopyMemory(m_memBits(0), ByVal pDIB + 40, m_bih.biSizelmage)
'and Bitmaplnfo variable-length UDT
ReDim m_memBitmaplnfo(0 To 39) 'don't need first 14 bytes (fileinfo)
Call CopyMemory(m_memBitmaplnfo(0), m_bih, Len(m_bih))
'create a file header 
With m_bfh
.bfType = BMP_MAGIC_COOKIE
.bfSize = 55 + m_bih.biSizelmage 'size of file as written to disk 
.bfReservedl = 0&
.bfReserved2 = 0&
.bf Off Bits = 54 'BitmaplnfoHeader + BitmapFileHeader 
End With
'and return True
CreateFromPackedDIBPointer = True 
End Function
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Public Function WriteToFile(ByVal filenam e As String) As Boolean 
Dim hFile As Integer 
On Error Resume Next 
hFile = FreeFile()
Open filename For Binary As hFile 
Put hFile, 1, m_bfh
Put hFile, Len(m_bfh) + 1, m_memBitmaplnfo  
Put hF ile ,, m_memBits 
Close hFile 
WriteToFile = True 
End Function
Private Function ExistFile(ByVal sSpec As String) As Boolean 
On Error Resume Next 
Call FileLen(sSpec)
ExistFile = (Err = 0)
End Function
Public Property Get BitCount() As Long 
BitCount = m_bih. biBitCount
End Property
Public Property Get Height() As Long 
Height = m_bih. biHeight 
End Property
Public Property Get W idth() As Long 
Width = m_bih. biW idth  
End Property
Public Property Get Compression() As Long 
Compression = m_bih. biCompression 
End Property
Public Property Get SizelnfoHeader() As Long 
SizelnfoHeader = m_bih.biSize 
End Property
Public Property Get Sizelmage() As Long 
Sizelmage = m_bih.biSizelmage 
End Property
Public Property Get Planes() As Long
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Planes = m_bih.biPlanes 
End Property
Public Property Get Clrlm portant() As Long 
Clrlmportant = m_bih.biClrlmportant 
End Property
Public Property Get ClrUsed() As Long 
ClrUsed = m_bih. biClrUsed 
End Property
Public Property Get XPPM() As Long 
XPPM = m_bih. biXPelsPerMeter 
End Property
Public Property Get YPPM() As Long 
YPPM = m_bih. biYPelsPerMeter 
End Property
Public Property Get FileType() As Long 
FileType = m_bfh.bfType 
End Property
Public Property Get SizeFileHeader() As Long 
SizeFileHeader = m_bfh.bfSize 
End Property
Public Property Get BitOffset() As Long 
BitOffset = m_bfh.bf Off Bits 
End Property
Public Property Get PointerToBits() As Long 
PointerToBits = VarPtr(m_memBits(0))
End Property
Public Property Get PointerToBitmaplnfo() As Long
PointerToBitmaplnfo = VarPtr(m_m emBitmaplnfo(0)) 
End Property
Public Property Get SizeBitmaplnfo() As Long
SizeBitmaplnfo = UBound(m_m emBitmaplnfo()) + 1 
End Property
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D.4 Class ModuIe-cFileDlg.cls
Option Explicit
Private Const MAX_PATH = 1024
Private Const MAX_FILE = 512
'Windows desktop virtual folder at the root of the name space 
vbCSIDL_DESKTOP = &H0& 'File system directory that contains the  
'user's program groups (which are also file 'system directories) 
vbCSIDLPROGRAMS = & H2&
'Control Panel - virtual folder containing 
'icons for the control panel applications 
vbCSIDLCONTROLS = &H3&
'Printers folder - virtual folder containing 'installed printers. 
vbCSIDL_PRINTERS = & H4& 'File system directory that serves as a 
'common repository for documents (M y Documents folder) 
vbCSIDL_PERSONAL = &H5&
'File system directory that contains the  
'user's favorite Internet Explorer URLs 
vbCSIDL_FAVORITES = & H 6&
'File system directory that corresponds to the  
'user's Startup program group 
vbCSIDL_STARTUP = & H7&
'File system directory that contains the  
'user's most recently used documents (Recent folder) 
vbCSIDL_RECENT = &H8& 'File system directory that contains 
'Send To menu items Public Const 
vbCSIDL_SENDTO = &H9&
'Recycle bin file system directory containing file 
'objects in the user's recycle bin. The location of 
'this directory is not in the registry; it is marked 
'with the hidden and system attributes to prevent the  
'user from moving or deleting it. 
vbCSIDL_BITBUCKET = &HA&
’File system directory containing Start menu items 
vbCSIDL_STARTMENU = &HB&
'File system directory used to physically store 
'file objects on the desktop (not to be confused 
'with the desktop folder itself).
vbCSIDL_DESKTOPDIRECTORY = &H10&
'My Computer - virtual folder containing everything 
'on the local computer: storage devices, printers,
'and Control Panel. The folder may also contain 'mapped network drives.
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vbCSIDL_DRIVES = &H11&
'Network Neighborhood - virtual folder representing 
'the top level of the network hierarchy 
vbCSIDL_NETWORK = & H 12&
'File system directory containing objects that 
'appear in the network neighborhood 
vbCSIDL_NETHOOD = & H 13&
'Virtual folder containing fonts 
vbCSIDL_FONTS = &H14&
'File system directory that serves as a
'common repository for docum ent templates ’(ShellNew folder.) 
vbCSIDL_TEMPLATES = & H 15&
End Enum
Private Declare Function SFIGetSpecialFolderLocation Lib "shell32.dll" _
(ByVal hWndOwner As Long, _
ByVal nFolder As SPECIAL_FOLDERS, _
pidl As Long) As Long 'returns NOERROR on success
'Converts an item identifier list to  a file system path.
Private Declare Function SHGetPathFromlDList Lib "shell32.dll" _
Alias "SFIGetPathFromlDListA" _
(ByVal pidl As Long, _
ByVal pszPath As String) As Long
Private Declare Sub CoTaskMemFree Lib "ole32.dll" (ByVal pv As Long)
Private Const NOERROR As Long = &H0
Private Type OPENFILENAME 
IStructSize As Long 
hWndOwner As Long 
hInstance As Long 
IpstrFilter As String 
IpstrCustomFilter As String 
nMaxCustFilter As Long 
nFilterlndex As Long 
IpstrFile As String 
nMaxFile As Long 
IpstrFileTitle As String 
nMaxFileTitle As Long 
IpstrlnitialDir As String 
IpstrTitle As String 
Flags As Long 
nFileOffset As Integer
' Filled with UDT size 
' Tied to Owner 
' Ignored (used only by templates) 
' Tied to Filter
' Ignored (exercise for reader)
' Ignored (exercise for reader)
' Tied to Filterlndex 
' Tied to FileName 
' Handled internally 
' Tied to FileTitle
' Handled internally 
Tied to InitDir 
' Tied to DlgTitle 
' Tied to Flags 
' Ignored (exercise for reader)
221
The Quantification of Achilles Tendon Neovascularity
nFileExtension As Integer 
IpstrDefExt As String 
ICustData As Long 
IpfnHook As Long 
IpTemplateName As Long
Ignored (exercise for reader) 
Tied to DefaultExt 
' Ignored (needed for hooks)
' Ignored (good luck with hooks)
' Ignored (good luck with templates)
End Type
Private Declare Function GetOpenFileNam e Lib "COMDLG32" _
Alias "GetOpenFileNameA" (filestruct As OPENFILENAME) As Long 
Private Declare Function GetSaveFileName Lib "COMDLG32" _
Alias "GetSaveFileNameA" (filestruct As OPENFILENAME) As Long 
Private Declare Function GetFileTitle Lib "COMDLG32" _
Alias "GetFileTitleA" (ByVal szFile As String, _
ByVal szTitle As String, ByVal cbBuf As Integer) As Integer 
'VFW "customized" File Dialogs
Private Declare Function GetOpenFileNam ePreview Lib "MSVFW32" _
Alias "GetOpenFileNamePreviewA" (filestruct As OPENFILENAME) As Long 
Private Declare Function GetSaveFileNamePreview Lib "MSVFW32" _
Alias "GetSaveFileNamePreviewA" (filestruct As OPENFILENAME) As Long
Public Enum EOpenFile
OFN_READONLY = &H1&
OFN_OVERWRITEPROMPT = &H2&
OFN_HIDEREADONLY = & H 4&
OFN_NOCHANGEDIR = &H8&
OFN_SHOWHELP = &H10&
OFN_ENABLEHOOK = & H20&
OFN_ENABLETEMPLATE = & H 40&
OFN_ENABLETEMPLATEHANDLE = &H80&
OFN_NOVALIDATE = &H 100&
OFN_ALLOWMULTISELECT = & H 200&
OFN_EXTENSION DIFFERENT = 8iH400&
OFN_PATHMUSTEXIST = 81H8OO&
OFN_FILEMUSTEXIST = &H10008t 
OFN_CREATEPROMPT = 8tH2000&
OFN_SHAREAWARE = 8tH4000&
OFN_NOREADONLYRETURN = &H 8000&
OFN_NOTESTFILECREATE = & H 10000  
OFN_NONETWORKBUTTON = 8iH20000  
OFN_NOLONGNAMES = &H40000  
OFN_EXPLORER = &H80000  
OFN_NODEREFERENCELINKS = 8iH100000  
OFN LONGNAMES = &H200000
End Enum
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Private Declare Function CommDlgExtendedError Lib "COMDLG32" () As Long
Public Enum EDialogError
CDERR_DIALOGFAILURE = &HFFFF&
CDERR_GENERALCODES = & H0&
CDERR_STRUCTSIZE = &H1&
CDERRJNITIALIZATION = & H 2&
CDERR_NOTEMPLATE = &H3&
CDERR_NOH INSTANCE = & H 4&
CDERR_LOADSTRFAILURE = & H5&
CDERR_FINDRESFAILURE = & H6&
CDERR_LOADRESFAILURE = &H7&
CDERR_LOCKRESFAILURE = & H8&
CDERR_MEMALLOCFAILURE = &H9&
CDERR_MEMLOCKFAILURE = &HA&
CDERR_NOHOOK = &HB&
CDERR_REGISTERMSGFAIL = &HC&
PDERR_PRINTERCODES = & H 1000&
PDERR_SETUPFAILURE = &H 1001&
PDERR_PARSEFAILURE = & H 1002&
PDERR_RETDEFFAILURE = & H 1003&
PDERR_LOADDRVFAILURE = & H 1004&
PDERR_GETDEVMODEFAIL = &H 1005&
PDERRJNITFAILURE = & H 1006&
PDERR_NODEVICES = &H 1007&
PDERR_NODEFAULTPRN = & H 1008&
PDERR_DNDMMISMATCH = 8iH1009&
PDERR_CREATEICFAILURE = SHlOOASt 
PDERR_PRINTERNOTFOUND = &H100B8i 
PDERR_DEFAULTDIFFERENT = 8iH100C&
CFERR_CHOOSEFONTCODES = 8iH2000&
CFERR_NOFONTS = &H 2001&
CFERR_MAXLESSTHANMIN = & H 2002&
FNERR_FILENAMECODES = & H 3000&
FNERR_SUBCLASSFAILURE = &H 3001&
FNERRJNVALIDFILENAME = & H 3002&
FNERR_BUFFERTOOSMALL = &H 3003&
CCERR CHOOSECOLOURCODES = &H5000&
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End Enum
Private Const sEmpty As String = ""
'Class member variables
Private m_FileMustExist As Boolean
Private m_MultiSelect As Boolean
Private m_ReadOnly As Boolean 'read only
Private m_HideReadOnly As Boolean
Private m_Filter As String
Private m_Filterlndex As Long
Private m JnitD ir As String
Private m_DlgTitle As String
Private m_DefaultExt As String
Private m_Flags As Long
Private m_OverwritePrompt As Boolean
Private m_hWnd As Long
Private Sub Class_lnitialize()
'Initialize default values 
m_hWnd = -1&  
m_FileMustExist = True 
m_MultiSelect = False 
m_HideReadOnly = True 
m_DlgTitle = App.title 
m_OverwritePrompt = True
m_lnitDir = GetSpecialFolderLocation(vbCSIDL_PERSONAL) ’default to M y Documents folder 
End Sub
Property Get OwnerHwnd() As Long 
OwnerHwnd = m_hWnd 
End Property
Property Let OwnerHwnd(ByVal vHwnd As Long) 
m_hWnd = vHwnd 
End Property
Property Get FileMustExist() As Boolean 
FileMustExist = m_FileMustExist 
End Property
Property Let FileMustExist(ByVal vNewValue As Boolean) 
m FileMustExist = vNewValue
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End Property
Property Get MultiSelect() As Boolean 
MultiSelect = m_MultiSelect 
End Property
Property Let MultiSelect(ByVal vNewValue As Boolean) 
m_MultiSelect = vNewValue  
End Property
Property Get ReadOnly() As Boolean 
Readonly = m_ReadOnly 
End Property
Property Get HideReadOnly() As Boolean 
HideReadOnly = m_HideReadOnly 
End Property
Property Let HideReadOnly(ByVal vNewValue As Boolean) 
m_HideReadOnly = vNewValue  
End Property
Property Get FilterQ As String 
Filter = m_Filter 
End Property
Property Let Filter(ByVal vFilterString As String) 
m_Filter = vFilterString 
End Property
Property Get Filterlndex() As Long 
Filterlndex = m_Filterlndex 
End Property
Property Let Filterlndex(ByVal vlndex As Long) 
m_Filterlndex = vlndex 
End Property
Property Get InitDirectoryO As String 
InitDirectory = m_lnitDir 
End Property
Property Let lnitDirectory(ByVal DirPath As String) 
m JnitD ir = DirPath 
End Property
Property Let lnitDirectorySpecial(ByVal SpecialDirectory As SPECIAL_FOLDERS) 
m JnitD ir = GetSpecialFolderLocation(SpecialDirectory)
End Property
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Property Get DlgTitle() As String 
DlgTitle = m_DlgTitle 
End Property
Property Let DlgTitle(ByVal title  As String) 
m_DlgTitle = title  
End Property
Property Get DefaultExt() As String 
DefaultExt = m_DefaultExt 
End Property
Property Let DefaultExt(ByVal fileExt As String) 
m_DefaultExt = fileExt 
End Property
Property Get Flags() As EOpenFile 
Flags = m_Flags 
End Property
Property Let Flags(ByVal vFlags As EOpenFile) 
m_Flags = vFlags 
End Property
Property Get OverwritePrompt() As Boolean 
Overwrite Prompt = m _OverwriteProm pt 
End Property
Property Let OverwritePrompt(ByVal vShowPrompt As Boolean) 
m_OverwritePrompt = vShowPrompt 
End Property
Public Function VBGetOpenFileName(filename As String, _
Optional FileTitle As String) As Boolean
Dim opfile As OPENFILENAME 
Dim s As String 
Dim afFlags As Long 
Dim ch As String 
Dim i As Integer
With opfile
.iStructSize = Len(opfile)
' Add in specific flags and strip out non-VB flags 
.Flags = (-m_FileMustExist *  OFN_FILEMUSTEXIST) O r_
(-m_MultiSelect * OFN_ALLOWMULTISELECT) O r_
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(-m_ReadOnly * OFN_READONLY) O r_
(-m_HideReadOnly * OFN_HIDEREADONLY) O r_
(m_Flags And CLng(Not (OFN_ENABLEHOOK Or _
OFN_ENABLETEMPLATE)))
' Owner can take handle of owning window  
If m_hWnd <> -1 Then .hW ndOwner = m_hWnd 
' InitDir can take initial directory string 
.IpstrlnitialDir = m Jn itD ir 
' DefaultExt can take default extension 
.IpstrDefExt = m_DefaultExt 
' DlgTitle can take dialog box title  
.IpstrTitle = m_DlgTitle
' To make Windows-style filter, replace | and : with nulls 
For i = 1 To Len(Filter) 
ch = Mid$(Filter, i, 1)
If ch = " | " Or ch = Then 
s = s & vbNullChar
Else
s = s & ch 
End If
Next
1 Put double null at end 
s = s & vbNullChar & vbNullChar 
.IpstrFilter = s
.nFilterlndex = m_Filterlndex
1 Pad file and file title buffers to maximum path 
s = filename & String$(MAX_PATH - Len(filename), 0)
.IpstrFile = s 
.nMaxFile = MAX_PATH
s = FileTitle & String$(MAX_FILE - Len(FileTitle), 0)
.IpstrFileTitle = s 
.nMaxFileTitle = MAX_FILE 
' All other fields set to zero
If GetOpenFileName(opfile) Then 
VBGetOpenFileName = True
filename = left$(.IpstrFile, lnStr(.IpstrFile, vbNullChar) -1 )
FileTitle = left$(.IpstrFileTitle, lnStr(.IpstrFileTitle, vbNullChar) -1 )  
m_Flags = .Flags 
' Return the filter index 
m_Filterlndex = .nFilterlndex 
’ Look up the filter the user selected and return that
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m_Filter = FilterLookup(.lpstrFilter, m_Filterlndex)
If (.Flags And OFN_READONLY) Then m_ReadOnly = True 
'save directory as init directory for user 
m JnitD ir = .IpstrFile
Else
VBGetOpenFileName = False 
filename = vbNullChar 
FileTitle = vbNullChar 
Flags = 0 
Filterlndex = -1 
Filter = vbNullChar 
End If 
End W ith  
End Function
Public Function VBGetOpenFileNamePreview(filename As String, _
Optional FileTitle As String) As Boolean
Dim opfile As OPENFILENAME 
Dim s As String 
Dim afFlags As Long 
Dim ch As String 
Dim i As Integer
With opfile
.IStructSize = Len(opfile)
' Add in specific flags and strip out non-VB flags 
.Flags = (-m_FileMustExist *  OFN_FILEMUSTEXIST) O r_
(-m _MultiSelect *  OFN_ALLOWMULTISELECT) O r_  
(-m_ReadOnly *  OFN_READONLY) O r_  
(-m_HideReadOnly *  OFN_HIDEREADONLY) O r_  
(m_Flags And CLng(Not (OFN_ENABLEHOOK O r_
OFNENABLETEMPLATE)))
' Owner can take handle of owning w indow  
If m_hWnd <> -1 Then .hW ndOwner = m h W n d  
' InitDir can take initial directory string 
.IpstrlnitialDir = m Jn itD ir 
' DefaultExt can take default extension 
.IpstrDefExt = m_DefaultExt 
' DlgTitle can take dialog box title  
.IpstrTitle = m_DlgTitle
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' To make Windows-style filter, replace | and : with nulls 
For i = 1 To Len(Filter) 
ch = Mid$(Filter, i, 1)
If ch = " |"  Or ch = Then  
s = s & vbNullChar
Else
s = s & ch 
End If
Next
’ Put double null at end 
s = s & vbNullChar & vbNullChar 
.IpstrFilter = s
.nFilterlndex = m_Filterlndex
1 Pad file and file title  buffers to  maximum path 
s = filename & String$(MAX_PATFI - Len(filename), 0)
.IpstrFile = s 
.nMaxFile = MAX_PATFI
s = FileTitle & String$(MAX_FILE - Len(FileTitle), 0)
.IpstrFileTitle = s 
.nMaxFileTitle = MAX_FILE 
’ All other fields set to zero
If GetOpenFileNamePreview(opfile) Then 
VBGetOpenFileNamePreview = True 
filename = left$(.IpstrFile, lnStr(.IpstrFile, vbNullChar) -1 )
FileTitle = left$(.IpstrFileTitle, lnStr(.IpstrFileTitle, vbNullChar) -1 )
m_Flags = .Flags
' Return the filter index
m_Filterlndex = .nFilterlndex
' Look up the filter the user selected and return that
m_Filter = FilterLookup(.IpstrFilter, m_Filterlndex)
If (.Flags And OFN_READONLY) Then m_ReadOnly = True 
'save directory as init directory for user 
m JnitD ir = .IpstrFile
Else
VBGetOpenFileNamePreview = False 
filename = vbNullChar 
FileTitle = vbNullChar 
Flags = 0 
Filterlndex = -1 
Filter = vbNullChar 
End If 
End W ith
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End Function
Public Function VBGetSaveFileName(filename As String, _
Optional FileTitle As String) As Boolean
Dim opfile As OPENFILENAME, s As String 
With opfile
.IStructSize = Len(opfile)
' Add in specific flags and strip out non-VB flags 
.Flags = (-m _OverwritePrompt * OFN_OVERWRITEPROMPT) O r_  
OFN_HIDEREADONLY Or _
(m_Flags And CLng(Not (OFN_ENABLEHOOK Or _
OFN_ENABLETEMPLATE)))
' Owner can take handle of owning w indow  
If m_hWnd <> -1 Then .hW ndOwner = m h W n d  
1 InitDir can take initial directory string 
.IpstrlnitialDir = m Jn itD ir 
' DefaultExt can take default extension 
.IpstrDefExt = m_DefaultExt 
' DlgTitle can take dialog box title  
.IpstrTitle = m_DlgTitle
' Make new filter with bars ( | ) replacing nulls and double null at end 
Dim ch As String, i As Integer 
For i = 1 To Len(Filter) 
ch = Mid$(Filter, i, 1)
If ch = " | " Or ch = Then 
s = s & vbNullChar
Else
s = s & ch 
End If
Next
' Put double null at end 
s = s & vbNullChar & vbNullChar 
.IpstrFilter = s
.nFilterlndex = m_Filterlndex
' Pad file and file title buffers to  maximum path 
s = filename & String$(MAX_PATH - Len(filename), 0)
.IpstrFile = s 
.nMaxFile = MAX_PATFI
s = FileTitle & String$(MAX_FILE - Len(FileTitle), 0)
.IpstrFileTitle = s
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.nMaxFileTitle = MAX_FILE 
' All other fields zero
If GetSaveFileName(opfile) Then 
VBGetSaveFileName = True
filename = left$(.IpstrFile, lnStr(.IpstrFile, vbNullChar) -1 )
FileTitle = left$(.IpstrFileTitle, lnStr(.IpstrFileTitle, vbNullChar) -1 )
m_Flags = .Flags
' Return the filter index
m_Filterlndex = .nFilterlndex
1 Look up the filter the user selected and return that
m_Filter = FilterLookup(.IpstrFilter, Filterlndex)
’save directory as init directory for user 
m JnitD ir = .IpstrFile
Else
VBGetSaveFileName = False 
filename = vbNullChar 
FileTitle = vbNullChar 
m_Flags = 0 
m_Filterlndex = 0 
m_Filter = vbNullChar 
End If 
End W ith  
End Function
Private Function FilterLookup(ByVal sFilters As String, ByVal iCur As Long) As String 
Dim iStart As Long 
Dim iEnd As Long 
Dim s As String
iStart = 1
If sFilters = vbNullChar Then Exit Function 
Do
' Cut out both parts marked by null character 
iEnd = InStrfiStart, sFilters, vbNullChar)
If iEnd = 0 Then Exit Function
iEnd = lnStr(iEnd + 1, sFilters, vbNullChar)
If iEnd Then
s = Mid$(sFilters, iStart, iEnd - iStart)
Else
s = Mid$(sFilters, iStart)
End If
iStart = iEnd + 1 
If iCur = 1 Then
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FilterLookup = s 
Exit Function 
End If
iCur = iCur - 1  
Loop While iCur 
End Function
Private Function StrZToStr(s As String) As String 
Dim TempString As String
TempString = left$(s, lnStr(s, vbNullChar) -1 )
If TempString = "" Then
'if VB string is accidently passed in there will be no NULL 
'so just pass back the original string in that case 
StrZToStr = s
Else
StrZToStr = TempString 
End If 
End Function
'This fuction is courtesy of Randy Birch and VBNet <www.mvps.org/vbnet> 
'however I changed it a bit to fit my class
Private Function GetSpecialFolderLocation(CSIDL As SPECIAL_FOLDERS) As String
Dim sPath As String 
Dim pidl As Long
'fill the idl structure with the specified folder item  
If SHGetSpecialFolderLocation(m_hWnd, CSIDL, pidl) = NOERROR Then
'if the pidl is returned, initialize 
'and get the path from the id list 
sPath = Space$(MAX_PATH)
If SHGetPathFromlDList(ByVal pidl, ByVal sPath) Then
'free the pidl and return the path 
Call CoTaskMemFree(ByVal VarPtr(pidl))
GetSpecialFolderLocation = left(sPath, lnStr(sPath, Chr$(0)) -1 )
End If 
End If
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End Function
1 Test file existence with error trapping  
Public Function ExistFile(ByVal sSpec As String) As Boolean 
On Error Resume Next 
Call FileLen(sSpec)
ExistFile = (Err = 0)
End Function
’Get FileTitle (filename w ithout path) from  any full path 
Public Function VBGetFileTitle(sFile As String) As String 
Dim sFileTitle As String, cFileTitle As Integer
cFileTitle = MAX_PATH
sFileTitle = String$(MAX_PATH, 0)
cFileTitle = GetFileTitle(sFile, sFileTitle, MAX_PATFI)
If cFileTitle Then
VBGetFileTitle = ""
Else
VBGetFileTitle = left$(sFileTitle, lnStr(sFileTitle, vbNullChar) -1 )  
End If
End Function
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Appendix E-Slices in Cases
E.l Radial blood vessels in an application case
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E.2 Achilles tendon of a professional athlete
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m
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Appendix F- More Details in Patient A
F.l Scanning 1
Volume of the neovascularization = 463 mm3
(Blue -  vascularization in the Achilles tendon, Orange -  vascularization outside the Achilles 
tendon):
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C
According to the different aspects of the neovascularization in the Achilles tendon, the 
pattern analysis was performed in two sections - upper and lower.
t
\
I j \** • Upperm ■ j v
V ‘ X  section
JT} i  Lower' 
section
r f
f I ! I *
FP-feeding point
'MT
m
-  tArtery
Upper
The upper section of the neovascularization shows a special branch type in the 3D model. 
According to the feeding analysis above, the point marked by FP near a yellow arrow is
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thought to be one of the feeders in upper section. Due to the resolution of the Doppler 
ultrasound, the hypothetical connection (marked by @) intermittently links the FP and main 
trunk (marked by MT). If we look into the neovascularization only, a rough tree-like sketch 
can be demonstrated in the graph below. The sketch is created by manually outlining the 
vascularization in the 3D model. Due to some Doppler signals are missing in slices, artificial 
connection is applied to predict an entirfe tree-like model and to observe the circulation in the 
neovessels. At the bottom of the upper section, a corridor to the lower section can be seen.
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However, the pattern changes significantly into a complicated spiral up type in the lower 
section as shown above. More feeders, which hypothetically come from tibial artery at two 
locations (marked with CD and <2) and nearby Super FPs), are coming to feed the 
neovessels. Another superior FP (marked with 0 )  is the most distinct feeder from anterior 
potential blood vessels.
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F.2 Scanning 2
Volume of the neovascularization = 9 mm3
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F.3 Scanning 3
Volume of the neovascularization = 48 mm3
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F.4 Scanning 4
Volume of the neovascularization = 117 mm3
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Appendix G-Source Codes in Controller
The first part shown below is the definition of some variables involved in the following 
software.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * *This is the variables definition in the software 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
S_L BIT PO.O ; assign left operation on joystick
S_R BIT P0.1 ; assign right operation on joystick
S_0 BIT P0.2 ; assign confirm operation on push button
S_C BIT P0.3 ; assign cancel operation on push button
LEDL BIT P0.4 ; assign left LED
LED R BIT P0.5 ; assign right LED
LEDRUNBIT P0.6 assign run LED
LEDS BIT POT ; assign stop LED
HALFFULL BIT P1.0 ; assign half/full step control bit
DIRECTION BIT P1.1 ; assign direction control bit
DOT_H BIT P1.3 ; assign LED dots
DO TL BIT P1.4 ; assign LED dots
MOTORCLK BIT P3.0 ; assign motor clock output bit
LEDONOFF EQU 30H ; assign LED status variable
LEDFLASH EQU 31H ; assign LED flash status
SEVEN_DIS EQU 32 H ; assign 7-seg display status
JOYFUNC EQU 33H ; assign joystick function variable
JOYSTEP EQU 34H assign joystick step variable
JOYFILT EQU 40H ; assign joystick filter variable
OKFUNC EQU 35H ; assign OK function variable
CALFUNC EQU 35H ; assign Cancel function variable
MOVESTEP EQU 37 H ; assign step variable
MOTORC1 EQU 38H ; assign motor variable
MOTORC2 EQU 39H ; assign motor variable
FILTER1 EQU 41H ; assign filterl variable
FILTER2 EQU 42H ; assign filter2 variable
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STAGE EQU 43H
INCREASE EQU 44H
DECREASE EQU 45H
INTERNAL EQU 46H
STEPS EQU 47H
SCAN_STEP EQU 48H
INTERNACOUNT EQU 49H
STEP COUNT EQU 50H
; assign stage variable 
; assign increase variable 
; assign decrease variable
; assign internal variable 
; assign steps variable 
; assign scan_step variable
. * * * * * * * * * *
; assign step counter 
End of the assignments * * * * * * * * * *
The main function in the software as shown below is to set a proper stack before execute the 
rest of the codes. There are three CALL functions to call for the subfunctions to test the 
seven-segment display, LED indicators, and initialize the scanning procedure, respectively. A 
JMP instruction will loop the main function in order to do another scan.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * *This is the main function 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
MAIN:
MOV SP, #55H
CALL TEST_SEVEN 
CALL TEST LED
MOV
MOV
CALL
JMP
JOYFILT, #00 
STAGE, #00 
IN TPO S
START
. * * * * * * * * * *
; set stack pointer SP=55H 
; call the test_seven subfunction 
; call the testjed subfunction
; set joyfilter=0 
; set stage=0
; call the ini_pos subfunction 
; loop 
End of the function * * * * * * * * * *
When the controller is energized, all the display devices including LED indicators and 
seven-segment display should be tested automatically to make sure the status display in the 
scanning are correct. The below is the test functions for the display devices.
. * * * * * * * * * * This is the test function * * * * * * * * * *
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. ********************************************************************************************************
TEST_SEVEN:
MOV
MOV
CALL
MOV
MOV
LOOP_7:
CALL
MOV
CALL
DJNZ
RET
COUNTUP:
MOV
ADD
DA
MOV
JMP
TEST_LED:
MOV
CALL
MOV
MOV
CALL
MOV
MOV
CALL
MOV
MOV
CALL
MOV
MOV
CALL
RET
SEVEN:
MOV
MOV
RET
LEDS:
MOV
MOV
CALL
MOV
LED_ONOFF, #0FFH; set the led initial status 
LED_FLASH, #0FFH ; set the flash variable
LEDS ; call leds subfunction
R7,#10 ; counter r7=10
SEVEN_DIS, #00H ; set 7-segment display status to 00
SEVEN 
R3, #20
DELAYF  
R7, COUNTUP
; 7-segment display on 
; delay counter r3=20 
; call delay function 
; delay
A, SEVEN DIS ; accumulator a=seven_dis
A, #11H ; a adds up with 11 h
A ; display conditioning
SEVEN_DIS, A ; put back the value to seven_dis
LOOP_7 ; loop
SEVENJDIS, #0FFH ; set seven_dis=ffh
SEVEN ; 7-segment display on
LED_ONOFF, #0EFH; led_onoff=efh 
LED_FLASH, #0EFH ; led_flash=efh
LEDS ; LEDs on
LEDONOFF, #0DFH ; led_onoff=dfh 
LEDFLASH, #0DFH; led_flash=dfh
LEDS ; LEDs on
LEDJDNOFF, #0BFH; led_onoff=bfh 
LED FLASH, #0BFH ; led_flash=bfh
LEDS ; LEDs on
LEDJDNOFF, #07FH; led_onoff=7fh 
LED FLASH, #07FH ; led_flash=7fh
LEDS
A, SEVEN_DIS 
P2, A
A, LED_ONOFF 
P0, A
D_D 
A, LED FLASH
; LEDs on
a=seven_dis 
output from p2
; a=led_onoff 
output from pO
; delay with switches detection 
a=led flash
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MOV
CALL
RET
PO, A
D D
; output from pO
; delay with switches detection
. * * * * * * * * * * End of the function * * * * * * * * * *
When the display devices tests are finished, the system will be waited for scanning settings. 
Meanwhile, the joystick can freely activate the stepper motor to drive the ultrasound probe 
travel either left or right along the rail. The functions involved are shown below.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
********** * * * * * * * * * *This is the initial position function 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
INTPOS:
MOV
CALL
INT_LOOP:
MOV
MOV
MOV
PROBE:
MOV
MOV
DIS:
MOV
CALL
JMP
SEVENJDIS, #00 
SEVEN
LEDJDNOFF, #4FH 
LED FLASH, #7FH 
JOYFUNC, #00
OKFUNC, #00 
CALFUNC, #00
; seven_dis=0
; 7-segment display on
led_onoff=4fh
led_flash=7fh
joyfunc=00, joystick used to move the probe
; okfunc=0, ok used to enter the next state 
; calfunc=0, cancel used to clear the display
, * * * * * * * * * *
MOVE J3TEP, #95 ; step set to 2mm as default
LEDS ; LEDs on
INT_LOOP ; loop
End of the function * * * * * * * * * *
During the delay necessary in the seven-segment display or LEDs operations, joystick and 
push buttons should be also taken care to determine whether they have been activated. The 
functions below are to detect the status of different buttons during the delay process, 
following a normal delay subfunction called by many places.
* * * * * * * * * * * * * * * * * * * *This is the delay function 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * DELAY WITH SWITCHES DETECTION
D D:
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DD1:
DD2:
MOV RO, #20
MOV R1, #20
JNB S_L, SW_L
JNB S_R, SW_R
JNB S_0, SW_0
JNB S_C, SW_C
MOV R2, #248 
DJNZ R2, $
DJNZ R1.DD2
DJNZ RO, DD1
RET
r0=20
r1=20
; detect joystick (left)
; detect joystick (right) 
; detect ok button 
; detect cancel button 
r2=248 
delay 
; delay 
; delay
. ***************************Q£|^y^Y WITH TIME SET 
DELAY_F:
DF1:
MOV R4, #20 ; r4=20
MOV R5, #248 ; r5=248
DJNZ R5, $ ; delay
DJNZ R4, DF2 ; delay
DJNZ R3, DF1 ; delay
RET
End of the function
There are four buttons can be used to set the system running parameters, left and right on 
joystick, ok and cancel on push buttons. The following functions are to detect and save the 
status of these buttons.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
********** j hjs js the switches detection function **********
********************************************************************************************************
***************************s w it c h e s  PROCESSING
SW_L:
SETB
PRE_FILTER:
PUSH
MOV
CJNE
FILTERING:
CALL
DIRECTION
ACC 
A, JOYFILT
A, #01, NOFILT
FILTER
; direction=1 as default
push acc to stack 
a=joyfilt 
condition jump
; call filter function 
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CH R:
SW R:
NOFILT:
JNB
JB
JMP
JB
JMP
CLR
JMP
POP
JMP
ACC
DIRECTION, CH_R ; direction determination 
S_L, PRE_JOY_PRO ; joystick preprocessing
FILTERING ; filter
S_R, PRE_JOY_PRO ; joystick preprocessing
FILTERING ; filter
DIRECTION ; clear direction variable
FILTERING ; filter
; pop acc from stack 
JOYPRO ; jump to joystick processing
. PROCESSING
PRE_JOY_PRO:
POP ACC ; pop acc from stack
JOY_PRO:
PUSH ACC ; push acc to stack
MOV A, JOYFUNC ; a=joyfunc
CJNE A, #0, JOYFUNC1 ; determine the joystick status
POP ACC ; pop acc from stack
CALL MOVING ; call driving function
RET
JOYFUNC1:
CJNE A, #1, JOYFUNC2 ; joystick status check
POP ACC ; pop acc from stack
CALL SETJVAL ; call set value function
RET
JOYFUNC2:
CJNE A, #2, JOYFUNC3 ; joystick status check
POP ACC ; pop acc from stack
CALL READY ; call ready function
JOYFUNC3:
POP ACC ; pop acc from stack
RET
***************************gyyU0l_l£5 PROCESSING OK 
SW_0:
CALL FILTER ! filter
JB S_0, OK_PRO ; check ok button
JMP SW_0 ; call operation
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OK_PRO:
PUSH ACC ; push acc to stack
MOV A, OKFUNC ; a=okfunc
CJNE A, #01, OK ; check and jump
;********** End of the function **********
After the joystick and push buttons are set by user, all the parameters will be saved in the 
variables to guide the controller driving the ultrasound probe. The settings including interval, 
step, direction are performed by the joystick, where the codes to scan the joystick are shown 
below.
This is the scan and move function 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * START SCAN
START_SCAN:
POP ACC
OK:
POP ACC
PUSH
CHECK 1:
CHECK 2:
CHECK 3:
SW C:
CJNE
CALL
CJNE
CALL
CJNE
JMP
JMP
ACC
MOV A, STAGE
; pop acc from stack
; pop acc from stack 
; push acc to stack 
; a=stage
A, #0, CHECK1  
DISTANCESET
A, #1, CHECK 2 
STEPS_SET
A, #2, CHECK 3
START SCAN
; determine the distance setting 
; call distance_set function
; determine the step setting 
; call step_set function
; determine the direction setting
: loop
End of the function
The instructions used to control the stepper motor consist of the pulse generator and counter 
used to determine whether the target steps have been finished. The running status including 
the counter down on seven-segment display and indicators are also provided to tell the
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performance of the system.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * *This is the moving and status display function 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * *
MOVING:
JB
CALL
MOVINGLOOP:
SETB
CALL
CLR
CALL
DJNZ
RET
MOVING THE PROBE
DIRECTION, SIMPLE_L 
SIMPLE_R
MOTORCLK 
DELAYMOTOR  
MOTORCLK 
DELAY MOTOR
; determine the moving direction 
; call simple_r funciton
set the bit 
call delay 
clear the bit 
call delay
MOVESTEP, MOVING_LOOP ; generate pulse wave
. ***************************gjMpLE l e d  ON WHEN MOVING THE PROBE
SIMPLEL:
SETB LED_R ; led_r dim
SETB LED_S ; led_s dim
CLR LED_L ; led_r light
CLR LED_RUN ; led_run light
JMP MOVING_LOOP ; loop
SIMPLE_R:
SETB LED L ; led j dim
SETB LED_S ; led_s dim
CLR LED_R ; led_r light
CLR LED_RUN ; led_run light
RET
SWITCH FILTER
FILTER:
F1:
MOV FILTER1, #4BH ;filter1=4bh
MOV FILTER2, #0F8H 
DJNZ FILTER2, $
DJNZ FILTER1, F1
RET
filter2=0f8h 
; loop 
; delay
End of the function
The interval, step, and direction are three main parameters during the ultrasound probe
258
The Quantification of Achilles Tendon Neovascularity
driven. Three subfunctions below record the user’s input to variables and feedback the 
settings through seven-segment display and indicators.
★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★ ★★ ★★ ★★ ★★ A****************************************************************
* * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
This is the parameters record function
r * *
* * * * * * * * * * * * * * * * * * * * * * * * * * * U ^ y £ j ^ y ^ | ^  g ^ j
DISTANCE SET:
* * * * * * * * * *
POP ACC ; pop acc from stack
MOV STAGE, #1 ; stage=1
MOV JOYFILT, #1 ; need filter
MOV INCREASE, #5 ; increase by 0.5mm
MOV DECREASE, #95H ; decrease=95h
MOV SEVEN DIS, #20H ; initial interval is 2.0mm
CLR D O T H ; change point
SETB D O T L ; change point
CALL SEVEN ; 7-seg display on
DISTANCE_LOOP:
MOV
MOV
MOV
MOV
MOV
CALL
JMP
LEDJDNOFF, #4FH 
LED_FLASH, #7FH 
JOYFUNC, #1 
OKFUNC, #0 
CALFUNC, #0 
LEDS
led status 
led flash
joystick used to set value 
; ok to enter the next state 
; cancel used to clear the display 
; leds on
DISTANCEJ_OOP ; loop
. ***************************gi"£p ^ET
STEPS SET:
POP ACC ; pop acc from stack
MOV STAGE, #2 ; stage=2
MOV JOYFILT, #1 ; need filter
MOV INCREASE, #2 ; increase by 2 step
MOV DECREASE, #98H ; decrease=98h
MOV SEVEN_DIS, #50H ; initial step 50
CLR D O T L ; change point
SETB DOT_H ; change point
CALL SEVEN ; 7-seg display on
>OP:
MOV LEDJDNOFF, #4FH ; led status
MOV LED_FLASH, #7FH ; led flash
MOV JOYFUNC, #1 ; joystick used to set value
MOV OKFUNC, #0 ; ok used to enter the next state
MOV CALFUNC, #0 ; cancel used to clear the display
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CALL
JMP
LEDS
STEP LOOP
; leds on 
; loop
. ***************************
RL SET:
RL LOOP:
DIRECTION SET
POP ACC
MOV STAGE, #3
MOV JOYFILT, #1
MOV SEVEN DIS, #0ABH
SETB D O T L
SETB D O T H
CALL SEVEN
MOV LEDJDNOFF, #4FH
MOV LED FLASH, #7FH
MOV JOYFUNC, #2 
MOV OKFUNC, #0
MOV CALFUNC, #0 
CALL LEDS
JMP RL LOOP
pop acc from stack 
; stage=3 
; need filter 
display data
; change point 
; change point 
; 7-seg display on
led status 
led flash
joystick used to set direction
; ok used to enter the next state 
cancel used to clear the display 
; leds on
; loop
. * * * * * * * * * * End of the function * * * * * * * * * *
The pulse wave used to drive the stepper motor correspond to the interval distance set by 
the user is calculated in the last section of the software demonstrated below. The rest step is 
also altered on the seven-segment display during the ultrasound probe scanning by the 
calculation in the SET_VAL function below. 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * *This is the pulse wave creation function 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
READY:
FINISHING THE SETTINGS
MOV STAGE, #4 ; stage=4
MOV JOYFILT, #0 ; need filter
MOV SEVEN JDIS, STEPS; display step
CALL SEVEN ; 7-seg display on
MOV
MOV
MOV
JOYFUNC, #3 
OKFUNC, #1 
CALFUNC, #0
; joystick is useless 
; okfunc=1 
;calfunc=0
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e a c h  STEP
SCAN R:
SCAN L:
JB
MOV
MOV
CALL
JMP
MOV
MOV
CALL
JMP
DIRECTION, SCAN L ; determine the direction
LEDONOFF, #57H 
LED_FLASH, #57H 
LEDS 
SCAN_R
LEDJDNOFF, #67H 
LED_FLASH, #67H 
LEDS 
SCAN L
led status 
led flash
; leds on 
; loop
led status 
led flash
; leds on 
; loop
MOTOR CLOCK DELAY
DELAYMOTOR:
MOV
DM1:
MOV
DJNZ
DJNZ
RET
MOTORC1, #12
MOTORC2, #150 
MOTORC2, $ 
MOTORC1, DM1
motorc1=12
motorc2=150 
; delay
; pulse wave generation
. * * * * * * * * * * * * * * * * * * * * * * * * * * * g E " j "  \/AL
SET VAL:
GOUP:
JNB
JMP
MOV
ADD
DA
MOV
PUSH
MOV
CJNE
POP
MOV
CALL
RET
GODOWN:
MOV
ADD
DA
MOV
PUSH
DIRECTION, GOUP ; count up 
GODOWN ; count down
A, SEVEN_DIS 
A, INCREASE 
A
SEVEN_DIS, A 
ACC 
A, STAGE
a=seven_dis
sum
; conditioning 
; save back to seven_dis 
; push acc into stack 
; a=stage
A, #1, STORE_STEP; store step
ACC
INTERNAL, A 
SEVEN
A, SEVEN_DIS 
A, DECREASE 
A
SEVEN_DIS, A 
ACC
pop acc from stack 
; internal=a
; 7-seg display on
a=seven_dis
deduction
; conditioning 
save back to seven jJis 
; push acc into stack
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MOV A, STAGE ; a=stage
CJNE A, #1, STORE STEP; store step
POP ACC 
MOV INTERNAL, A
CALL SEVEN
RET
STORESTEP:
POP ACC 
MOV STEPS, A 
CALL SEVEN
RET
; pop acc from stack 
; internal=a
; 7-seg display on
; pop acc from stack 
; steps=a
; 7-seg display on
END
.********** End 0f the software **********
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